<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?subarticle pgen.1009853.r001?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS Genetics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-7390</issn>
    <issn pub-type="epub">1553-7404</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8559959</article-id>
    <article-id pub-id-type="pmid">34669738</article-id>
    <article-id pub-id-type="publisher-id">PGENETICS-D-21-00900</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Computational Biology</subject>
          <subj-group>
            <subject>Genome Analysis</subject>
            <subj-group>
              <subject>Genome-Wide Association Studies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Genome Analysis</subject>
              <subj-group>
                <subject>Genome-Wide Association Studies</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Human Genetics</subject>
            <subj-group>
              <subject>Genome-Wide Association Studies</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Asthma</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pulmonology</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Asthma</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Single Nucleotide Polymorphisms</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Functional Genomics</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Computational Biology</subject>
          <subj-group>
            <subject>Genome Analysis</subject>
            <subj-group>
              <subject>Genome Annotation</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Genome Analysis</subject>
              <subj-group>
                <subject>Genome Annotation</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Mathematical and Statistical Techniques</subject>
          <subj-group>
            <subject>Statistical Methods</subject>
            <subj-group>
              <subject>Test Statistics</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Statistics</subject>
            <subj-group>
              <subject>Statistical Methods</subject>
              <subj-group>
                <subject>Test Statistics</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Computer and Information Sciences</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Engineering and Technology</subject>
        <subj-group>
          <subject>Software Engineering</subject>
          <subj-group>
            <subject>Computer Software</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR</article-title>
      <alt-title alt-title-type="running-head">Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9224-4410</contrib-id>
        <name>
          <surname>Hutchinson</surname>
          <given-names>Anna</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9993-3916</contrib-id>
        <name>
          <surname>Reales</surname>
          <given-names>Guillermo</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6138-3496</contrib-id>
        <name>
          <surname>Willis</surname>
          <given-names>Thomas</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9755-1703</contrib-id>
        <name>
          <surname>Wallace</surname>
          <given-names>Chris</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Department of Medicine, University of Cambridge, Cambridge, United Kingdom</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>Emory University School of Medicine, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>I have read the journal’s policy and the authors of this manuscript have the following competing interests: Anna Hutchinson is a GSK-sponsored iCASE student.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>anna.hutchinson@mrc-bsu.cam.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>20</day>
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <volume>17</volume>
    <issue>10</issue>
    <elocation-id>e1009853</elocation-id>
    <history>
      <date date-type="received">
        <day>1</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>30</day>
        <month>9</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Hutchinson et al</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Hutchinson et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pgen.1009853.pdf"/>
    <abstract>
      <p>Genome-wide association studies (GWAS) have identified thousands of genetic variants that are associated with complex traits. However, a stringent significance threshold is required to identify robust genetic associations. Leveraging relevant auxiliary covariates has the potential to boost statistical power to exceed the significance threshold. Particularly, abundant pleiotropy and the non-random distribution of SNPs across various functional categories suggests that leveraging GWAS test statistics from related traits and/or functional genomic data may boost GWAS discovery. While type 1 error rate control has become standard in GWAS, control of the false discovery rate can be a more powerful approach. The conditional false discovery rate (cFDR) extends the standard FDR framework by conditioning on auxiliary data to call significant associations, but current implementations are restricted to auxiliary data satisfying specific parametric distributions, typically GWAS <italic toggle="yes">p</italic>-values for related traits. We relax these distributional assumptions, enabling an extension of the cFDR framework that supports auxiliary covariates from arbitrary continuous distributions (“Flexible cFDR”). Our method can be applied iteratively, thereby supporting multi-dimensional covariate data. Through simulations we show that Flexible cFDR increases sensitivity whilst controlling FDR after one or several iterations. We further demonstrate its practical potential through application to an asthma GWAS, leveraging various functional genomic data to find additional genetic associations for asthma, which we validate in the larger, independent, UK Biobank data resource.</p>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>Genome-wide association studies (GWAS) detect regions of the human genome that are associated with various traits, including complex diseases, but the power to detect these genomic regions is currently limited by sample size. The conditional false discovery rate (cFDR) provides a tool to leverage one GWAS study to improve power in another. The motivation is that if two traits have some genetic correlation, then our interpretation of a low but not significant <italic toggle="yes">p</italic>-value for the trait of interest will differ depending on whether that SNP shows strong or absent evidence of association with the related trait. Here, we describe an extension to the cFDR framework, called “Flexible cFDR”, that controls the FDR and supports auxiliary data from arbitrary distributions, surpassing current implementations of cFDR which are restricted to leveraging GWAS <italic toggle="yes">p</italic>-values from related traits. In practice, our method can be used to iteratively leverage various types of functional genomic data with GWAS data to increase power for GWAS discovery. We describe the use of Flexible cFDR to supplement data from a GWAS of asthma with auxiliary data from functional genomic experiments. We identify associations novel to the original GWAS and validate these discoveries with reference to a larger, more highly-powered GWAS of asthma.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000266</institution-id>
            <institution>Engineering and Physical Sciences Research Council</institution>
          </institution-wrap>
        </funding-source>
        <award-id>EP/R511870/1</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9224-4410</contrib-id>
          <name>
            <surname>Hutchinson</surname>
            <given-names>Anna</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100004330</institution-id>
            <institution>GlaxoSmithKline</institution>
          </institution-wrap>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9224-4410</contrib-id>
          <name>
            <surname>Hutchinson</surname>
            <given-names>Anna</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100004440</institution-id>
            <institution>Wellcome Trust</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WT107881</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9755-1703</contrib-id>
          <name>
            <surname>Wallace</surname>
            <given-names>Chris</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award004">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100004440</institution-id>
            <institution>Wellcome Trust</institution>
          </institution-wrap>
        </funding-source>
        <award-id>WT107881</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9993-3916</contrib-id>
          <name>
            <surname>Reales</surname>
            <given-names>Guillermo</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award005">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
            <institution>Medical Research Council</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MC UU 00002/4</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9755-1703</contrib-id>
          <name>
            <surname>Wallace</surname>
            <given-names>Chris</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award006">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
            <institution>Medical Research Council</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MC UU 00002/4</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6138-3496</contrib-id>
          <name>
            <surname>Willis</surname>
            <given-names>Thomas</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award007">
        <funding-source>
          <institution>NIHR Cambridge Biomedical Research Centre</institution>
        </funding-source>
        <award-id>BRC-1215-20014</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9755-1703</contrib-id>
          <name>
            <surname>Wallace</surname>
            <given-names>Chris</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>AH is funded by the Engineering and Physical Sciences Research Council (EPSRC) <ext-link xlink:href="https://epsrc.ukri.org/" ext-link-type="uri">https://epsrc.ukri.org/</ext-link> (EP/R511870/1) and GlaxoSmithKline (GSK) <ext-link xlink:href="https://www.gsk.com/" ext-link-type="uri">https://www.gsk.com/</ext-link>. CW is funded by the Wellcome Trust <ext-link xlink:href="https://wellcome.ac.uk/" ext-link-type="uri">https://wellcome.ac.uk/</ext-link> (WT107881), the Medical Research Council (MRC) <ext-link xlink:href="https://mrc.ukri.org/" ext-link-type="uri">https://mrc.ukri.org/</ext-link> (MC UU 00002/4) and supported by the NIHR Cambridge BRC <ext-link xlink:href="https://cambridgebrc.nihr.ac.uk/" ext-link-type="uri">https://cambridgebrc.nihr.ac.uk/</ext-link> (BRC-1215-20014). GR is funded by the Wellcome Trust <ext-link xlink:href="https://wellcome.ac.uk/" ext-link-type="uri">https://wellcome.ac.uk/</ext-link> (WT107881). TW is funded by the Medical Research Council (MRC) <ext-link xlink:href="https://mrc.ukri.org/" ext-link-type="uri">https://mrc.ukri.org/</ext-link> (MC UU 00002/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="6"/>
      <table-count count="4"/>
      <page-count count="37"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2021-11-01</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>All the data underlying this study are publicly available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.5554628" ext-link-type="uri">https://doi.org/10.5281/zenodo.5554628</ext-link>. This resource contains the full results for Applications 1 and 2. The methods were run using the following data: 1) Publicly available GWAS summary statistics (<ext-link xlink:href="https://www.ebi.ac.uk/gwas/studies/GCST006862" ext-link-type="uri">https://www.ebi.ac.uk/gwas/studies/GCST006862</ext-link>). 2) Publicly available GenoCanyon scores (<ext-link xlink:href="http://zhaocenter.org/GenoCanyon_Downloads.html" ext-link-type="uri">http://zhaocenter.org/GenoCanyon_Downloads.html</ext-link>). 3) Publicly available H3K27ac ChIP-seq data from NIH Roadmap (<ext-link xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/" ext-link-type="uri">https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/</ext-link>). All other relevant data are available within the manuscript and its <xref rid="sec032" ref-type="sec">Supporting information</xref> files.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>All the data underlying this study are publicly available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.5554628" ext-link-type="uri">https://doi.org/10.5281/zenodo.5554628</ext-link>. This resource contains the full results for Applications 1 and 2. The methods were run using the following data: 1) Publicly available GWAS summary statistics (<ext-link xlink:href="https://www.ebi.ac.uk/gwas/studies/GCST006862" ext-link-type="uri">https://www.ebi.ac.uk/gwas/studies/GCST006862</ext-link>). 2) Publicly available GenoCanyon scores (<ext-link xlink:href="http://zhaocenter.org/GenoCanyon_Downloads.html" ext-link-type="uri">http://zhaocenter.org/GenoCanyon_Downloads.html</ext-link>). 3) Publicly available H3K27ac ChIP-seq data from NIH Roadmap (<ext-link xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/" ext-link-type="uri">https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/</ext-link>). All other relevant data are available within the manuscript and its <xref rid="sec032" ref-type="sec">Supporting information</xref> files.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>Genome-wide association studies (GWAS) identify risk loci for a phenotype by assaying single nucleotide polymorphisms (SNPs) in large participant cohorts and marginally testing for associations between each SNP and the phenotype of interest. Conducting univariate tests for each SNP in parallel presents a huge multiple testing problem for which a stringent <italic toggle="yes">p</italic>-value threshold is required to confidently call significant associations.</p>
    <p>The statistical power to detect associations can be increased by leveraging relevant auxiliary covariates. For example, pervasive pleiotropy throughout the genome [<xref rid="pgen.1009853.ref001" ref-type="bibr">1</xref>] suggests that leveraging GWAS test statistics for related traits may be beneficial, whilst the non-random distribution of trait-associated SNPs across various functional categories [<xref rid="pgen.1009853.ref002" ref-type="bibr">2</xref>] suggests that incorporating functional genomic data may also be useful. In fact, the expansive range of relevant auxiliary covariates has accumulated in a wealth of covariate-informed multiple testing methods which leverage auxiliary covariates (e.g. SNP-level data) with test statistics for variables (e.g. GWAS <italic toggle="yes">p</italic>-values for SNPs) to increase statistical power. These methods have been extensively researched both in the statistical literature [<xref rid="pgen.1009853.ref003" ref-type="bibr">3</xref>–<xref rid="pgen.1009853.ref013" ref-type="bibr">13</xref>] and specifically in the context of GWAS [<xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>–<xref rid="pgen.1009853.ref022" ref-type="bibr">22</xref>] with a consistent aim of minimizing type-2 errors (or equivalently increasing statistical power) whilst controlling some appropriate type-1 error rate, such as the false discovery rate (FDR).</p>
    <p>The conventional multiple testing correction procedures control some error measure by assuming that each hypothesis is equally likely <italic toggle="yes">a priori</italic> to be true or false. For example, the Bejamini-Hochberg (BH) procedure [<xref rid="pgen.1009853.ref023" ref-type="bibr">23</xref>] provides nearly optimal control of the FDR under the condition that almost all null hypotheses are true [<xref rid="pgen.1009853.ref010" ref-type="bibr">10</xref>]. The simplest extension to incorporate covariates is independent filtering [<xref rid="pgen.1009853.ref009" ref-type="bibr">9</xref>] whereby test statistics are first censored based on the value of the covariate and a multiple testing method (for example, the BH procedure) is then applied on the remaining subset of test statistics. Alternatively, the test statistics can be grouped based on covariate values and the BH procedure can be applied separately within each group, as in stratified FDR [<xref rid="pgen.1009853.ref004" ref-type="bibr">4</xref>]. However, these simplistic approaches do not make full use of the information contained within the covariate values and require subjective covariate thresholding which may lead to data dredging bias [<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>].</p>
    <p>Insinuating a more unified approach of incorporating covariates, the conventional multiple testing correction procedures can incorporate weights for each variable, such that the raw test statistics are no longer considered exchangeable [<xref rid="pgen.1009853.ref024" ref-type="bibr">24</xref>, <xref rid="pgen.1009853.ref025" ref-type="bibr">25</xref>]. However, it is non-trivial to convert covariate values to weights satisfying certain constraints required for type-1 error rate control (typically non-negative weights that average 1 [<xref rid="pgen.1009853.ref019" ref-type="bibr">19</xref>]), and consequently the covariate values are typically still only used in an initial stratification step. For example, the grouped Benjamini-Hochberg (GBH) procedure [<xref rid="pgen.1009853.ref005" ref-type="bibr">5</xref>] groups test statistics based on covariate values and derives group-specific weights that are proportional to the estimated proportion of true nulls in each group, whilst the independent hypothesis weighting (IHW) method calculates optimal group-specific weights which maximise the number of discoveries, whilst controlling the FDR [<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>]. In the GWAS setting, the FINDOR method (which was shown to be generally less powerful, but superior in terms of false positive findings, to stratified FDR, GBH and IHW methods) was developed to leverage auxiliary data relating to how well SNPs tag functional categories that are enriched for heritability with GWAS test statistics [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>, <xref rid="pgen.1009853.ref026" ref-type="bibr">26</xref>, <xref rid="pgen.1009853.ref027" ref-type="bibr">27</xref>]. SNPs are grouped based on the auxiliary data and group-specific weights, that are proportional to the ratio of the estimated proportion of alternative to null SNPs in each group [<xref rid="pgen.1009853.ref005" ref-type="bibr">5</xref>, <xref rid="pgen.1009853.ref028" ref-type="bibr">28</xref>], are derived for use in a weighted Bonferroni procedure [<xref rid="pgen.1009853.ref003" ref-type="bibr">3</xref>]. The FINDOR methodology is similar to that of the GBH procedure, but includes an additional step whereby the weights are normalised to average 1. This normalisation step is significant because Roeder et al. [<xref rid="pgen.1009853.ref019" ref-type="bibr">19</xref>] demonstrated that using a data-dependent weighting scheme with weights that average to 1 preserves control of type-1 error with high probability if the number of weights learned is significantly less than number of hypothesis test performed [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>]. Whilst grouping-based approaches are satisfactory when they capture all information provided by the covariate, as is possible in the case of categorical covariates, this assumption is restrictive in the case of continuous covariates or more complex multi-dimensional covariate spaces. Moreover, subjective thresholding and coarse binning is generally required, meaning that the entire dynamic range of the auxiliary data is often not fully exploited (for example, applying FINDOR to Biobank style data with the recommended 100 bins results in bins containing approximately 100K SNPs within which covariate values will vary).</p>
    <p>Other notable methods in the GWAS literature include those that require subjective thresholding, such as GenoWAP [<xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>], or those that require additional knowledge, such as the distribution of the true effect size [<xref rid="pgen.1009853.ref019" ref-type="bibr">19</xref>–<xref rid="pgen.1009853.ref021" ref-type="bibr">21</xref>]. GenoWAP was developed to leverage scores of SNP functionality (called “GenoCanyon scores” [<xref rid="pgen.1009853.ref029" ref-type="bibr">29</xref>]) with GWAS test statistics and includes a thresholding step to define “functional” SNPs. Related methods in the statistical literature include those which estimate the proportion of true null hypotheses conditional on observed covariates and use these as plug-in estimates for the FDR [<xref rid="pgen.1009853.ref030" ref-type="bibr">30</xref>], such as Boca and Leek’s FDR regression [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>], those utilising local false discovery rates (defined as the posterior probability that a variable is null given the observed test statistic [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>]) [<xref rid="pgen.1009853.ref007" ref-type="bibr">7</xref>, <xref rid="pgen.1009853.ref033" ref-type="bibr">33</xref>, <xref rid="pgen.1009853.ref034" ref-type="bibr">34</xref>] and those that focus power on more promising hypotheses [<xref rid="pgen.1009853.ref010" ref-type="bibr">10</xref>, <xref rid="pgen.1009853.ref011" ref-type="bibr">11</xref>, <xref rid="pgen.1009853.ref035" ref-type="bibr">35</xref>, <xref rid="pgen.1009853.ref036" ref-type="bibr">36</xref>]. Specifically, the AdaPT method [<xref rid="pgen.1009853.ref010" ref-type="bibr">10</xref>] adaptively estimates a Bayes optimal <italic toggle="yes">p</italic>-value rejection threshold, but this requires a SNP filtering stage in the GWAS context due to high computational demand [<xref rid="pgen.1009853.ref037" ref-type="bibr">37</xref>]. A comprehensive overview of these statistical methods for covariate-informed multiple testing is provided by Ignatiadis and Huber [<xref rid="pgen.1009853.ref038" ref-type="bibr">38</xref>].</p>
    <p>The conditional FDR (cFDR) approach developed and applied by Andreassen and colleagues [<xref rid="pgen.1009853.ref039" ref-type="bibr">39</xref>–<xref rid="pgen.1009853.ref043" ref-type="bibr">43</xref>] is a natural extension to the FDR in the presence of auxiliary covariates. This intuitive approach mitigates many of the aforementioned shortcomings: it does not bin variables and thus makes full use of the dynamic range of covariate values, it does not include any subjective thresholding, and does not require the definition of a normalised weighting scheme. However, it was designed for a very specific setting, that is to increase GWAS discovery (in the “principal trait”) by leveraging GWAS test statistics from a genetically related (“conditional”) trait.</p>
    <p>We were interested to see whether a more general form of cFDR could address the same covariate-informed multiple testing problems as the range of methods listed above. Here, we describe “Flexible cFDR”, a new cFDR framework [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] that enjoys all of the benefits of the conventional cFDR approach but now supports continuous auxiliary data from arbitrary distributions, thus enabling broader applicability. Specifically, our computationally efficient approach extends the usage of cFDR beyond only GWAS to the accelerating field of functional genomics and can be applied iteratively to incorporate additional layers of data. Integrating functional genomic data with GWAS test statistics is not a new concept, and is motivated by SNP enrichment studies [<xref rid="pgen.1009853.ref002" ref-type="bibr">2</xref>, <xref rid="pgen.1009853.ref016" ref-type="bibr">16</xref>, <xref rid="pgen.1009853.ref045" ref-type="bibr">45</xref>, <xref rid="pgen.1009853.ref046" ref-type="bibr">46</xref>]. For example, Pickrell [<xref rid="pgen.1009853.ref016" ref-type="bibr">16</xref>] found that loci that associated with serum high-density lipoprotein (HDL) concentrations were enriched for several functional annotations, including enhancer regions in HepG2 cells and coding exons. When using their “fgwas” model to integrate these functional annotations with GWAS test statistics, they were able to identify new loci that robustly associated with HDL concentrations. However, the fgwas approach outputs posterior probabilities rather than <italic toggle="yes">p</italic>-values, as are typical in GWAS, and currently only supports binary auxiliary data. In contrast, Flexible cFDR outputs quantities analogous to <italic toggle="yes">p</italic>-values and also supports a wide range of auxiliary data types, including (but not limited to) continuous data derived from functional genomic experiments (e.g. fold change values from ATAC-seq or ChIP-seq) and GWAS-related values (e.g. allele frequencies, sample sizes, Bayes factors or <italic toggle="yes">p</italic>-values).</p>
    <p>We show through detailed simulations that Flexible cFDR increases sensitivity whilst controlling the FDR, and performs as well or better than the existing cFDR framework in the subset of use-cases supported by the latter. We demonstrate the utility of our method by leveraging a variety of functional genomic data with GWAS <italic toggle="yes">p</italic>-values for asthma [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>] to prioritise new genetic associations, and compare our results to those from four existing methods which have previously been shown to outperform other approaches [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>, <xref rid="pgen.1009853.ref048" ref-type="bibr">48</xref>]: Boca and Leek’s FDR regression [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>], a Bayesian approach, GenoWAP [<xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>] and two grouping-based approaches, IHW [<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>] and FINDOR [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>]. We evaluate results according to validation status in the larger, independent, UK Biobank data set [<xref rid="pgen.1009853.ref049" ref-type="bibr">49</xref>].</p>
  </sec>
  <sec sec-type="materials|methods" id="sec002">
    <title>Materials and methods</title>
    <sec id="sec003">
      <title>Conditional false discovery rate</title>
      <p>We begin by restating the definition and empirical estimator of the conditional Bayesian false discovery rate (cFDR). Consider <italic toggle="yes">p</italic>-values for <italic toggle="yes">m</italic> SNPs, denoted by <italic toggle="yes">p</italic><sub>1</sub>, …, <italic toggle="yes">p</italic><sub><italic toggle="yes">m</italic></sub>, corresponding to the null hypotheses of no association between the SNP and a principal trait (denoted by <inline-formula id="pgen.1009853.e001"><alternatives><graphic xlink:href="pgen.1009853.e001.jpg" id="pgen.1009853.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula>). Let <italic toggle="yes">p</italic><sub>1</sub>, …, <italic toggle="yes">p</italic><sub><italic toggle="yes">m</italic></sub> be realisations from the random variable <italic toggle="yes">P</italic>. The Bayesian false discovery rate (FDR) is defined as the probability that the null hypothesis is true for a random SNP in a set of SNPs with <italic toggle="yes">P</italic> ≤ <italic toggle="yes">p</italic>:
<disp-formula id="pgen.1009853.e002"><alternatives><graphic xlink:href="pgen.1009853.e002.jpg" id="pgen.1009853.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula>
This Bayesian definition of a tail area FDR [<xref rid="pgen.1009853.ref050" ref-type="bibr">50</xref>] is asymptotically equivalent [<xref rid="pgen.1009853.ref051" ref-type="bibr">51</xref>] to the FDR introduced by Benjamini and Hochberg [<xref rid="pgen.1009853.ref023" ref-type="bibr">23</xref>], which is the expected fraction of false discoveries amongst all discoveries.</p>
      <p>Given additional <italic toggle="yes">p</italic>-values, <italic toggle="yes">q</italic><sub>1</sub>, …, <italic toggle="yes">q</italic><sub><italic toggle="yes">m</italic></sub>, for the same <italic toggle="yes">m</italic> SNPs for a “conditional trait”, the Bayesian FDR can be extended to the conditional Bayesian FDR (cFDR) by conditioning on both the principal and the conditional trait variables (in contrast to the standard FDR which conditions only on the principal trait variable). Assuming that <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub> and <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> (for <italic toggle="yes">i</italic> = 1, …, <italic toggle="yes">m</italic>) are independent and identically distributed (iid) realisations of random variables <italic toggle="yes">P</italic>, <italic toggle="yes">Q</italic> satisfying:
<disp-formula id="pgen.1009853.e003"><alternatives><graphic xlink:href="pgen.1009853.e003.jpg" id="pgen.1009853.e003g" position="anchor"/><mml:math id="M3" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>∼</mml:mo><mml:mi>U</mml:mi><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mi>P</mml:mi></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo>⫫</mml:mo><mml:mi>Q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula>
then the cFDR is defined as the probability <inline-formula id="pgen.1009853.e004"><alternatives><graphic xlink:href="pgen.1009853.e004.jpg" id="pgen.1009853.e004g" position="anchor"/><mml:math id="M4" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> is true at a random SNP given that the observed <italic toggle="yes">p</italic>-values at that SNP are less than or equal to <italic toggle="yes">p</italic> in the principal trait and <italic toggle="yes">q</italic> in the conditional trait [<xref rid="pgen.1009853.ref039" ref-type="bibr">39</xref>]. Using Bayes theorem,
<disp-formula id="pgen.1009853.e005"><alternatives><graphic xlink:href="pgen.1009853.e005.jpg" id="pgen.1009853.e005g" position="anchor"/><mml:math id="M5" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>|</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula></p>
      <p>The cFDR framework implicitly assumes that there is a “positive stochastic monotonic relationship” between <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic>, meaning that on average SNPs with smaller <italic toggle="yes">p</italic>-values in the conditional trait are enriched for smaller <italic toggle="yes">p</italic>-values in the principal trait. This assumption is naturally satisfied in the typical use-case of cFDR that leverages <italic toggle="yes">p</italic>-values for genetically related traits.</p>
      <p>Using Bayes theorem and standard conditional probability rules, <xref rid="pgen.1009853.e005" ref-type="disp-formula">Eq (3)</xref> can be simplified to:
<disp-formula id="pgen.1009853.e006"><alternatives><graphic xlink:href="pgen.1009853.e006.jpg" id="pgen.1009853.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula>
[<xref rid="pgen.1009853.ref052" ref-type="bibr">52</xref>].</p>
      <p>It is conventional in the cFDR literature to conservatively approximate <inline-formula id="pgen.1009853.e007"><alternatives><graphic xlink:href="pgen.1009853.e007.jpg" id="pgen.1009853.e007g" position="anchor"/><mml:math id="M7" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo><mml:mo>≈</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>, and this is reasonable in the GWAS setting where the proportion of true signals is expected to be very low (this may be debateable as sample sizes increase, but it is still appropriate in terms of being conservative). Given the assumptions in Property (<xref rid="pgen.1009853.e003" ref-type="disp-formula">2</xref>), we can also approximate <inline-formula id="pgen.1009853.e008"><alternatives><graphic xlink:href="pgen.1009853.e008.jpg" id="pgen.1009853.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo><mml:mo>≈</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>, noting that this is an equality if <italic toggle="yes">p</italic> is correctly calibrated. The estimated cFDR is therefore:
<disp-formula id="pgen.1009853.e009"><alternatives><graphic xlink:href="pgen.1009853.e009.jpg" id="pgen.1009853.e009g" position="anchor"/><mml:math id="M9" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula>
and existing methods use empirical cumulative distribution functions (CDFs) to estimate <inline-formula id="pgen.1009853.e010"><alternatives><graphic xlink:href="pgen.1009853.e010.jpg" id="pgen.1009853.e010g" position="anchor"/><mml:math id="M10" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and <italic toggle="yes">Pr</italic>(<italic toggle="yes">P</italic> ≤ <italic toggle="yes">p</italic>, <italic toggle="yes">Q</italic> ≤ <italic toggle="yes">q</italic>) [<xref rid="pgen.1009853.ref039" ref-type="bibr">39</xref>, <xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>].</p>
      <p>Having derived <inline-formula id="pgen.1009853.e011"><alternatives><graphic xlink:href="pgen.1009853.e011.jpg" id="pgen.1009853.e011g" position="anchor"/><mml:math id="M11" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> values for each <italic toggle="yes">p</italic>-value-covariate pair, a simple rejection rule would be to reject <inline-formula id="pgen.1009853.e012"><alternatives><graphic xlink:href="pgen.1009853.e012.jpg" id="pgen.1009853.e012g" position="anchor"/><mml:math id="M12" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> for any <inline-formula id="pgen.1009853.e013"><alternatives><graphic xlink:href="pgen.1009853.e013.jpg" id="pgen.1009853.e013g" position="anchor"/><mml:math id="M13" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>≤</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>, for 0 &lt; <italic toggle="yes">α</italic> &lt; 1. However, as discussed in Liley and Wallace [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>], <inline-formula id="pgen.1009853.e014"><alternatives><graphic xlink:href="pgen.1009853.e014.jpg" id="pgen.1009853.e014g" position="anchor"/><mml:math id="M14" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> is not monotonically increasing with <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub> and we do not wish to reject the null for some (<italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub>) but not for some other pair (<italic toggle="yes">p</italic><sub><italic toggle="yes">j</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">j</italic></sub>) with <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> = <italic toggle="yes">q</italic><sub><italic toggle="yes">j</italic></sub> but <italic toggle="yes">p</italic><sub><italic toggle="yes">j</italic></sub> &lt; <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>.</p>
      <p>Andreassen et al. [<xref rid="pgen.1009853.ref039" ref-type="bibr">39</xref>] use the decision rule:
<disp-formula id="pgen.1009853.e015"><alternatives><graphic xlink:href="pgen.1009853.e015.jpg" id="pgen.1009853.e015g" position="anchor"/><mml:math id="M15" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>Reject</mml:mtext><mml:mspace width="4pt"/><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mspace width="4pt"/><mml:mtext>if:</mml:mtext><mml:mspace width="4pt"/><mml:mo>∃</mml:mo><mml:mspace width="4pt"/><mml:msup><mml:mi>p</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>≥</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>:</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msup><mml:mi>p</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>≤</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula>
which closely follows the BH procedure [<xref rid="pgen.1009853.ref023" ref-type="bibr">23</xref>]. Yet unlike the BH procedure, this rejection rule does not control frequentist FDR at <italic toggle="yes">α</italic> [<xref rid="pgen.1009853.ref052" ref-type="bibr">52</xref>]. Liley and Wallace [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] described a method to transform the cFDR estimates into “<italic toggle="yes">v</italic>-values”, which are analogous to <italic toggle="yes">p</italic>-values and can be used to control FDR (e.g. in the BH procedure). However this approach is currently only suited to instances where the auxiliary data may be modelled using a mixture of centered normal distributions (for example by transforming auxiliary <italic toggle="yes">p</italic>-values to <italic toggle="yes">Z</italic> scores; <inline-formula id="pgen.1009853.e016"><alternatives><graphic xlink:href="pgen.1009853.e016.jpg" id="pgen.1009853.e016g" position="anchor"/><mml:math id="M16" display="inline" overflow="scroll"><mml:mrow><mml:mi>q</mml:mi><mml:mo>≔</mml:mo><mml:mo>-</mml:mo><mml:msup><mml:mi>ϕ</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mi>q</mml:mi><mml:mn>2</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>).</p>
    </sec>
    <sec id="sec004">
      <title>Flexible cFDR</title>
      <p>The cFDR estimator in <xref rid="pgen.1009853.e009" ref-type="disp-formula">Eq (5)</xref> holds in the more general setting where <italic toggle="yes">q</italic><sub>1</sub>, …, <italic toggle="yes">q</italic><sub><italic toggle="yes">m</italic></sub> are real continuous values from some arbitrary distribution that is positively stochastically monotonic in <italic toggle="yes">p</italic>. However, the current methods were designed with specific assumptions about the distribution of the auxiliary data (<italic toggle="yes">p</italic>-values from related traits and thus bounded by [0, 1]). Sparse data regions are likely to be found more often in unbounded auxiliary data from arbitrary distributions (for example near the extreme observations) and empirical CDFs are typically inaccurate in sparse data regions because they are step functions. Moreover, the method used to control the frequentist FDR [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] assumes auxiliary data can be modelled using a mixture of centered Gaussian distributions, meaning that it is not yet applicable for auxiliary data from arbitrary distributions. We consequently describe a new, more versatile cFDR framework for data pairs consisting of <italic toggle="yes">p</italic>-values for the principal trait (<italic toggle="yes">p</italic>) and continuous covariates from more general distributions (<italic toggle="yes">q</italic>). We call our method “Flexible cFDR” and show that it is naturally suited to leveraging functional genomic data, which is not typically Gaussian.</p>
      <sec id="sec005">
        <title>Flexible cFDR estimator</title>
        <p>To estimate both <inline-formula id="pgen.1009853.e017"><alternatives><graphic xlink:href="pgen.1009853.e017.jpg" id="pgen.1009853.e017g" position="anchor"/><mml:math id="M17" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and <italic toggle="yes">Pr</italic>(<italic toggle="yes">P</italic> ≤ <italic toggle="yes">p</italic>, <italic toggle="yes">Q</italic> ≤ <italic toggle="yes">q</italic>) in <xref rid="pgen.1009853.e009" ref-type="disp-formula">Eq (5)</xref> we first fit a bivariate kernel density estimate (KDE) using a normal kernel. To do this, we transform the <italic toggle="yes">p</italic>-values for the principal trait (derived from a two-tailed test, as is typical in GWAS) to absolute <italic toggle="yes">Z</italic>-scores (<italic toggle="yes">Z</italic><sub><italic toggle="yes">p</italic></sub>; since the sign of the associated <italic toggle="yes">Z</italic>-scores are essential arbitrary as they depend on which allele is designated “effect’). Since the absolute <italic toggle="yes">Z</italic>-scores are bounded by 0, the KDE will penalise the lack of negative data points and may underestimate the true density in regions close to 0. To avoid this boundary effect, we mirror the absolute <italic toggle="yes">Z</italic>-scores onto the negative real line together with their associated <italic toggle="yes">Q</italic> values but only estimate the KDE on the non-negative part of the data, akin to the “reflection technique” described by Silverman [<xref rid="pgen.1009853.ref053" ref-type="bibr">53</xref>]. We consequently model the PDF corresponding to <italic toggle="yes">Z</italic><sub><italic toggle="yes">p</italic></sub>, <italic toggle="yes">Q</italic> in the usual way as
<disp-formula id="pgen.1009853.e018"><alternatives><graphic xlink:href="pgen.1009853.e018.jpg" id="pgen.1009853.e018g" position="anchor"/><mml:math id="M18" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac></mml:mstyle><mml:munder><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mi>ϕ</mml:mi><mml:mo>(</mml:mo><mml:msqrt><mml:mrow><mml:mo>(</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>x</mml:mi><mml:mo>-</mml:mo><mml:mo>{</mml:mo><mml:mo>-</mml:mo><mml:msup><mml:mi>ϕ</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mn>2</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mfrac></mml:mstyle><mml:msup><mml:mo>)</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>y</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mfrac></mml:mstyle><mml:msup><mml:mo>)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula>
where <italic toggle="yes">ϕ</italic> is the standard normal density and the values <italic toggle="yes">σ</italic><sub><italic toggle="yes">p</italic></sub> and <italic toggle="yes">σ</italic><sub><italic toggle="yes">q</italic></sub> are the bandwidths determined using a well-supported rule-of-thumb [<xref rid="pgen.1009853.ref054" ref-type="bibr">54</xref>], which assumes independent samples. Consequently, we fit the KDE to a subset of independent SNPs in the data set (independent SNP sets can be readily found using a variety of software packages including LDAK [<xref rid="pgen.1009853.ref055" ref-type="bibr">55</xref>] and PLINK [<xref rid="pgen.1009853.ref056" ref-type="bibr">56</xref>]). We integrate over <italic toggle="yes">P</italic> and <italic toggle="yes">Q</italic> to estimate <italic toggle="yes">Pr</italic>(<italic toggle="yes">P</italic> ≤ <italic toggle="yes">p</italic>, <italic toggle="yes">Q</italic> ≤ <italic toggle="yes">q</italic>).</p>
        <p>Hard thresholding is used to approximate the distribution of <inline-formula id="pgen.1009853.e019"><alternatives><graphic xlink:href="pgen.1009853.e019.jpg" id="pgen.1009853.e019g" position="anchor"/><mml:math id="M19" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> by <italic toggle="yes">Q</italic>|<italic toggle="yes">P</italic> &gt; 1/2 in the earlier cFDR methods [<xref rid="pgen.1009853.ref039" ref-type="bibr">39</xref>, <xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>]. Instead, in Flexible cFDR we empirically evaluate the influence of specific <italic toggle="yes">p</italic>-value quantities on the null hypothesis by utilising local false discovery rates, which estimate <inline-formula id="pgen.1009853.e020"><alternatives><graphic xlink:href="pgen.1009853.e020.jpg" id="pgen.1009853.e020g" position="anchor"/><mml:math id="M20" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>]. We approximate <inline-formula id="pgen.1009853.e021"><alternatives><graphic xlink:href="pgen.1009853.e021.jpg" id="pgen.1009853.e021g" position="anchor"/><mml:math id="M21" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> assuming that the majority of information about <inline-formula id="pgen.1009853.e022"><alternatives><graphic xlink:href="pgen.1009853.e022.jpg" id="pgen.1009853.e022g" position="anchor"/><mml:math id="M22" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> is contained in <italic toggle="yes">P</italic> so that
<disp-formula id="pgen.1009853.e023"><alternatives><graphic xlink:href="pgen.1009853.e023.jpg" id="pgen.1009853.e023g" position="anchor"/><mml:math id="M23" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>≈</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula>
where <italic toggle="yes">Pr</italic>(<italic toggle="yes">P</italic> = <italic toggle="yes">p</italic>, <italic toggle="yes">Q</italic> = <italic toggle="yes">q</italic>) is estimated from our bivariate KDE and <inline-formula id="pgen.1009853.e024"><alternatives><graphic xlink:href="pgen.1009853.e024.jpg" id="pgen.1009853.e024g" position="anchor"/><mml:math id="M24" display="inline" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>|</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> is estimated using the local false discovery rate. In order to avoid boundary effects, we mirror the absolute <italic toggle="yes">Z</italic>-scores onto the negative real line and extract only the local false discovery rates for the non-negative part of the data, utilising the <monospace>locfdr</monospace> R package (<ext-link xlink:href="https://cran.r-project.org/web/packages/locfdr/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/locfdr/index.html</ext-link>) to do this.</p>
        <p>We therefore have that
<disp-formula id="pgen.1009853.e025"><alternatives><graphic xlink:href="pgen.1009853.e025.jpg" id="pgen.1009853.e025g" position="anchor"/><mml:math id="M25" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mfrac></mml:mstyle><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula>
where <inline-formula id="pgen.1009853.e026"><alternatives><graphic xlink:href="pgen.1009853.e026.jpg" id="pgen.1009853.e026g" position="anchor"/><mml:math id="M26" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is derived by integrating <xref rid="pgen.1009853.e023" ref-type="disp-formula">Eq (8)</xref> over P and <inline-formula id="pgen.1009853.e027"><alternatives><graphic xlink:href="pgen.1009853.e027.jpg" id="pgen.1009853.e027g" position="anchor"/><mml:math id="M27" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is derived by integrating <xref rid="pgen.1009853.e023" ref-type="disp-formula">Eq (8)</xref> over P and Q. We then integrate over Q to obtain
<disp-formula id="pgen.1009853.e028"><alternatives><graphic xlink:href="pgen.1009853.e028.jpg" id="pgen.1009853.e028g" position="anchor"/><mml:math id="M28" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mfrac></mml:mstyle><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(10)</label></disp-formula>
where we use ^ to denote that these are estimates under the assumption <inline-formula id="pgen.1009853.e029"><alternatives><graphic xlink:href="pgen.1009853.e029.jpg" id="pgen.1009853.e029g" position="anchor"/><mml:math id="M29" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mrow><mml:mo>⫫</mml:mo><mml:mi>Q</mml:mi><mml:mo>|</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>.</p>
        <p>Our final cFDR estimator is therefore:
<disp-formula id="pgen.1009853.e030"><alternatives><graphic xlink:href="pgen.1009853.e030.jpg" id="pgen.1009853.e030g" position="anchor"/><mml:math id="M30" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mo>×</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mi>∞</mml:mi></mml:mrow><mml:mi>q</mml:mi></mml:msubsup><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow><mml:mi>∞</mml:mi></mml:msubsup><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mi>d</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(11)</label></disp-formula>
where <italic toggle="yes">z</italic><sub><italic toggle="yes">p</italic></sub> is the <italic toggle="yes">Z</italic>-score associated with <italic toggle="yes">p</italic>.</p>
        <p>As in the conventional cFDR approach, our estimator implicitly assumes a positive stochastic monotonic relationship between <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic>. However, this is not guaranteed for the more general covariates that can now be leveraged with Flexible cFDR. If instead this relationship is negative (such that low <italic toggle="yes">p</italic>-values are enriched for high values of <italic toggle="yes">q</italic>), then the sign of the auxiliary data values can simply be reversed and the method can proceed as usual.</p>
      </sec>
      <sec id="sec006">
        <title>Mapping p-value-covariate pairs to v-values</title>
        <p>We describe a similar approach to that by Liley and Wallace [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] but remove the restrictive parametric assumptions placed on the auxiliary data.</p>
        <p>Following Liley and Wallace [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>], we define “L-regions” as the set of points with <inline-formula id="pgen.1009853.e031"><alternatives><graphic xlink:href="pgen.1009853.e031.jpg" id="pgen.1009853.e031g" position="anchor"/><mml:math id="M31" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>≤</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> and the “L-curve” as the rightmost border of the L-region, found through calculating <inline-formula id="pgen.1009853.e032"><alternatives><graphic xlink:href="pgen.1009853.e032.jpg" id="pgen.1009853.e032g" position="anchor"/><mml:math id="M32" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> values for <italic toggle="yes">p</italic>, <italic toggle="yes">q</italic> pairs defined using a two-dimensional grid of <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic> values. For each observed <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> pair we find the L-curve, which corresponds to the contour of estimated <inline-formula id="pgen.1009853.e033"><alternatives><graphic xlink:href="pgen.1009853.e033.jpg" id="pgen.1009853.e033g" position="anchor"/><mml:math id="M33" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. We then define the L-region from this L-curve.</p>
        <p>We derive <italic toggle="yes">v</italic>-values, which are essentially the probability of a newly-sampled realisation (<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>) of <italic toggle="yes">P</italic>, <italic toggle="yes">Q</italic> falling in the L-region under <inline-formula id="pgen.1009853.e034"><alternatives><graphic xlink:href="pgen.1009853.e034.jpg" id="pgen.1009853.e034g" position="anchor"/><mml:math id="M34" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula>. These are readily calculable by integrating the PDF of <inline-formula id="pgen.1009853.e035"><alternatives><graphic xlink:href="pgen.1009853.e035.jpg" id="pgen.1009853.e035g" position="anchor"/><mml:math id="M35" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>, denoted by <italic toggle="yes">f</italic><sub>0</sub>(<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>), over the L-region:
<disp-formula id="pgen.1009853.e036"><alternatives><graphic xlink:href="pgen.1009853.e036.jpg" id="pgen.1009853.e036g" position="anchor"/><mml:math id="M36" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>v</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>∈</mml:mo><mml:mi>L</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mo>∫</mml:mo><mml:mrow><mml:mi>L</mml:mi><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>p</mml:mi><mml:mi>d</mml:mi><mml:mi>q</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(12)</label></disp-formula>
[<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>]. In the original method, <italic toggle="yes">f</italic><sub>0</sub>(<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>) is estimated using a mixture-Gaussian distribution, but to support auxiliary data from arbitrary distributions (where the only distributional constraint is that it is positively stochastically monotonic in <italic toggle="yes">p</italic>) we utilise the assumptions in Property (<xref rid="pgen.1009853.e003" ref-type="disp-formula">2</xref>) to write <inline-formula id="pgen.1009853.e037"><alternatives><graphic xlink:href="pgen.1009853.e037.jpg" id="pgen.1009853.e037g" position="anchor"/><mml:math id="M37" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mi>f</mml:mi><mml:mn>0</mml:mn><mml:mi>q</mml:mi></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> (since the PDF of <italic toggle="yes">p</italic> conditional on <inline-formula id="pgen.1009853.e038"><alternatives><graphic xlink:href="pgen.1009853.e038.jpg" id="pgen.1009853.e038g" position="anchor"/><mml:math id="M38" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> is the standard uniform density). We estimate <inline-formula id="pgen.1009853.e039"><alternatives><graphic xlink:href="pgen.1009853.e039.jpg" id="pgen.1009853.e039g" position="anchor"/><mml:math id="M39" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>f</mml:mi><mml:mn>0</mml:mn><mml:mi>q</mml:mi></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mi>q</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> as an intermediate step in the derivation of <inline-formula id="pgen.1009853.e040"><alternatives><graphic xlink:href="pgen.1009853.e040.jpg" id="pgen.1009853.e040g" position="anchor"/><mml:math id="M40" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mi>Q</mml:mi><mml:mo>≤</mml:mo><mml:mi>q</mml:mi><mml:mo>|</mml:mo><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> (<xref rid="pgen.1009853.e025" ref-type="disp-formula">Eq 9</xref>).</p>
        <p>The <italic toggle="yes">v</italic>-value, <italic toggle="yes">v</italic><sub><italic toggle="yes">i</italic></sub>, can be interpreted as the probability that a randomly-chosen (<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>) pair has an equal or more extreme <inline-formula id="pgen.1009853.e041"><alternatives><graphic xlink:href="pgen.1009853.e041.jpg" id="pgen.1009853.e041g" position="anchor"/><mml:math id="M41" display="inline" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> value than <inline-formula id="pgen.1009853.e042"><alternatives><graphic xlink:href="pgen.1009853.e042.jpg" id="pgen.1009853.e042g" position="anchor"/><mml:math id="M42" display="inline" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>c</mml:mi><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> under <inline-formula id="pgen.1009853.e043"><alternatives><graphic xlink:href="pgen.1009853.e043.jpg" id="pgen.1009853.e043g" position="anchor"/><mml:math id="M43" display="inline" overflow="scroll"><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> and is thus analogous to a <italic toggle="yes">p</italic>-value. We refer readers to Theorem 3.1 and its accompanying proof in Liley and Wallace (2021) [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] which shows that the <italic toggle="yes">v</italic>-values are uniformly distributed under the null hypothesis for <italic toggle="yes">X</italic> = (<italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub>) ∈ [0, 1]<sup>2</sup>, and this naturally holds for Flexible cFDR where <italic toggle="yes">X</italic> = (<italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub>) ∈ [0, 1] × [<italic toggle="yes">q</italic><sub><italic toggle="yes">low</italic></sub>, <italic toggle="yes">q</italic><sub><italic toggle="yes">high</italic></sub>] (where <italic toggle="yes">q</italic><sub><italic toggle="yes">low</italic></sub> and <italic toggle="yes">q</italic><sub><italic toggle="yes">high</italic></sub> are the lower and upper limits of the KDE support respectively).</p>
        <p>Deriving <italic toggle="yes">v</italic>-values, which are analogous to <italic toggle="yes">p</italic>-values, means that the output from Flexible cFDR can be used directly in any conventional error rate controlling procedure, such as the BH method [<xref rid="pgen.1009853.ref023" ref-type="bibr">23</xref>]. The derivation of <italic toggle="yes">v</italic>-values also allow for iterative usage, whereby the <italic toggle="yes">v</italic>-values from the previous iteration are used as the “principal trait” <italic toggle="yes">p</italic>-values in the current iteration [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>]. This allows users to incorporate additional layers of auxiliary data into the analysis at each iteration, akin to leveraging multi-dimensional covariates, and this approach is exemplified both in our simulation analysis and in our application utilising ChIP-seq data.</p>
      </sec>
      <sec id="sec007">
        <title>Adapting to sparse data regions</title>
        <p>To ensure that the integral of the KDE approximated in our method equals 1, we define the limits of its support to be 10% wider than the range of the data. This however introduces a sparsity problem whereby the data required to fit the KDE in or near these regions is very sparse. Adaptive KDE methods that find larger value bandwidths for these sparser regions are computationally impractical for large GWAS data sets. Instead, we opt to use left-censoring whereby all <italic toggle="yes">q</italic> &lt; <italic toggle="yes">q</italic><sub><italic toggle="yes">low</italic></sub> are set equal to <italic toggle="yes">q</italic><sub><italic toggle="yes">low</italic></sub> and the value for <italic toggle="yes">q</italic><sub><italic toggle="yes">low</italic></sub> is found by considering the number of data points required in a grid space to reliably estimate the density (<xref rid="pgen.1009853.s001" ref-type="supplementary-material">S1 Fig</xref>). Note that since our method utilises cumulative densities, the sparsity of data for extremely large <italic toggle="yes">q</italic> is not an issue.</p>
        <p>Occasionally, in regions where (<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>) are jointly sparse, the <italic toggle="yes">v</italic>-value can appear extreme compared to the <italic toggle="yes">p</italic>-value. To avoid artifactually inflating evidence for association, we fit a spline to <italic toggle="yes">log</italic><sub>10</sub>(<italic toggle="yes">v</italic>/<italic toggle="yes">p</italic>) against <italic toggle="yes">q</italic> and calculate the distance between each data point and the fitted spline, mapping the small number of outlying points back to the spline and recalculating the corresponding <italic toggle="yes">v</italic>-value as required (<xref rid="pgen.1009853.s002" ref-type="supplementary-material">S2 Fig</xref>).</p>
      </sec>
      <sec id="sec008">
        <title>Flexible cFDR software</title>
        <p>We have created an R package, <monospace>fcfdr</monospace>, that implements the Flexible cFDR method (<ext-link xlink:href="https://github.com/annahutch/fcfdr" ext-link-type="uri">https://github.com/annahutch/fcfdr</ext-link>). The software web-page (<ext-link xlink:href="https://annahutch.github.io/fcfdr/" ext-link-type="uri">https://annahutch.github.io/fcfdr/</ext-link>) contains fully reproducible vignettes which illustrate how the Flexible cFDR method can be used to generate <italic toggle="yes">v</italic>-values from GWAS <italic toggle="yes">p</italic>-values and auxiliary data, and how these can be used directly in any error rate controlling procedure (for example using the <monospace>p.adjust</monospace> function with <monospace>method=“BH”</monospace> for FDR-adjusted <italic toggle="yes">p</italic>-values).</p>
        <p>Flexible cFDR supports a wide range of auxiliary data types and is particularly suited to leveraging functional genomic data, which is not typically Gaussian (e.g. fold change values from ChIP-seq or per-SNP scores of functionality). We include vignettes (<ext-link xlink:href="https://annahutch.github.io/fcfdr/articles/extra-information.html" ext-link-type="uri">https://annahutch.github.io/fcfdr/articles/extra-information.html</ext-link>; <ext-link xlink:href="https://annahutch.github.io/fcfdr/articles/t1d_app.html" ext-link-type="uri">https://annahutch.github.io/fcfdr/articles/t1d_app.html</ext-link>) exemplifying the types of functional genomic data that can be leveraged and also describing how the LDAK method [<xref rid="pgen.1009853.ref055" ref-type="bibr">55</xref>] can be used to generate an independent subset of SNPs for input into the software.</p>
      </sec>
    </sec>
    <sec id="sec009">
      <title>Simulations</title>
      <p>We used simulations to assess the performance of Flexible cFDR when iteratively leveraging various types of auxiliary data. We validated Flexible cFDR against the existing framework, which we call “Empirical cFDR” [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>], in two cases where <italic toggle="yes">q</italic> ∈ [0, 1] (as required by Empirical cFDR). We then evaluated the performance of Flexible cFDR in three novel use-cases where the auxiliary data is no longer restricted to [0, 1]. We also analysed the simulation data using Boca and Leek’s FDR regression (referred to as BL) [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>], which was the only other method that allowed for multiple covariates of this nature.</p>
      <sec id="sec010">
        <title>Simulating GWAS results (<italic toggle="yes">p</italic>)</title>
        <p>We first simulated GWAS <italic toggle="yes">p</italic>-values for the arbitrary “principal trait” to be used as <italic toggle="yes">p</italic> in our simulations. We collected haplotype data for 3781 individuals from the UK10K project (REL-2012–06-02) [<xref rid="pgen.1009853.ref057" ref-type="bibr">57</xref>] for 80,356 SNPs with minor allele frequency (MAF) ≥ 0.05 residing on chromosome 22. We split the haplotype data into 24 LD blocks representing approximately independent genomic regions defined by the LD detect method [<xref rid="pgen.1009853.ref058" ref-type="bibr">58</xref>], and further stratified these so that no more than 1000 SNPs were in each stratification. For each stratification, we sampled 2, 3 or 4 causal variants with log odds ratio (OR) effect sizes simulated from the standard Gaussian prior used for case-control genetic fine-mapping studies, <italic toggle="yes">N</italic>(0, 0.2<sup>2</sup>) [<xref rid="pgen.1009853.ref059" ref-type="bibr">59</xref>] (the mean number of simulated causal variants in each simulation was 54). We then used the <monospace>simGWAS</monospace> R package [<xref rid="pgen.1009853.ref060" ref-type="bibr">60</xref>] to simulate <italic toggle="yes">Z</italic>-scores from a GWAS in each region for 5000 cases and 5000 controls. We collated the <italic toggle="yes">Z</italic>-scores from each region and converted these to <italic toggle="yes">p</italic>-values representing the evidence of association between the SNPs and the arbitrary principal trait.</p>
        <p>To generate an independent subset of SNPs required to fit the KDE, we converted the haplotype data to genotype data and used the <monospace>write.plink</monospace> function [<xref rid="pgen.1009853.ref056" ref-type="bibr">56</xref>] to generate the files required for the LDAK software [<xref rid="pgen.1009853.ref055" ref-type="bibr">55</xref>]. We generated LDAK weights for each of the SNPs and used the subset of SNPs with non-zero LDAK weights as an independent subset of SNPs (an LDAK weight of zero means that its signal is (almost) perfectly captured by neighbouring SNPs) [<xref rid="pgen.1009853.ref061" ref-type="bibr">61</xref>]. Over the restricted interval of MAF values considered (MAF ≥ 0.05), we found that the MAF distributions of the whole SNP set and the independent subset were largely comparable, so we did not here perform the MAF matching procedure discussed below in our analysis of asthma data.</p>
      </sec>
      <sec id="sec011">
        <title>Simulating auxiliary data (q)</title>
        <p>We consider five use-cases of cFDR (simulations A-E), defined by (i) the distribution of the auxiliary data <italic toggle="yes">q</italic> (ii) the relationship between <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic> and (iii) the relationship between different <italic toggle="yes">q</italic> in each iteration (5 realisations of <italic toggle="yes">q</italic> were sampled in each simulation representing multi-dimensional covariates so that cFDR could be applied iteratively) (<xref rid="pgen.1009853.t001" ref-type="table">Table 1</xref>). We denote the value of <italic toggle="yes">q</italic> at SNP <italic toggle="yes">i</italic> in realisation <italic toggle="yes">k</italic> as <inline-formula id="pgen.1009853.e044"><alternatives><graphic xlink:href="pgen.1009853.e044.jpg" id="pgen.1009853.e044g" position="anchor"/><mml:math id="M44" display="inline" overflow="scroll"><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>.</p>
        <table-wrap position="float" id="pgen.1009853.t001">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Summary of simulation analysis.</title>
          </caption>
          <alternatives>
            <graphic xlink:href="pgen.1009853.t001" id="pgen.1009853.t001g" position="float"/>
            <table frame="hsides" rules="groups" cellspacing="0" style="border-collapse:collapse">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" style="border-right-width:thick;border-bottom-width:thick" rowspan="1" colspan="1">Simulation</th>
                  <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Distribution of <italic toggle="yes">q</italic></th>
                  <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Relationship between <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub> and <inline-formula id="pgen.1009853.e045"><alternatives><graphic xlink:href="pgen.1009853.e045" id="pgen.1009853.e045g" position="anchor"/><mml:math id="M45" display="inline" overflow="scroll"><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula></th>
                  <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Average pairwise correlation<xref rid="t001fn001" ref-type="table-fn"><sup>a</sup></xref> between <italic toggle="yes">q</italic><sup>(<italic toggle="yes">k</italic>)</sup> and <italic toggle="yes">q</italic><sup>(<italic toggle="yes">l</italic>)</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">A</td>
                  <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-values (all null)</td>
                  <td align="left" rowspan="1" colspan="1">Independent</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">B</td>
                  <td align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-values (related trait)</td>
                  <td align="left" rowspan="1" colspan="1">Shared causal variants</td>
                  <td align="left" rowspan="1" colspan="1">0.04</td>
                </tr>
                <tr>
                  <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">C</td>
                  <td align="left" rowspan="1" colspan="1">Functional</td>
                  <td align="left" rowspan="1" colspan="1">Independent</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">D</td>
                  <td align="left" rowspan="1" colspan="1">Functional</td>
                  <td align="left" rowspan="1" colspan="1">Dependent</td>
                  <td align="left" rowspan="1" colspan="1">0.08</td>
                </tr>
                <tr>
                  <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">E</td>
                  <td align="left" rowspan="1" colspan="1">Functional</td>
                  <td align="left" rowspan="1" colspan="1">Dependent</td>
                  <td align="left" rowspan="1" colspan="1">0.19</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p><sup><italic toggle="yes">a</italic></sup> Pairwise correlation values are the Pearson correlation coefficients.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>In simulation A, we sampled <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> ∼ <italic toggle="yes">Unif</italic>(0, 1) to represent iterating over null <italic toggle="yes">p</italic>-values (<xref rid="pgen.1009853.s003" ref-type="supplementary-material">S3A Fig</xref>). In simulation B, we investigated the standard use-case of cFDR by iterating over <italic toggle="yes">p</italic>-values from “related traits” (<xref rid="pgen.1009853.s003" ref-type="supplementary-material">S3B Fig</xref>). To do this, we used the <monospace>simGWAS</monospace> R package [<xref rid="pgen.1009853.ref060" ref-type="bibr">60</xref>] to simulate <italic toggle="yes">p</italic>-values, specifying the shared causal variants such that each pair of vectors <italic toggle="yes">p</italic>, <italic toggle="yes">q</italic> were guaranteed to share causal variants in exactly 4 of the 24 LD blocks, whilst each pair of vectors <italic toggle="yes">q</italic><sup>(<italic toggle="yes">k</italic>)</sup>, <italic toggle="yes">q</italic><sup>(<italic toggle="yes">j</italic>)</sup> were expected to share causal variants in 4 of the 24 LD blocks.</p>
        <p>In simulations C-E, we simulated auxiliary data representing functional genomic data sampled from arbitrary distributions and which varied based on dependence structure with the principal trait <italic toggle="yes">p</italic>-values. In simulation C, we sampled <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> from a bimodal mixture normal distribution that was independent of <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub>: <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> ∼ 0.5 × <italic toggle="yes">N</italic>(−2, 0.5<sup>2</sup>) + 0.5 × <italic toggle="yes">N</italic>(3, 2<sup>2</sup>) (<xref rid="pgen.1009853.s003" ref-type="supplementary-material">S3C Fig</xref>). In simulations D and E we simulated continuous auxiliary data that was dependent on <italic toggle="yes">p</italic><sub><italic toggle="yes">i</italic></sub> by first defining “functional SNPs” as causal variants plus any SNPs within 10,000-bp (to incorporate SNPs residing in the same arbitrary “functional mark”), and “non-functional SNPs” as the remainder. In simulation D, we then sampled <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> from different mixture normal distributions for functional and non-functional SNPs:
<disp-formula id="pgen.1009853.e046"><alternatives><graphic xlink:href="pgen.1009853.e046.jpg" id="pgen.1009853.e046g" position="anchor"/><mml:math id="M46" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mi>w</mml:mi><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>w</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:msup><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:msup><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="4pt"/><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mtext>SNP</mml:mtext><mml:mspace width="4pt"/><mml:mi>i</mml:mi><mml:mspace width="4pt"/><mml:mtext>is</mml:mtext><mml:mspace width="4pt"/><mml:mtext>non-functional</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>w</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>w</mml:mi><mml:mo>×</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:msup><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:msup><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="4pt"/><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mtext>SNP</mml:mtext><mml:mspace width="4pt"/><mml:mi>i</mml:mi><mml:mspace width="4pt"/><mml:mtext>is</mml:mtext><mml:mspace width="4pt"/><mml:mtext>functional</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo/></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(13)</label></disp-formula>
where <italic toggle="yes">μ</italic><sub>1</sub> ∈ {2.5, 3, 4}, <italic toggle="yes">μ</italic><sub>2</sub> ∈ {−1.5, −2, −3}, <italic toggle="yes">w</italic> ∈ {0.6, 0.7, 0.8, 0.9, 0.95} vary across iterations.</p>
        <p>Since we anticipate our method being used to leverage functional genomic data iteratively, we also evaluated the impact of repeatedly iterating over auxiliary data that captures the same functional mark. To do this, in simulation E we iterated over realisations of <italic toggle="yes">q</italic> that are sampled from the same distribution,
<disp-formula id="pgen.1009853.e047"><alternatives><graphic xlink:href="pgen.1009853.e047.jpg" id="pgen.1009853.e047g" position="anchor"/><mml:math id="M47" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mn>2</mml:mn></mml:msup><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mspace width="4pt"/><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mtext>SNP</mml:mtext><mml:mspace width="4pt"/><mml:mi>i</mml:mi><mml:mspace width="4pt"/><mml:mtext>is</mml:mtext><mml:mspace width="4pt"/><mml:mtext>non-functional</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mi>N</mml:mi><mml:mo>(</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:msup><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:msup><mml:mo>)</mml:mo><mml:mo>,</mml:mo><mml:mspace width="4pt"/><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mtext>SNP</mml:mtext><mml:mspace width="4pt"/><mml:mi>i</mml:mi><mml:mspace width="4pt"/><mml:mtext>is</mml:mtext><mml:mspace width="4pt"/><mml:mtext>functional</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo/></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(14)</label></disp-formula></p>
      </sec>
      <sec id="sec012">
        <title>Running empirical cFDR, Flexible cFDR and BL</title>
        <p>Following the vignette for the Empirical cFDR software (<ext-link xlink:href="https://github.com/jamesliley/cfdr/blob/master/vignettes/cfdr_vignette.Rmd" ext-link-type="uri">https://github.com/jamesliley/cfdr/blob/master/vignettes/cfdr_vignette.Rmd</ext-link>), we first used the <monospace>vl</monospace> function to generate L-curves. As recommended in the documentation and to ensure that the rejection rules were not being applied to the same data from which they were determined, we used the leave-one-out-procedure whereby L-curves were fit separately for data points in each LD block using data points from the other LD blocks. To ensure that the cFDR curves were strictly decreasing (preventing a complication whereby all <italic toggle="yes">v</italic>-values corresponding to the smallest <italic toggle="yes">p</italic>-values were given the same value), we reduced the value of the <monospace>gx</monospace> parameter to the minimum <italic toggle="yes">p</italic>-value in the LD block. We then estimated the distribution of <inline-formula id="pgen.1009853.e048"><alternatives><graphic xlink:href="pgen.1009853.e048.jpg" id="pgen.1009853.e048g" position="anchor"/><mml:math id="M48" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> using the <monospace>fit.2g</monospace> function and integrated its density over the computed L-regions using the <monospace>il</monospace> function, specifying a mixture Gaussian distribution for the <italic toggle="yes">Z</italic>-scores.</p>
        <p>Flexible cFDR was implemented using the <monospace>flexible_cfdr</monospace> function in the <monospace>fcfdr</monospace> R package with default parameter values. Both cFDR methods were applied iteratively 5 times in each simulation to represent leveraging multi-dimensional covariates.</p>
        <p>For BL, we used the <monospace>lm_qvalue</monospace> function in the <monospace>swfdr</monospace> Bioconductor R package (version 1.16.0 <ext-link xlink:href="https://github.com/leekgroup/swfdr" ext-link-type="uri">https://github.com/leekgroup/swfdr</ext-link>) to derive adjusted <italic toggle="yes">p</italic>-values. The covariate matrix that we used consisted of five columns for <italic toggle="yes">q</italic><sup>(1)</sup>, <italic toggle="yes">q</italic><sup>(2)</sup>, <italic toggle="yes">q</italic><sup>(3)</sup>, <italic toggle="yes">q</italic><sup>(4)</sup>, <italic toggle="yes">q</italic><sup>(5)</sup>.</p>
      </sec>
      <sec id="sec013">
        <title>Evaluating sensitivity, specificity and FDR control</title>
        <p>To quantify the results from our simulations, we used the BH procedure to derive FDR-adjusted <italic toggle="yes">v</italic>-values from empirical and Flexible cFDR (which we call “FDR values” for conciseness). For BL, we used the adjusted <italic toggle="yes">p</italic>-values as the quantity of interest. We then calculated proxies for the sensitivity (true positive rate) and the specificity (true negative rate) at an FDR threshold of <italic toggle="yes">α</italic> = 5 × 10<sup>−6</sup>, which roughly corresponds to the genome-wide significance <italic toggle="yes">p</italic>-value threshold of 5 × 10<sup>−8</sup> (<xref rid="pgen.1009853.s004" ref-type="supplementary-material">S4 Fig</xref>). We defined a subset of “truly associated SNPs” as any SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≥ 0.8 with any of the causal variants. Similarly, we defined a subset of “truly not-associated SNPs” as any SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all of the causal variants. (Note that there are 3 non-overlapping sets of SNPs: “truly associated”, “truly not-associated” and neither of these). We calculated the sensitivity proxy as the proportion of truly associated SNPs that were called significant and the specificity proxy as the proportion of truly not-associated SNPs that were called not significant. To examine whether our results were robust to using different <italic toggle="yes">r</italic><sup>2</sup> values to define truly associated and truly not-associated SNPs, we also evaluated our sensitivity and specificity proxies using larger <italic toggle="yes">r</italic><sup>2</sup> values.</p>
        <p>To assess whether the FDR was controlled within a manageable number of simulations, we raised <italic toggle="yes">α</italic> to 0.05 and calculated the proportion of SNPs called FDR significant which were truly not-associated (that is, <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all of the causal variants).</p>
      </sec>
    </sec>
    <sec id="sec014">
      <title>Application to asthma</title>
      <p>We demonstrate the utility of our method by leveraging a variety of functional genomic data with GWAS <italic toggle="yes">p</italic>-values for asthma [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]. Specifically, we describe two applications: (1) leveraging GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values and (2) leveraging ChIP-seq data in relevant cell types with asthma GWAS <italic toggle="yes">p</italic>-values. We compare the performance of Flexible cFDR to that of four existing methods in the applications which support their usage.</p>
      <sec id="sec015">
        <title>Asthma GWAS data</title>
        <p>Asthma GWAS summary statistics for 2,001,256 SNPs were downloaded from the NHGRI-EBI GWAS Catalog [<xref rid="pgen.1009853.ref062" ref-type="bibr">62</xref>] for study accession GCST006862 [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>] on 10/10/2019. We used the <italic toggle="yes">p</italic>-values generated from a meta-analysis of several GWASs for individuals of European ancestry under a random effects model, totalling 19,954 asthma cases and 107,715 controls. The genomic inflation factor for this study was λ = 1.055, implying minimal inflation of test statistics. The UCSC liftOver utility [<xref rid="pgen.1009853.ref063" ref-type="bibr">63</xref>] was used to convert GRCh38/hg38 into GRCh37/hg19 coordinates, and those that could not be accurately converted were removed. All co-ordinates reported are for GRCh37/hg19. We call this GWAS data the “discovery GWAS data set”.</p>
        <p>We analysed these data with methods that leverage auxiliary data as described below, and evaluated results using data from a larger asthma GWAS performed by the Neale Lab (self-reported asthma: 20002_1111) for 41,934 asthma cases and 319,207 controls from UK Biobank [<xref rid="pgen.1009853.ref049" ref-type="bibr">49</xref>] (URL: <ext-link xlink:href="https://www.dropbox.com/s/kp9bollwekaco0s/20002_1111.gwas.imputed_v3.both_sexes.tsv.bgz?dl=0" ext-link-type="uri">https://www.dropbox.com/s/kp9bollwekaco0s/20002_1111.gwas.imputed_v3.both_sexes.tsv.bgz?dl=0</ext-link> downloaded on 10/05/2020). Specifically, if a SNP was claimed to be significant in the discovery GWAS data set or after applying cFDR (or a comparator method), and it was also significant in the Neale Lab UK Biobank validation data, then we say that it is validated. We used the BH procedure to derive FDR-adjusted <italic toggle="yes">p</italic>-values (which we call “FDR values” for conciseness) and defined significant SNPs as those with <italic toggle="yes">FDR</italic> ≤ 0.000148249, which corresponds to the genome-wide significance <italic toggle="yes">p</italic>-value threshold of <italic toggle="yes">p</italic> ≤ 5 × 10<sup>−8</sup> (0.000148249 is the maximum FDR value amongst SNPs with raw <italic toggle="yes">p</italic>-values ≤ 5 × 10<sup>−8</sup> in the discovery GWAS data set). We restricted analysis to the 1,968,651 SNPs that were present in both the discovery and the validation GWAS data sets.</p>
        <p>We down-sampled the independent subset of SNPs to match the MAF distribution in this subset to that in the whole set of SNPs. This accounts for the confounding of LDAK weights and GWAS <italic toggle="yes">p</italic>-values by MAF: less common SNPs (<italic toggle="yes">MAF</italic> &lt; 0.05) are over-represented among the independent subset and have, on average, larger <italic toggle="yes">p</italic>-values. Matching in this way prevents a bias of the KDE fit towards the behaviour of rarer SNPs. We used MAFs estimated from the CEU sub population of the 1000 Genomes resource [<xref rid="pgen.1009853.ref064" ref-type="bibr">64</xref>], and for the 639 SNPs with missing MAF values we used values randomly sampled from the empirical MAF distribution derived from the other SNPs. This reduced the independent subset of SNPs for fitting the KDE from 509,716 to 247,879 SNPs.</p>
        <p>To identify independent hits we used the LD clumping algorithm in PLINK 1.9 [<xref rid="pgen.1009853.ref056" ref-type="bibr">56</xref>], using a 5 Mb window and an <italic toggle="yes">r</italic><sup>2</sup> threshold of 0.01 [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>]. We used haplotype data from the 503 individuals of European ancestry from 1000 Genomes project Phase 3 [<xref rid="pgen.1009853.ref064" ref-type="bibr">64</xref>] as a reference panel to calculate LD between SNPs. The SNP with the smallest <italic toggle="yes">p</italic>-value in the discovery GWAS data set in each LD clump was called the “index SNP”.</p>
      </sec>
      <sec id="sec016">
        <title>Application 1: Leveraging GenoCanyon scores</title>
        <p>Tools have now been developed that integrate various genomic and epigenomic annotation data to quantify the pathogenicity, functionality and/or deleteriousness of both coding and non-coding GWAS variants [<xref rid="pgen.1009853.ref029" ref-type="bibr">29</xref>, <xref rid="pgen.1009853.ref065" ref-type="bibr">65</xref>–<xref rid="pgen.1009853.ref068" ref-type="bibr">68</xref>]. For example, GenoCanyon scores aim to infer the functional potential of each position in the human genome [<xref rid="pgen.1009853.ref029" ref-type="bibr">29</xref>]. They are derived from the union of 22 computational and experimental annotations (broadly falling into conservation measure, open chromatin, histone modification and TFBS categories) in different cell types. We downloaded GenoCanyon scores from <ext-link xlink:href="http://zhaocenter.org/GenoCanyon_Downloads.html" ext-link-type="uri">http://zhaocenter.org/GenoCanyon_Downloads.html</ext-link> for each of the 1,968,651 SNPs that GWAS <italic toggle="yes">p</italic>-values were available for, noting a bimodal distribution for the scores (<xref rid="pgen.1009853.s005" ref-type="supplementary-material">S5A Fig</xref>).</p>
      </sec>
      <sec id="sec017">
        <title>Application 2: Leveraging ChIP-seq data</title>
        <p>The histone modification H3K27ac is associated with active enhancers [<xref rid="pgen.1009853.ref069" ref-type="bibr">69</xref>] and so SNPs residing in genomic regions with high H3K27ac counts in trait-relevant cell types may be more likely to be associated with the trait of interest [<xref rid="pgen.1009853.ref070" ref-type="bibr">70</xref>].</p>
        <p>We downloaded consolidated fold-enrichment ratios of H3K27ac ChIP-seq counts relative to expected background counts from NIH Roadmap [<xref rid="pgen.1009853.ref071" ref-type="bibr">71</xref>] (<ext-link xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/" ext-link-type="uri">https://egg2.wustl.edu/roadmap/data/byFileType/signal/consolidated/macs2signal/foldChange/</ext-link>) in primary tissues and cells relevant for asthma: immune cells and lung tissue. We mapped each SNP in our GWAS data set to its corresponding genomic region and recorded the H3K27ac fold change values for each SNP in each cell type using bedtools intersect [<xref rid="pgen.1009853.ref072" ref-type="bibr">72</xref>]. For SNPs on the boundary of a genomic region (and therefore mapping to two regions) we randomly selected one of the regions.</p>
        <p>The raw H3K27ac fold change data had very long tails and so we transformed the values: <italic toggle="yes">q</italic> ≔ <italic toggle="yes">log</italic>(<italic toggle="yes">q</italic> + 1). We observed that the data for the different cell types roughly fell into two clusters (<xref rid="pgen.1009853.s006" ref-type="supplementary-material">S6 Fig</xref>): lymphoid cells (consisting of CD19<sup>+</sup>, CD8<sup>+</sup> memory, CD4<sup>+</sup> CD25<sup>-</sup> CD45RA<sup>+</sup> naive, CD4<sup>+</sup> CD25<sup>-</sup> CD45RO<sup>+</sup> memory, CD4<sup>+</sup> CD25<sup>+</sup> CD127<sup>-</sup> Treg, CD4<sup>+</sup> CD25int CD127<sup>+</sup> Tmem, CD8 naive, CD4 memory, CD4 naive and CD4<sup>+</sup> CD25<sup>-</sup> Th cells) clustered with CD56 cells whilst lung tissue clustered with monocytes (CD14<sup>+</sup> cells). We therefore averaged the transformed H3K27ac fold change values in lymphoid and CD56 cell types to derive <italic toggle="yes">q</italic>1, and the transformed H3K27ac fold change values in lung tissue and monocytes to derive <italic toggle="yes">q</italic>2, adding a small amount of noise [<italic toggle="yes">N</italic>(0, 0.1<sup>2</sup>)] to the latter to smooth out the discrete valued counts (<xref rid="pgen.1009853.s007" ref-type="supplementary-material">S7 Fig</xref>).</p>
      </sec>
    </sec>
    <sec id="sec018">
      <title>Analysis methods</title>
      <sec id="sec019">
        <title>Flexible cFDR</title>
        <p>We used the <monospace>flexible_cfdr</monospace> function in the <monospace>fcfdr</monospace> R package to generate <italic toggle="yes">v</italic>-values derived by leveraging the auxiliary data described above with asthma GWAS <italic toggle="yes">p</italic>-values. We defined our independent SNP set as the set of 509,716 SNPs given a non-zero LDAK weight [<xref rid="pgen.1009853.ref061" ref-type="bibr">61</xref>] for the <monospace>indep_index</monospace> parameter and we used the optional <monospace>maf</monospace> parameter in the software to supply the MAF values required for our MAF matching procedure. We used the BH procedure to derive FDR values and used these as the output of interest.</p>
      </sec>
      <sec id="sec020">
        <title>GenoWAP</title>
        <p>GenoWAP is a Bayesian method that leverages GenoCanyon scores with GWAS <italic toggle="yes">p</italic>-values to output posterior scores of disease-specific functionality for each SNP [<xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>]. The GenoWAP software requires a <monospace>threshold</monospace> parameter defining functional SNPs according to their GenoCanyon score. For this, we used the default recommended value of 0.1, which corresponded to 40% of the SNPs in our data set being “functional”. We used the <monospace>GenoWAP.py</monospace> python script to obtain posterior scores for each SNP, and used these as the output of interest. GenoWAP could only be used for application 1 because it only supports auxiliary data that is GenoCanyon scores.</p>
      </sec>
      <sec id="sec021">
        <title>IHW</title>
        <p>Independent hypothesis weighting (IHW) [<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>] is a statistical method for covariate-informed multiple testing whereby variables are divided into groups and optimal group specific weights are derived (which maximise the number of discoveries whilst controlling the FDR) for use in a weighted BH procedure. We used the <monospace>IHW</monospace> Bioconductor R package (version 1.18) with default parameters, specifying the level of FDR control <monospace>alpha = 0.000148249</monospace>, and used the adjusted <italic toggle="yes">p</italic>-values as the output of interest. IHW could only be used for application 1 because it is not clear how to use this method to leverage multi-dimensional covariate vectors.</p>
      </sec>
      <sec id="sec022">
        <title>Boca and Leek’s FDR regression</title>
        <p>BL estimates the proportion of null hypotheses conditional on observed covariates and uses these as plug-in estimates for the FDR [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>]. We used the <monospace>swfdr</monospace> Bioconductor R package (version 1.16.0) to derive adjusted <italic toggle="yes">p</italic>-values [<xref rid="pgen.1009853.ref073" ref-type="bibr">73</xref>] and used these as the output of interest. For application 1, the <monospace>lm_qvalue</monospace> function was used with a covariate matrix consisting of a single column of GenoCanyon scores for each SNP. For application 2, the <monospace>lm_qvalue</monospace> function was used with a covariate matrix consisting of two columns for <italic toggle="yes">q</italic>1 and <italic toggle="yes">q</italic>2.</p>
      </sec>
      <sec id="sec023">
        <title>FINDOR</title>
        <p>FINDOR is a <italic toggle="yes">p</italic>-value re-weighting method which leverages a wider range of non-cell-type-specific functional annotations. FINDOR uses the baseline-LD model from Gazal et al. [<xref rid="pgen.1009853.ref027" ref-type="bibr">27</xref>] for prediction, and so we were unable to directly compare the methods when leveraging the same GenoCanyon or ChIP-seq auxiliary data. Instead, as recommended we used FINDOR to leverage the 96 annotations from the latest version of the baseline-LD model (version 2.2) with asthma GWAS <italic toggle="yes">p</italic>-values. Briefly, this auxiliary data contains the 75 annotations from Gazal et al. [<xref rid="pgen.1009853.ref027" ref-type="bibr">27</xref>] (including functional regions, histone marks, MAF bins and LD-related annotations) plus extra annotations including synonymous/ non-synonymous, conserved annotations, 2 flanking bivalent TSS/ enhancer annotations from NIH Roadmap [<xref rid="pgen.1009853.ref071" ref-type="bibr">71</xref>], promoter/ enhancer annotations [<xref rid="pgen.1009853.ref074" ref-type="bibr">74</xref>], promoter/ enhancer sequence age annotations [<xref rid="pgen.1009853.ref075" ref-type="bibr">75</xref>] and 11 new annotations from Hujoel et al. [<xref rid="pgen.1009853.ref076" ref-type="bibr">76</xref>] (5 new binary annotations and corresponding flanking annotations and 1 continuous count annotation). We matched SNPs to their annotations using rsID and GRCh37/hg19 coordinates.</p>
        <p>To run FINDOR, stratified LD score regression (S-LDSC) must first be implemented to obtain annotation effect size estimates, <inline-formula id="pgen.1009853.e049"><alternatives><graphic xlink:href="pgen.1009853.e049.jpg" id="pgen.1009853.e049g" position="anchor"/><mml:math id="M49" display="inline" overflow="scroll"><mml:mover accent="true"><mml:msub><mml:mi>τ</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>. To run S-LDSC, we downloaded (i) partitioned LD scores from the baseline-LD model v2.2 [<xref rid="pgen.1009853.ref027" ref-type="bibr">27</xref>], (ii) regression weight LD scores and (iii) allele frequencies for available variants in the 1000 Genomes Phase 3 data set. We then used the <monospace>munge_sumstats.py</monospace> python script in the <monospace>ldsc</monospace> package to convert the asthma GWAS summary statistics to the correct format for use in the <monospace>ldsc</monospace> software. We restrict analysis to HapMap3 SNPs using the <monospace>-merge-alleles</monospace> flag, as recommended in the LDSC and FINDOR documentation.</p>
        <p>We ran S-LDSC with the <monospace>-print-coefficients</monospace> flag to generate the <monospace>.result</monospace> file containing the annotation effect size estimates required for FINDOR. Specifically, pre-computed regression weight LD scores were read in for 1,187,349 variants, for which 1,034,758 remained after merging with reference panel SNP LD scores, for which 1,032,395 SNPs remained after merging with regression SNP LD scores.</p>
        <p>To run FINDOR, partitioned LD scores must also be supplied for the SNPs in the data set. To do this, we downloaded the 1000 Genomes EUR Phase 3 PLINK files and annotation data and followed the ‘LD Score Estimation Tutorial’ on the LDSC GitHub page. Partitioned LD scores could be generated for the 1,976,360 (out of 2,001,256) SNPs in the asthma data set that were also present in the 1000 Genomes Phase 3 data set.</p>
        <p>We then generated a file for the asthma GWAS data [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>], including columns for sample sizes, SNP IDs and <italic toggle="yes">Z</italic>-scores. We used this file, along with the computed partitioned LD scores and the <monospace>.result</monospace> file from S-LDSC to obtain re-weighted <italic toggle="yes">p</italic>-values for the 1,968,651 SNPs using FINDOR. We used the BH procedure to convert these to FDR values and used these as our output of interest.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="results" id="sec024">
    <title>Results</title>
    <sec id="sec025">
      <title>Simulations show Flexible cFDR controls FDR and increases sensitivity where appropriate</title>
      <p>We expect that leveraging irrelevant data should not change our conclusions about a study. Simulations A and C showed that the sensitivity and specificity remained stable across iterations and that the FDR was controlled at a pre-defined level when leveraging independent auxiliary data with Flexible cFDR (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1A and 1C</xref>). In contrast, when leveraging relevant data, we hope that the sensitivity improves whilst the specificity remains high. This is what we observed for Flexible cFDR in simulations B and D (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1B and 1D</xref>). The increase in sensitivity related to how informative the auxiliary data was, whereby the sensitivity generally increased more in simulation B than simulation D, where the average Pearson correlation coefficient between <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic><sup>(<italic toggle="yes">k</italic>)</sup> was <italic toggle="yes">r</italic> = 0.07 and <italic toggle="yes">r</italic> = 0.04 respectively. These findings were robust to the <italic toggle="yes">r</italic><sup>2</sup> threshold used to define our sensitivity (<xref rid="pgen.1009853.s008" ref-type="supplementary-material">S8 Fig</xref>) and specificity (<xref rid="pgen.1009853.s009" ref-type="supplementary-material">S9 Fig</xref>) proxies.</p>
      <fig position="float" id="pgen.1009853.g001">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>Simulation results.</title>
          <p>Mean +/- standard error for the sensitivity, specificity and FDR of FDR values from empirical and Flexible cFDR when iterating over independent (A; “simulation A”) and dependent (B; “simulation B”) auxiliary data that is bounded by [0, 1]. Panels C and D show the results from Flexible cFDR when iterating over independent (C; “simulation C”) and dependent (D; “simulation D”) auxiliary data simulated from bimodal mixture normal distributions. BL refers to results when using Boca and Leek’s FDR regression to leverage the 5-dimensional covariate data. Iteration 0 corresponds to the original FDR values. Our sensitivity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≥ 0.8 with a causal variant (“truly associated”), that were detected with a FDR value less than 5 × 10<sup>−6</sup>. Our specificity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”), that were not detected with a FDR value less than 5 × 10<sup>−6</sup>. Our FDR proxy is calculated as the proportion of SNPs that were detected with a FDR value less than 0.05, that had <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”) (we raised <italic toggle="yes">α</italic> to 0.05 in order to assess FDR control within a manageable number of simulations). Results were averaged across 100 simulations.</p>
        </caption>
        <graphic xlink:href="pgen.1009853.g001" position="float"/>
      </fig>
      <p>For simulations A and B, we could compare Flexible cFDR performance to that of the current method, Empirical cFDR, since <italic toggle="yes">q</italic> could be transformed to a mixture Gaussian [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>]. Performance was similar for simulation A, whilst for simulation B, the sensitivity of the two methods was comparable but Empirical cFDR exhibited a greater decrease in the specificity and failed to control the FDR in later iterations (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1B</xref>). This contrasts with earlier results for Empirical cFDR, which showed good control of FDR [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>], and reflects the structure of our simulations which assume dependence between different realisations of <italic toggle="yes">q</italic>.</p>
      <p>A leave-one-out procedure is required for the Empirical cFDR method, as it utilises empirical CDFs and including an observation when estimating its own L-curve causes the curve to deviate around the observed point [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>]. Flexible cFDR does not require a leave-one-out procedure as KDEs are used instead of empirical CDFs. Additionally, Flexible cFDR is quicker to run than Empirical cFDR, taking approximately 3 minutes compared to Empirical cFDR which takes approximately 6 minutes to complete a single iteration on 80,356 SNPs (using one core of an Intel Xeon E5–2670 processor running at 2.6GHz). Together, these findings indicate that Flexible cFDR performs no worse, and generally better, than Empirical cFDR in use-cases where both methods are supported.</p>
      <p>We also benchmarked the performance of Flexible cFDR against that of BL [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>], which was the only other method that allows for multiple covariates of this nature. We found that BL failed to control the FDR when leveraging independent covariate data, which may be due to the correlations between SNPs (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1A and 1C</xref>). Indeed, Boca and Leek [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>] found that control of the FDR by BL was worse with increasing correlation, but we note that correlation between SNPs is ubiquitous in GWAS data. When leveraging dependent covariate data, BL was consistently less powerful than Flexible cFDR (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1B and 1D</xref>) and it failed to control the FDR in simulations leveraging dependent covariates from arbitrary distributions (<xref rid="pgen.1009853.g001" ref-type="fig">Fig 1D</xref>), which represent the general use-case of the method [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>].</p>
      <p>We anticipate that Flexible cFDR will typically be used to leverage functional genomic data iteratively and it is helpful that specificity remains high and FDR is controlled in simulation D. It is obvious that repeated conditioning on the <italic toggle="yes">same</italic> data should produce erroneous results, with SNPs with a modest <italic toggle="yes">p</italic> but extreme <italic toggle="yes">q</italic> incorrectly attaining greater significance with each iteration. For strict validity, we require <inline-formula id="pgen.1009853.e050"><alternatives><graphic xlink:href="pgen.1009853.e050.jpg" id="pgen.1009853.e050g" position="anchor"/><mml:math id="M50" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>⫫</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> as the <italic toggle="yes">v</italic>-value from iteration <italic toggle="yes">k</italic> will contain some information about <inline-formula id="pgen.1009853.e051"><alternatives><graphic xlink:href="pgen.1009853.e051.jpg" id="pgen.1009853.e051g" position="anchor"/><mml:math id="M51" display="inline" overflow="scroll"><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>, and the cFDR assumes <inline-formula id="pgen.1009853.e052"><alternatives><graphic xlink:href="pgen.1009853.e052.jpg" id="pgen.1009853.e052g" position="anchor"/><mml:math id="M52" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⫫</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> at the next iteration. However, even when <inline-formula id="pgen.1009853.e053"><alternatives><graphic xlink:href="pgen.1009853.e053.jpg" id="pgen.1009853.e053g" position="anchor"/><mml:math id="M53" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:menclose notation="updiagonalstrike"><mml:mo>⫫</mml:mo></mml:menclose></mml:mrow><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>, we expect the dependence between <italic toggle="yes">v</italic> and <italic toggle="yes">q</italic> to be quite weak, hence the acceptable FDR control in simulations B and D above.</p>
      <p>Given the wealth of functional marks available for similar tissues and cell types (for example subsets of peripheral immune cells), we wanted to assess robustness of our procedure to more extreme dependence by repeatedly iterating over auxiliary data that is capturing the same functional mark. In simulation E, the sensitivity increased with each iteration at the expense of a drop in the specificity and loss of FDR control in later iterations (<xref rid="pgen.1009853.g002" ref-type="fig">Fig 2</xref>). The drop in specificity and loss of FDR control is exacerbated when iterating over <italic toggle="yes">exactly</italic> the same auxiliary data in each iteration (<xref rid="pgen.1009853.s010" ref-type="supplementary-material">S10 Fig</xref>), as expected. We therefore recommend that care should be taken not to repeatedly iterate over functional data that is capturing the same genomic feature, and in a real data example that follows, we average over cell types which show correlated values for functional data.</p>
      <fig position="float" id="pgen.1009853.g002">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Simulation results for scenario E.</title>
          <p>Mean +/- standard error for the sensitivity (A), specificity (B) and FDR (C) of FDR values from Flexible cFDR when iterating over auxiliary data sampled from the same distribution (“simulation E”). Iteration 0 corresponds to the original FDR values. Our sensitivity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≥ 0.8 with a causal variant (“truly associated”), that were detected with a FDR value less than 5 × 10<sup>−6</sup>. Our specificity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”), that were not detected with a FDR value less than 5 × 10<sup>−6</sup>. Our FDR proxy is calculated as the proportion of SNPs that were detected with a FDR value less than 0.05, that had <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”) (we raised <italic toggle="yes">α</italic> to 0.05 in order to assess FDR control within a manageable number of simulations). Results were averaged across 100 simulations.</p>
        </caption>
        <graphic xlink:href="pgen.1009853.g002" position="float"/>
      </fig>
    </sec>
    <sec id="sec026">
      <title>Analysis of asthma GWAS leveraging GenoCanyon scores</title>
      <p>Overall, 655 SNPs were FDR significant (<italic toggle="yes">FDR</italic> ≤ 0.000148249) in the original asthma GWAS [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]. We used Flexible cFDR to leverage GenoCanyon scores measuring SNP functionality with asthma GWAS <italic toggle="yes">p</italic>-values and have made all of the results publicly available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.5554628" ext-link-type="uri">https://doi.org/10.5281/zenodo.5554628</ext-link>. SNPs with high GenoCanyon scores were enriched for smaller asthma <italic toggle="yes">p</italic>-values (<xref rid="pgen.1009853.s011" ref-type="supplementary-material">S11 Fig</xref>) and accordingly FDR values from Flexible cFDR for SNPs with high GenoCanyon scores (and therefore more likely to be functional) were lower than their corresponding original FDR values, whilst those for SNPs with low GenoCanyon scores (and therefore less likely to be functional) were higher than their corresponding original FDR values (<xref rid="pgen.1009853.s012" ref-type="supplementary-material">S12 Fig</xref>). (Due to the positive stochastic monotonicity requirement for cFDR, the Flexible cFDR software reversed the sign of the GenoCanyon scores for its internal calculations). Specifically, Flexible cFDR identified 12 newly FDR significant SNPs (rs4705950, rs6903823, rs9262141, rs1264349, rs2106074, rs3130932, rs9268831, rs3129719, rs1871665, rs16924428, rs1663687 and rs12900122) which had high GenoCanyon scores (mean GenoCanyon score = 0.77) and 3 SNPs were no longer FDR significant which had low GenoCanyon scores (mean GenoCanyon score = 0.01). At the locus level no newly significant, or newly not-significant, loci were identified.</p>
      <p>We compared the results from Flexible cFDR to those from IHW [<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>], BL [<xref rid="pgen.1009853.ref031" ref-type="bibr">31</xref>] and GenoWAP [<xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>] when leveraging the exact same auxiliary data and have made all of the results publicly available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.5554628" ext-link-type="uri">https://doi.org/10.5281/zenodo.5554628</ext-link>. IHW groups SNPs based on their covariate values and derives optimal group-specific weights for use in a weighted BH procedure. Interestingly, all SNPs were allocated a weight of 1 in this instance, meaning that IHW reduced to the conventional BH procedure (and so the adjusted <italic toggle="yes">p</italic>-values from IHW were identical to the original FDR values from the discovery GWAS data set [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]).</p>
      <p>In BL, logistic regression is used to estimate how the distribution of input <italic toggle="yes">p</italic>-values depends on the GenoCanyon scores to estimate the probability that the null hypothesis of no association is true for each SNP. These probabilities ranged from 0.957 for the SNP with the largest GenoCanyon score to 0.993 for the SNP with the smallest GenoCanyon score (<xref rid="pgen.1009853.s006" ref-type="supplementary-material">S6B Fig</xref>). The consequence of the narrow range of these values is that the adjusted values from BL were very similar to the original FDR values (<xref rid="pgen.1009853.s013" ref-type="supplementary-material">S13 Fig</xref>). Specifically, BL only identified 3 newly FDR significant SNPs, and these were all also identified by Flexible cFDR. One of these had a very high GenoCanyon score (rs1871665 with score = 0.999) whilst the other two had medium (rs16924428 with score = 0.532) or low (rs9268831 with score = 0.224) scores. No SNPs were identified as no longer FDR significant after applying BL and at the locus level, no newly significant, or newly not-significant, loci were identified.</p>
      <p>Since GenoWAP outputs posterior probabilities rather than <italic toggle="yes">p</italic>-values, we compared the performance of the methods with GenoWAP based on the rankings of SNPs using the UK Biobank data resource. Firstly, at the SNP-level, for each of the 5152 SNPs that passed FDR significance in the UK Biobank data, we compared the rank of the FDR value in the discovery data set with (1) the rank of the FDR value after applying Flexible cFDR, (2) the rank of the FDR value from BL and (3) the rank of the (negative) posterior score from GenoWAP. (IHW was not included in this comparison because the output from IHW was just the original FDR values). We found that the percentage of FDR significant SNPs in the UK Biobank data which had an improved rank after applying each of the methods was similar (<xref rid="pgen.1009853.t002" ref-type="table">Table 2</xref>) and that 68.5% of the SNPs that improved ranks in at least one of the methods improved rank in all of the methods. Similarly, the percentage of the 1,963,499 SNPs that were not FDR significant in UK Biobank which had a decreased rank after applying each of the methods was similar (<xref rid="pgen.1009853.t002" ref-type="table">Table 2</xref>) and 49.6% of the SNPs that decreased rank in at least one of the methods decreased rank in all of the methods.</p>
      <table-wrap position="float" id="pgen.1009853.t002">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Summary of SNP-level results when leveraging GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
          <p>Table lists the percentage of the 5152 FDR significant SNPs in UK Biobank which improved rank (“UK Biobank significant which improved rank”) and the percentage of the 1,963,499 SNPs that were not FDR significant in UK Biobank which decreased rank (“UK Biobank not-significant which decreased rank”) after applying Flexible cFDR, BL or GenoWAP.</p>
        </caption>
        <alternatives>
          <graphic xlink:href="pgen.1009853.t002" id="pgen.1009853.t002g" position="float"/>
          <table frame="hsides" rules="groups" cellspacing="0" style="border-collapse:collapse">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" style="border-right-width:thick;border-bottom-width:thick" rowspan="1" colspan="1"/>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Flexible cFDR</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">BL</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">GenoWAP</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">UK Biobank significant which improved rank</td>
                <td align="char" char="." rowspan="1" colspan="1">60.3%</td>
                <td align="char" char="." rowspan="1" colspan="1">52.4%</td>
                <td align="char" char="." rowspan="1" colspan="1">61.5%</td>
              </tr>
              <tr>
                <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">UK Biobank not-significant which decreased rank</td>
                <td align="char" char="." rowspan="1" colspan="1">46.8%</td>
                <td align="char" char="." rowspan="1" colspan="1">58.0%</td>
                <td align="char" char="." rowspan="1" colspan="1">44.8%</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>Secondly, we focused on the 114 loci that passed FDR significance in the UK Biobank data set. Within each of the 114 loci, we identified the SNP with the lowest <italic toggle="yes">p</italic>-value and called this the “index SNP”. For each index SNP, we compared the rank of the FDR values in the discovery GWAS data set with (1) the rank of the FDR value after applying Flexible cFDR, (2) the rank of the FDR value from BL and (3) the rank of the (negative) posterior score from GenoWAP. We found that the percentage of UK Biobank significant SNPs (including index SNPs) that improved rank after applying Flexible cFDR was greater than that for BL (Tables <xref rid="pgen.1009853.t002" ref-type="table">2</xref> and <xref rid="pgen.1009853.t003" ref-type="table">3</xref>), which matched results from our simulation analysis which showed that BL was generally less sensitive than Flexible cFDR. Similarly, the percentage of the 301 loci that were not FDR significant in UK Biobank which had a decreased rank after applying each of the methods was similar (<xref rid="pgen.1009853.t003" ref-type="table">Table 3</xref>) and 51.4% of the lead variants that decreased rank in at least one of the methods decreased rank in all of the methods.</p>
      <table-wrap position="float" id="pgen.1009853.t003">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>Summary of locus-level results when leveraging GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
          <p>Table lists the percentage of the 114 FDR significant index SNPs in UK Biobank which improved rank (“UK Biobank significant which improved rank”) and the percentage of the 301 index SNPs that were not FDR significant in UK Biobank which decreased rank (“UK Biobank not-significant which decreased rank”) after applying Flexible cFDR, BL or GenoWAP.</p>
        </caption>
        <alternatives>
          <graphic xlink:href="pgen.1009853.t003" id="pgen.1009853.t003g" position="float"/>
          <table frame="hsides" rules="groups" cellspacing="0" style="border-collapse:collapse">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" style="border-right-width:thick;border-bottom-width:thick" rowspan="1" colspan="1"/>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Flexible cFDR</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">BL</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">GenoWAP</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">UK Biobank significant which improved rank</td>
                <td align="char" char="." rowspan="1" colspan="1">42.1%</td>
                <td align="char" char="." rowspan="1" colspan="1">28.9%</td>
                <td align="char" char="." rowspan="1" colspan="1">55.3%</td>
              </tr>
              <tr>
                <td align="left" style="border-right-width:thick" rowspan="1" colspan="1">UK Biobank not-significant which decreased rank</td>
                <td align="char" char="." rowspan="1" colspan="1">40.5%</td>
                <td align="char" char="." rowspan="1" colspan="1">40.9%</td>
                <td align="char" char="." rowspan="1" colspan="1">34.6%</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p>In all, the results were similar for Flexible cFDR, BL and GenoWAP when leveraging GenoCanyon scores of SNP functionality with asthma GWAS <italic toggle="yes">p</italic>-values, but rather unexciting as no newly significant loci were identified. We suggest that this is due to the one-dimensional non-trait-specific auxiliary data that is being leveraged, which is unlikely to capture enough disease relevant information to substantially alter conclusions from a study. This is supported by our intermediary results, where the optimal weights derived in IHW were all equal to 1 and the estimated proportions of true null hypotheses conditional on the GenoCanyon scores in BL were almost negligible.</p>
    </sec>
    <sec id="sec027">
      <title>Analysis of asthma GWAS leveraging ChIP-seq data uncovers new genetic associations</title>
      <p>In agreement with reports that GWAS SNPs are enriched in active chromatin [<xref rid="pgen.1009853.ref077" ref-type="bibr">77</xref>], we observed that H3K27ac fold change values in asthma relevant cell types were negatively correlated with asthma GWAS <italic toggle="yes">p</italic>-values (<xref rid="pgen.1009853.s014" ref-type="supplementary-material">S14 Fig</xref>) such that SNPs with high fold change values were enriched for smaller <italic toggle="yes">p</italic>-values (<xref rid="pgen.1009853.s015" ref-type="supplementary-material">S15 Fig</xref>). (Due to the positive stochastic monotonicity requirement for cFDR, the Flexible cFDR software reversed the sign of the fold change values for its internal calculations). Accordingly, FDR values from Flexible cFDR for SNPs with high H3K27ac fold-change counts in asthma relevant cell types were lower than their corresponding original FDR values, whilst those for SNPs with low H3K27ac fold-change counts in asthma relevant cell types were higher than their corresponding original FDR values (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3A, 3B and 3C</xref>).</p>
      <fig position="float" id="pgen.1009853.g003">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Using Flexible cFDR to leverage H3K27ac data with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
          <p>(A) (-log<sub>10</sub>) FDR values after 2 iterations of Flexible cFDR leveraging H3K27ac counts in relevant cell types against raw (-log<sub>10</sub>) FDR values coloured by the average value of the auxiliary data across iterations. (B) As in A but non-log-transformed FDR values. (C) As in B but coloured by (log<sub>10</sub>) counts of data points in each hexbin. (D) Box plots of (-log<sub>10</sub>) <italic toggle="yes">p</italic>-values in the discovery GWAS and the UK Biobank data set for the 655 SNPs that were FDR significant in the original GWAS (Iteration 0), 51 SNPs that were newly FDR significant after iteration 1 of Flexible cFDR (leveraging average H3K27ac fold change values in lymphoid and CD56 cell types) and 24 SNPs that were newly FDR significant after iteration 2 of Flexible cFDR (subsequently leveraging average H3K27ac fold change values in lung tissue and CD14<sup>+</sup> cells). Black dashed line at genome-wide significance (<italic toggle="yes">p</italic> = 5 × 10<sup>−8</sup>). (E) Sensitivity proxy and (F) specificity proxy for the H3K27ac application results. Sensitivity proxy is calculated as the proportion of SNPs that are FDR significant in the UK Biobank data set that are also FDR significant in the original GWAS (iteration 0), after iteration 1 of Flexible cFDR or after iteration 2 of Flexible cFDR. Specificity is calculated as the proportion of SNPs that are not FDR significant in the UK Biobank data set that are also not FDR significant in the original GWAS (iteration 0), after iteration 1 of Flexible cFDR or after iteration 2 of Flexible cFDR.</p>
        </caption>
        <graphic xlink:href="pgen.1009853.g003" position="float"/>
      </fig>
      <p>The 655 SNPs that were FDR significant (<italic toggle="yes">FDR</italic> ≤ 0.000148249) in the original asthma GWAS [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>] have strong replication <italic toggle="yes">p</italic>-values in the UK Biobank data set used for validation (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3D</xref>; Iteration 0). By leveraging H3K27ac data, Flexible cFDR identified weaker signals that were not significant in the original data but have reassuringly small <italic toggle="yes">p</italic>-values in the UK Biobank data (median <italic toggle="yes">p</italic>-value in UK Biobank data for these SNPs is 4.65 × 10<sup>−21</sup>; <xref rid="pgen.1009853.g003" ref-type="fig">Fig 3D</xref>). Specifically, Flexible cFDR identified 51 newly significant SNPs when leveraging average H3K27ac fold change values in lymphoid and CD56 cell types (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3D</xref>; Iteration 1), and 24 newly significant SNPs when subsequently leveraging average H3K27ac fold change values in lung tissue and monocytes (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3D</xref>; Iteration 2). The maximum <italic toggle="yes">p</italic>-value for the 69 newly significant SNPs (6 SNPs newly significant after iteration 1 were no longer significant after iteration 2) in the discovery GWAS data set was 2.15 × 10<sup>−6</sup> and the maximum UK Biobank <italic toggle="yes">p</italic>-value for these SNPs was 0.02. The newly significant SNPs had relatively small estimated effect sizes (<xref rid="pgen.1009853.s016" ref-type="supplementary-material">S16 Fig</xref>), implying that there may be many more regions associated with asthma with increasingly smaller effect sizes that are missed by current GWAS sample sizes.</p>
      <p>As a proxy for sensitivity, we calculated the proportion of FDR significant SNPs in the UK Biobank data set that were also found to be FDR significant both before (“iteration 0”) and after each iteration of Flexible cFDR. We found that the sensitivity increased from 0.127 to 0.131 after iteration 1 (leveraging average H3K27ac fold change values in lymphoid and CD56 cell types) and to 0.133 after iteration 2 (leveraging average H3K27ac fold change values in lung tissue and monocytes) (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3E</xref>). As a proxy for specificity, we calculated the proportion of SNPs not FDR significant in the UK Biobank data set that were also not FDR significant both before (“iteration 0”) and after each iteration of Flexible cFDR, finding that the specificity remained close to 1 (≥ 0.9999975) (<xref rid="pgen.1009853.g003" ref-type="fig">Fig 3F</xref>). One could expect that the order of which the auxiliary data is iterated over may impact the results from Flexible cFDR. Reassuringly, in this application we found that the order of which we iterated over the auxiliary data had minimal impact on the results (<xref rid="pgen.1009853.s017" ref-type="supplementary-material">S17 Fig</xref>).</p>
      <p>At the locus level, 18 loci were FDR significant (<italic toggle="yes">FDR</italic> ≤ 0.000148249) in the original asthma GWAS [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]. When used to leverage H3K27ac fold change values, Flexible cFDR identified 4 additional significant loci with index SNPs: rs9501077 (chr6:31167512), rs4148869 (chr6:32806576), rs9467715 (chr6:26341301) and rs167769 (chr12:57503775) (<xref rid="pgen.1009853.g004" ref-type="fig">Fig 4</xref> and <xref rid="pgen.1009853.t004" ref-type="table">Table 4</xref>). Three of the four (rs4148869, rs9467715 and rs167769) validated in the UK Biobank data set at Bonferroni corrected significance (for 4 tests the Bonferroni corrected significance threshold corresponding to <italic toggle="yes">α</italic> = 0.05 is 0.05/4 = 0.0125). One locus was found to be no longer FDR significant with index SNP rs12543811 (chr8:81278885).</p>
      <fig position="float" id="pgen.1009853.g004">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>Manhattan plot of FDR values before and after applying Flexible cFDR to leverage H3K27ac data with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
          <p>Manhattan plots of -log<sub>10</sub> FDR values before (A) and after (B) applying Flexible cFDR leveraging H3K27ac counts in asthma relevant cell types. Points are coloured by chromosome and green points indicate the four index SNPs that are newly identified as FDR significant after Flexible cFDR (rs167769, rs9467715, rs9501077 and rs4148869) whilst the red point indicates the single index SNP that was newly identified as not FDR significant by Flexible cFDR (rs12543811). Black dashed line at FDR significance threshold [−<italic toggle="yes">log</italic><sub>10</sub>(0.000148249)].</p>
        </caption>
        <graphic xlink:href="pgen.1009853.g004" position="float"/>
      </fig>
      <table-wrap position="float" id="pgen.1009853.t004">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.t004</object-id>
        <label>Table 4</label>
        <caption>
          <title>Summary of newly significant asthma index SNPs when using Flexible cFDR to leverage H3K27ac data.</title>
          <p>Details of index SNPs that became newly FDR significant (<italic toggle="yes">FDR</italic> &lt; 0.000148249) after using Flexible cFDR to leverage H3K27ac fold change values with asthma GWAS <italic toggle="yes">p</italic>-values. Table contains the rsIDs (SNP), genomic positions (Chr: chromosome, BP: base pair), reference (Ref) and alternative (Alt) alleles, log ORs (beta), standard errors (SE) and <italic toggle="yes">p</italic>-values from the discovery GWAS, mean H3K27ac fold change values across asthma relevant cell types, <italic toggle="yes">p</italic>-values from UK Biobank and resultant <italic toggle="yes">v</italic>-values from Flexible cFDR. For the original <italic toggle="yes">p</italic>-values (and <italic toggle="yes">v</italic>-values), the corresponding FDR values are also given, calculated using the BH procedure.</p>
        </caption>
        <alternatives>
          <graphic xlink:href="pgen.1009853.t004" id="pgen.1009853.t004g" position="float"/>
          <table frame="hsides" rules="groups" cellspacing="0" style="border-collapse:collapse">
            <colgroup span="1">
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
              <col align="left" valign="middle" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">SNP</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Chr</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">BP</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Ref</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">Alt</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">beta</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">SE</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">H3K27ac percentile<xref rid="t004fn001" ref-type="table-fn"><sup>a</sup></xref></th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">p</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">FDR (p)</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">p (UKBB)</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">v</th>
                <th align="left" style="border-bottom-width:thick" rowspan="1" colspan="1">FDR (v)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs167769</td>
                <td align="left" rowspan="1" colspan="1">12</td>
                <td align="left" rowspan="1" colspan="1">57503775</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">7.87×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">1.50×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">98.4th</td>
                <td align="left" rowspan="1" colspan="1">1.55×10<sup>−7</sup></td>
                <td align="left" rowspan="1" colspan="1">4.04×10<sup>−4</sup></td>
                <td align="left" rowspan="1" colspan="1">4.69×10<sup>−24</sup></td>
                <td align="left" rowspan="1" colspan="1">3.75×10<sup>−9</sup></td>
                <td align="left" rowspan="1" colspan="1">1.51×10<sup>−5</sup></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs9467715</td>
                <td align="left" rowspan="1" colspan="1">6</td>
                <td align="left" rowspan="1" colspan="1">26341301</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">-8.61×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">1.61×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">67.9th</td>
                <td align="left" rowspan="1" colspan="1">8.96×10<sup>−8</sup></td>
                <td align="left" rowspan="1" colspan="1">2.49×10<sup>−4</sup></td>
                <td align="left" rowspan="1" colspan="1">5.93×10<sup>−4</sup></td>
                <td align="left" rowspan="1" colspan="1">3.83×10<sup>−8</sup></td>
                <td align="left" rowspan="1" colspan="1">1.15×10<sup>−4</sup></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs9501077</td>
                <td align="left" rowspan="1" colspan="1">6</td>
                <td align="left" rowspan="1" colspan="1">31167512</td>
                <td align="left" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">-8.06×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">1.54×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">90.5th</td>
                <td align="left" rowspan="1" colspan="1">1.53×10<sup>−7</sup></td>
                <td align="left" rowspan="1" colspan="1">3.99×10<sup>−4</sup></td>
                <td align="left" rowspan="1" colspan="1">2.01×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">1.91×10<sup>−8</sup></td>
                <td align="left" rowspan="1" colspan="1">6.26×10<sup>−5</sup></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs4148869</td>
                <td align="left" rowspan="1" colspan="1">6</td>
                <td align="left" rowspan="1" colspan="1">32806576</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">7.03×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">1.39×10<sup>−2</sup></td>
                <td align="left" rowspan="1" colspan="1">99.6th</td>
                <td align="left" rowspan="1" colspan="1">4.03×10<sup>−7</sup></td>
                <td align="left" rowspan="1" colspan="1">9.28×10<sup>−4</sup></td>
                <td align="left" rowspan="1" colspan="1">1.49×10<sup>−15</sup></td>
                <td align="left" rowspan="1" colspan="1">9.07×10<sup>−9</sup></td>
                <td align="left" rowspan="1" colspan="1">3.22×10<sup>−5</sup></td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="t004fn001">
            <p><sup><italic toggle="yes">a</italic></sup> Mean H3K27ac percentile across cell types.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>SNPs rs9501077 and rs4148869 reside in the major histocompatibility complex (MHC) region of the genome, which is renowned for its strong long-range LD structures that make it difficult to dissect genetic architecture in this region. rs9501077 and rs4148869 are in linkage equilibrium (<italic toggle="yes">r</italic><sup>2</sup> = 0.001), and are in very weak LD with the index SNP for the whole MHC region (rs9268969; <italic toggle="yes">FDR</italic> = 7.35 × 10<sup>−15</sup>; <italic toggle="yes">r</italic><sup>2</sup> = 0.005 and <italic toggle="yes">r</italic><sup>2</sup> = 0.001 respectively). rs9501077 (<italic toggle="yes">p</italic> = 1.53 × 10<sup>−7</sup>) has relatively high H3K27ac counts in asthma relevant cell types (mean percentile is 90th) and Flexible cFDR uses this extra disease-relevant information to increase the significance of this SNP beyond the significance threshold (FDR before Flexible cFDR = 3.99 × 10<sup>−4</sup>, FDR after Flexible cFDR = 6.26 × 10<sup>−5</sup>; <xref rid="pgen.1009853.t004" ref-type="table">Table 4</xref>). rs9501077 is found in the long non-coding RNA (lncRNA) gene, <italic toggle="yes">HCG27</italic> (HLA Complex Group 27), which has been linked to psoriasis [<xref rid="pgen.1009853.ref078" ref-type="bibr">78</xref>], however the finding of a significant association with asthma for this SNP was not replicated in the UK Biobank data (UK Biobank <italic toggle="yes">p</italic> = 0.020).</p>
      <p>SNP rs4148869 has very high H3K27ac fold change values in asthma relevant cell types (mean percentile is 99.6th) and so Flexible cFDR decreases the FDR value for this SNP from 9.28 × 10<sup>−4</sup> to 3.22 × 10<sup>−5</sup> when leveraging this auxiliary data (<xref rid="pgen.1009853.t004" ref-type="table">Table 4</xref>). This SNP is a 5’ UTR variant in the <italic toggle="yes">TAP2</italic> gene. The protein TAP2 assembles with TAP1 to form a transporter associated with antigen processing (TAP) complex. The TAP complex transports foreign peptides to the endoplasmic reticulum where they attach to MHC class I proteins which in turn are trafficked to the surface of the cell for antigen presentation to initiate an immune response [<xref rid="pgen.1009853.ref079" ref-type="bibr">79</xref>]. Studies have found <italic toggle="yes">TAP2</italic> to be associated with various immune-related disorders, including autoimmune thyroiditis and type 1 diabetes [<xref rid="pgen.1009853.ref080" ref-type="bibr">80</xref>, <xref rid="pgen.1009853.ref081" ref-type="bibr">81</xref>], and pulmonary tuberculosis in Iranian populations [<xref rid="pgen.1009853.ref082" ref-type="bibr">82</xref>]. Recently, Ma and colleagues [<xref rid="pgen.1009853.ref083" ref-type="bibr">83</xref>] identified three cis-regulatory eSNPS for <italic toggle="yes">TAP2</italic> as candidates for childhood-onset asthma risk (rs9267798, rs4148882 and rs241456). One of these (rs4148882) is present in the asthma GWAS data set used for our analysis (<italic toggle="yes">FDR</italic> = 0.12) and is in weak LD with rs4148869 (<italic toggle="yes">r</italic><sup>2</sup> = 0.4).</p>
      <p>SNP rs9467715 is a regulatory region variant with a raw FDR value that is very nearly significant in the original GWAS (<italic toggle="yes">FDR</italic> = 2.49 × 10<sup>−4</sup> compared with FDR threshold of 1.48 × 10<sup>−4</sup> used to call significant SNPs). This SNP has moderate H3K27ac fold change values in asthma relevant cell types (mean percentile is 67.9th) so that when these are leveraged using Flexible cFDR, the SNP is just pushed past the FDR significance threshold (FDR after Flexible cFDR = 1.15 × 10<sup>−4</sup>; <xref rid="pgen.1009853.t004" ref-type="table">Table 4</xref>).</p>
      <p>SNP rs167769 has a borderline FDR value in the original GWAS discovery data set (<italic toggle="yes">FDR</italic> = 4.04 × 10<sup>−4</sup>) but was found to be significant in the multi-ancestry analysis in the same manuscript (<italic toggle="yes">FDR</italic> = 1.61 × 10<sup>−5</sup>) [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]. This SNP has very high H3K27ac fold change values in asthma relevant cell types (mean percentile is 98.4th) and Flexible cFDR decreases the FDR value for this SNP to 1.51 × 10<sup>−5</sup> when leveraging this auxiliary data (<xref rid="pgen.1009853.t004" ref-type="table">Table 4</xref>). rs167769 is an intron variant in <italic toggle="yes">STAT6</italic>, a gene that is activated by cytokines IL-4 and IL-13 [<xref rid="pgen.1009853.ref084" ref-type="bibr">84</xref>, <xref rid="pgen.1009853.ref085" ref-type="bibr">85</xref>] to initiate a Th2 response and ultimately inhibit transcribing of innate immune response genes [<xref rid="pgen.1009853.ref086" ref-type="bibr">86</xref>, <xref rid="pgen.1009853.ref087" ref-type="bibr">87</xref>]. Transgenic mice over-expressing constitutively active <italic toggle="yes">STAT6</italic> in T cells are predisposed towards Th2 responses and allergic inflammation [<xref rid="pgen.1009853.ref088" ref-type="bibr">88</xref>, <xref rid="pgen.1009853.ref089" ref-type="bibr">89</xref>] whilst <italic toggle="yes">STAT6</italic>-knockout mice are protected from allergic pulmonary manifestations [<xref rid="pgen.1009853.ref090" ref-type="bibr">90</xref>]. Accordingly, rs167769 is strongly associated with <italic toggle="yes">STAT6</italic> expression in the blood [<xref rid="pgen.1009853.ref091" ref-type="bibr">91</xref>–<xref rid="pgen.1009853.ref093" ref-type="bibr">93</xref>] and lungs [<xref rid="pgen.1009853.ref094" ref-type="bibr">94</xref>] and is associated with increased risk of childhood atopic dermatitis [<xref rid="pgen.1009853.ref095" ref-type="bibr">95</xref>, <xref rid="pgen.1009853.ref096" ref-type="bibr">96</xref>], which often progresses to allergic airways diseases such as asthma in adulthood. No genetic variants in the <italic toggle="yes">STAT6</italic> gene region (chr12:57489187–57525922) were identified as significant in the original GWAS, and only rs167769 was identified as significant after leveraging H3K27ac data using Flexible cFDR (<xref rid="pgen.1009853.s018" ref-type="supplementary-material">S18 Fig</xref>).</p>
      <p>One significant index SNP was no longer significant after applying Flexible cFDR. rs12543811 is located between genes <italic toggle="yes">TPD52</italic> and <italic toggle="yes">ZBTB10</italic> and has moderate H3K27ac fold change values in asthma relevant cell types (mean percentile is 52th). This SNP only just exceeds the FDR significance threshold in the original GWAS (FDR = 1.08 × 10<sup>−4</sup> compared with FDR threshold of 1.48 × 10<sup>−4</sup> used to call significant SNPs) but by leveraging its H3K27ac fold change values using Flexible cFDR, the resultant FDR value is just below the significance threshold (FDR after Flexible cFDR = 3.04 × 10<sup>−4</sup>; <xref rid="pgen.1009853.s019" ref-type="supplementary-material">S19 Fig</xref>). This SNP is in strong LD with rs7009110 (<italic toggle="yes">r</italic><sup>2</sup> = 0.79) which has previous been associated with asthma plus hay fever but not with asthma alone [<xref rid="pgen.1009853.ref097" ref-type="bibr">97</xref>]. Conditional analyses show that these two SNPs represent the same signal which is likely to be associated with allergic asthma [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>]. rs12543811 was found to be significant in the UK Biobank data (UK Biobank <italic toggle="yes">p</italic> = 1.42 × 10<sup>−19</sup>).</p>
    </sec>
    <sec id="sec028">
      <title>Comparison with existing methods</title>
      <sec id="sec029">
        <title>Boca and Leek’s FDR regression</title>
        <p>We compared the results from Flexible cFDR when leveraging cell-type specific ChIP-seq data to those from BL when leveraging the exact same auxiliary data (<xref rid="pgen.1009853.g005" ref-type="fig">Fig 5</xref>). The estimated probabilities that each SNP was null (not associated), which are calculated as an intermediate step in the method, ranged from 0.746 to 1 and were negatively correlated with H3K27ac fold change values in asthma relevant cell types (<xref rid="pgen.1009853.s020" ref-type="supplementary-material">S20 Fig</xref>). In total, BL identified five SNPs as newly FDR significant, which replicate in the UK Biobank validation data set (rs4705950 UK Biobank <italic toggle="yes">p</italic> = 7.2 × 10<sup>−23</sup>, rs9268831 UK Biobank <italic toggle="yes">p</italic> = 1.3 × 10<sup>−42</sup>, rs17533090 UK Biobank <italic toggle="yes">p</italic> = 4.4 × 10<sup>−41</sup>, rs1871665 UK Biobank <italic toggle="yes">p</italic> = 5.5 × 10<sup>−24</sup> and rs16924428 UK Biobank <italic toggle="yes">p</italic> = 3.6 × 10<sup>−40</sup>) (<xref rid="pgen.1009853.g005" ref-type="fig">Fig 5B</xref>). These SNPs are a subset of the 69 newly significant SNPs identified by Flexible cFDR, except for rs16924428 which has very low H3K27ac fold change values in asthma relevant cell types (average value = 0.087). The sensitivity increased slightly from 0.127 to 0.128 after applying BL (compared to 0.133 after Flexible cFDR) (<xref rid="pgen.1009853.g005" ref-type="fig">Fig 5C</xref>) and the specificity remained stable at 0.9999995 (<xref rid="pgen.1009853.g005" ref-type="fig">Fig 5D</xref>). No SNPs were FDR significant in the discovery data set and no longer FDR significant after applying BL, and no new loci were found to be newly FDR significant (or newly not FDR significant).</p>
        <fig position="float" id="pgen.1009853.g005">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Using Boca and Leek’s FDR regression to leverage H3K27ac data with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
            <p>(A) (-log<sub>10</sub>) adjusted <italic toggle="yes">p</italic>-values from BL against raw (-log<sub>10</sub>) FDR values coloured by average value of <italic toggle="yes">q</italic> (H3K27ac fold change value). (B) Box plots of (-log<sub>10</sub>) <italic toggle="yes">p</italic>-values in the discovery GWAS data set and the UK Biobank data set for the 655 SNPs that were FDR significant in the original GWAS (“before”) and 5 newly significant SNPs after applying BL (“after”). Black dashed line at genome-wide significance threshold (5 × 10<sup>−8</sup>). (C) Sensitivity and (D) specificity proxies for the results. Sensitivity proxy is calculated as the proportion of SNPs that are FDR significant in the UK Biobank data set that are also FDR significant in the original GWAS or after applying BL. Specificity is calculated as the proportion of SNPs that are not FDR significant in the UK Biobank data set that are also not FDR significant in the original GWAS or after BL.</p>
          </caption>
          <graphic xlink:href="pgen.1009853.g005" position="float"/>
        </fig>
      </sec>
      <sec id="sec030">
        <title>FINDOR</title>
        <p>We next compared results from Flexible cFDR when leveraging cell-type specific ChIP-seq data to those from FINDOR which leverages a wider range of non-cell-type-specific functional annotations, and have made all of the results publicly available at <ext-link xlink:href="https://doi.org/10.5281/zenodo.5554628" ext-link-type="uri">https://doi.org/10.5281/zenodo.5554628</ext-link>. FINDOR identified 119 newly FDR significant SNPs which had a median <italic toggle="yes">p</italic>-value of 4.44 × 10<sup>−15</sup> in the UK Biobank validation data, but the maximum UK Biobank <italic toggle="yes">p</italic>-value for these 119 newly significant SNPs was 0.98 (<xref rid="pgen.1009853.g006" ref-type="fig">Fig 6A and 6B</xref>). The proportion of FDR significant SNPs in the UK Biobank data set that were also FDR significant in the discovery GWAS data set increased from 0.127 to 0.146 (compared to 0.128 after BL and 0.133 after Flexible cFDR) (<xref rid="pgen.1009853.g006" ref-type="fig">Fig 6C</xref>) and the specificity remained ≥ 0.99999 (<xref rid="pgen.1009853.g006" ref-type="fig">Fig 6D</xref>). The increase in sensitivity from FINDOR is greater than that of Flexible cFDR and BL, which may reflect the information gain in leveraging 96 annotations rather than a single histone mark.</p>
        <fig position="float" id="pgen.1009853.g006">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1009853.g006</object-id>
          <label>Fig 6</label>
          <caption>
            <title>Results from FINDOR re-weighting of asthma GWAS <italic toggle="yes">p</italic>-values leveraging 96 baseline-LD model annotations.</title>
            <p>(A) (-log<sub>10</sub>) FDR values from FINDOR against (-log<sub>10</sub>) original FDR values coloured by FINDOR weights. (B) Box plots of (-log<sub>10</sub>) <italic toggle="yes">p</italic>-values in the discovery GWAS data set and the UK Biobank data set for the 655 SNPs that were FDR significant in the original GWAS (“before”) and 119 newly significant SNPs after re-weighting using FINDOR (“after”). Black dashed line at genome-wide significance threshold (5 × 10<sup>−8</sup>). (C) Sensitivity and (D) specificity proxies for the FINDOR results. Sensitivity proxy is calculated as the proportion of SNPs that are FDR significant in the UK Biobank data set that are also FDR significant in the original GWAS or after <italic toggle="yes">p</italic>-value re-weighting using FINDOR. Specificity is calculated as the proportion of SNPs that are not FDR significant in the UK Biobank data set that are also not FDR significant in the original GWAS or after <italic toggle="yes">p</italic>-value re-weighting using FINDOR. Manhattan plots of FDR values before (E) and after (F) re-weighting by FINDOR. Green points indicate the two index SNPs that are newly identified as FDR significant by FINDOR [rs13018263 (chr2:103092270) and rs9501077 (chr6:31167512)]. Red points indicate the two index SNPs that are newly identified as not FDR significant by FINDOR [rs2589561 (chr10:9046645) and rs17637472 (chr17:47461433)]. Black dashed line at FDR significance threshold [−<italic toggle="yes">log</italic><sub>10</sub>(0.000148249)].</p>
          </caption>
          <graphic xlink:href="pgen.1009853.g006" position="float"/>
        </fig>
        <p>At the locus level, FINDOR identified two newly FDR significant index SNPs: rs13018263 (chr2:103092270; original <italic toggle="yes">FDR</italic> = 6.79 × 10<sup>−4</sup>, new <italic toggle="yes">FDR</italic> = 10<sup>−4</sup>) and rs9501077 (chr6:31167512; original <italic toggle="yes">FDR</italic> = 3.99 × 10<sup>−4</sup>, new <italic toggle="yes">FDR</italic> = 4.86 × 10<sup>−5</sup>) (<xref rid="pgen.1009853.g006" ref-type="fig">Fig 6E and 6F</xref>). SNP rs13018263 is an intronic variant in <italic toggle="yes">SLC9A4</italic> and is strongly significant in the UK Biobank validation data set (<italic toggle="yes">p</italic> = 4.78 × 10<sup>−31</sup>). Ferreira and colleagues [<xref rid="pgen.1009853.ref098" ref-type="bibr">98</xref>] highlighted rs13018263 as a potential eQTL for <italic toggle="yes">IL18RAP</italic>, a gene which is involved in IL-18 signalling which in turn mediates Th1 responses [<xref rid="pgen.1009853.ref099" ref-type="bibr">99</xref>], and is situated just upstream of <italic toggle="yes">SLC9A4</italic>. Genetic variants in <italic toggle="yes">IL18RAP</italic> are associated with many immune-mediated diseases, including atopic dermatitis [<xref rid="pgen.1009853.ref100" ref-type="bibr">100</xref>] and type 1 diabetes [<xref rid="pgen.1009853.ref101" ref-type="bibr">101</xref>]. Interestingly, although different auxiliary data was leveraged using Flexible cFDR and FINDOR in our analyses, both methods found index SNP rs9501077 to be newly significant, but this SNP did not validate in the UK Biobank data (UK Biobank <italic toggle="yes">p</italic> = 0.020).</p>
        <p>Two additional index SNPs were found to be no longer significant after re-weighting by FINDOR, rs2589561 (chr10:9046645; original <italic toggle="yes">FDR</italic> = 5.25 × 10<sup>−5</sup>, new <italic toggle="yes">FDR</italic> = 3.06 × 10<sup>−3</sup>) and rs17637472 (chr17:47461433; original <italic toggle="yes">FDR</italic> = 1.42 × 10<sup>−5</sup>, new <italic toggle="yes">FDR</italic> = 9.42 × 10<sup>−4</sup>), however both of these SNPs were strongly significant in the UK Biobank validation data set (<italic toggle="yes">p</italic> = 2.09 × 10<sup>−29</sup> and <italic toggle="yes">p</italic> = 1.75 × 10<sup>−14</sup> respectively).</p>
        <p>SNP rs2589561 is a gene desert that is 929kb from <italic toggle="yes">GATA3</italic>, a transcription factor of the Th2 pathway which mediates the immune response to allergens [<xref rid="pgen.1009853.ref047" ref-type="bibr">47</xref>, <xref rid="pgen.1009853.ref102" ref-type="bibr">102</xref>]. Hi-C data in hematopoietic cells showed that two proxies of rs2589561 (<italic toggle="yes">r</italic><sup>2</sup> &gt; 0.9) are located in a region that interacts with the <italic toggle="yes">GATA3</italic> promoter in CD4+ T cells [<xref rid="pgen.1009853.ref103" ref-type="bibr">103</xref>], suggesting that rs2589561 could function as a distal regulator of <italic toggle="yes">GATA3</italic> in this asthma relevant cell type. rs2589561 has relatively high H3K27ac fold change values in the asthma relevant cell types leveraged by Flexible cFDR (mean percentile is 85th) and Flexible cFDR decreased the FDR value from 5.25 × 10<sup>−5</sup> to 2.41 × 10<sup>−5</sup>.</p>
        <p>SNP rs17637472 is a strong cis-eQTL for <italic toggle="yes">GNGT2</italic> in blood [<xref rid="pgen.1009853.ref091" ref-type="bibr">91</xref>–<xref rid="pgen.1009853.ref093" ref-type="bibr">93</xref>, <xref rid="pgen.1009853.ref104" ref-type="bibr">104</xref>], a gene whose protein product is involved in NF-<italic toggle="yes">κ</italic>B activation [<xref rid="pgen.1009853.ref105" ref-type="bibr">105</xref>]. This SNP has moderate H3K27ac fold change values in relevant cell types (mean percentile is 62th) and the FDR values for this SNP were similar both before and after using Flexible cFDR to leverage the H3K27ac data (original <italic toggle="yes">FDR</italic> = 1.42 × 10<sup>−5</sup>, new <italic toggle="yes">FDR</italic> = 1.46 × 10<sup>−5</sup>).</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec031">
    <title>Discussion</title>
    <p>Developments in molecular biology have enabled researchers to decipher the functional effects of various genomic signatures. We are now in a position to prioritise sequence variants associated with various phenotypes not just by their genetic association statistics but also based on our biological understanding of their functional role. Originally designed for the specific purpose of leveraging test statistics from genetically related traits, we have extended the cFDR framework [<xref rid="pgen.1009853.ref044" ref-type="bibr">44</xref>] to support auxiliary data from arbitrary continuous distributions. Our extension, Flexible cFDR, provides a statistically robust framework to leverage functional genomic data with genetic association statistics to boost power for GWAS discovery.</p>
    <p>We compared the performance of Flexible cFDR to that of four comparator methods which have previously been shown to outperform other approaches [<xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>, <xref rid="pgen.1009853.ref048" ref-type="bibr">48</xref>]: GenoWAP, IHW, BL and FINDOR. We also tried to compare our method to AdaPT [<xref rid="pgen.1009853.ref010" ref-type="bibr">10</xref>], but this approach uses a <italic toggle="yes">p</italic>-value masking procedure which takes many iterations of optimisation and can be computationally expensive [<xref rid="pgen.1009853.ref106" ref-type="bibr">106</xref>]. We found AdaPT to be too computationally demanding for large-scale GWAS data and previous studies suggest that a SNP pre-filtering stage is required [<xref rid="pgen.1009853.ref037" ref-type="bibr">37</xref>]. Of the methods considered, we found that only BL was as versatile as Flexible cFDR. Specifically, IHW currently only supports univariate covariates and, unlike Flexible cFDR, cannot be applied iteratively to leverage multi-dimensional covariates. In GenoWAP, the prior probabilities used in the model are calculated as the mean GenoCanyon score (or tissue-specific GenoSkyline [<xref rid="pgen.1009853.ref107" ref-type="bibr">107</xref>] or GenoSkyline-Plus [<xref rid="pgen.1009853.ref108" ref-type="bibr">108</xref>] score) of the surrounding 10, 000 base pairs, thereby restricting its utility to leveraging only these scores (which we found were unlikely to capture enough disease relevant information to substantially alter conclusions from a study). Whilst in FINDOR, SNPs are binned based on how well they tag heritability enriched categories and this requires the estimation of <italic toggle="yes">χ</italic><sup>2</sup> statistics (i.e., tagged variance) for each SNP using a range of functional annotations, which are generally those in the baselineLD model [<xref rid="pgen.1009853.ref027" ref-type="bibr">27</xref>]. Users are thus required to run LD-score regression prior to running FINDOR, and this two-step approach may limit the accessibility of the method. Although BL was as versatile as Flexible cFDR, we found that it failed to control the FDR in some simulations and was less powerful than Flexible cFDR in a simulation-based analysis. Whilst FINDOR was shown to be the most powerful method, this may reflect the information gain in leveraging 96 annotations rather than a single histone mark. This emphasises the importance of being able to iterate over different auxiliary measures, and suggests that a fruitful area of extension for cFDR will be to increase the robustness of FDR control for dependent <italic toggle="yes">q</italic> across multiple iterations. A related extension would be to formally assess robustness of the cFDR approach to the order of which the auxiliary data is iterated over.</p>
    <p>Flexible cFDR has several key advantages over competing methods. It does not bin variables and does not rely on subjective thresholding or normalised weighting schemes, which hinder many of the existing methods [<xref rid="pgen.1009853.ref003" ref-type="bibr">3</xref>–<xref rid="pgen.1009853.ref006" ref-type="bibr">6</xref>, <xref rid="pgen.1009853.ref009" ref-type="bibr">9</xref>, <xref rid="pgen.1009853.ref014" ref-type="bibr">14</xref>, <xref rid="pgen.1009853.ref015" ref-type="bibr">15</xref>, <xref rid="pgen.1009853.ref025" ref-type="bibr">25</xref>]. Moreover, Flexible cFDR outputs quantities analogous to <italic toggle="yes">p</italic>-values which can be used directly in any error-rate controlling procedure, and which also permit iteration to support multi-dimensional covariate data. Whilst LD between SNPs is often a concern (e.g. because methods such as KDE assume independence between observations), we fit the KDE to a subset of LD-independent SNPs but then generate <italic toggle="yes">v</italic>-values for the full set of SNPs, thereby benefiting from computational efficiency but also facilitating downstream analyses which typically require the full set of SNPs, such as fine-mapping or meta-analysis. LD means that the <italic toggle="yes">v</italic>-values will be positively correlated, so we appeal to the established robustness of the BH FDR estimation to positive dependency [<xref rid="pgen.1009853.ref109" ref-type="bibr">109</xref>].</p>
    <p>Whilst larger case and control cohort sizes will boost statistical power for GWAS discovery, incorporating functional data provides an additional layer of biological evidence that an increase in sample sizes alone cannot provide. There are also instances in the rare disease domain where case sample sizes are restricted by the number of cases available for recruitment (for example in primary immunodeficiency disorder [<xref rid="pgen.1009853.ref110" ref-type="bibr">110</xref>]), and our method has potential utility in these instances as it provides an alternative approach to increase statistical power. The choice of functional data to use may be guided by prior knowledge, or in a data driven manner using a method such as GARFIELD [<xref rid="pgen.1009853.ref111" ref-type="bibr">111</xref>] to quantify the enrichment of GWAS signals in different functional marks. Moreover, our method intrinsically evaluates the relevance of the auxiliary data by comparing the joint probability density of the test statistics and the auxiliary data to the joint density assuming independence, and can therefore be used to inform researchers of relevant functional signatures and cell types.</p>
    <p>Our manuscript describes four key advances enabling the extension of the cFDR framework to the functional genomics setting. Firstly, we derive an estimator based on a 2-dimensional KDE of the bivariate distribution rather than empirical estimates, making our method considerably faster than earlier empirical approaches. Secondly, the cFDR framework estimates <inline-formula id="pgen.1009853.e054"><alternatives><graphic xlink:href="pgen.1009853.e054.jpg" id="pgen.1009853.e054g" position="anchor"/><mml:math id="M54" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> with the relatively coarse approximation <italic toggle="yes">q</italic>|<italic toggle="yes">p</italic> &gt; 1/2. In contrast, Flexible cFDR utilises the local false discovery rate in its estimator for <inline-formula id="pgen.1009853.e055"><alternatives><graphic xlink:href="pgen.1009853.e055.jpg" id="pgen.1009853.e055g" position="anchor"/><mml:math id="M55" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>. The local false discovery rate conditions the probability of a null hypothesis on the point value of its <italic toggle="yes">p</italic>-value, and its use allows for finer-grained estimation of <inline-formula id="pgen.1009853.e056"><alternatives><graphic xlink:href="pgen.1009853.e056.jpg" id="pgen.1009853.e056g" position="anchor"/><mml:math id="M56" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>. Thirdly, we remove the assumption that <inline-formula id="pgen.1009853.e057"><alternatives><graphic xlink:href="pgen.1009853.e057.jpg" id="pgen.1009853.e057g" position="anchor"/><mml:math id="M57" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>q</mml:mi><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> can be transformed to a mixture of centered normals, and instead integrate over the previously estimated KDE, which relaxes the distributional assumptions placed on the auxiliary data. Finally, Flexible cFDR is supported by user-oriented software documented on an easy-to-navigate website (<ext-link xlink:href="https://annahutch.github.io/fcfdr/" ext-link-type="uri">https://annahutch.github.io/fcfdr/</ext-link>). The website features several fully reproducible vignettes which illustrate how the method can be applied to a particular data set at the desired level of error control. We hope this support will make Flexible cFDR accessible to a wider range of researchers.</p>
    <p>One can see that the performance of Flexible cFDR depends on how well the KDE fits the data. Usual concerns about KDE apply, including that fits may be poor if there are regions with very sparse data. The auxiliary data can be transformed to improve the KDE fitting procedure, as in application 2 where we log-transformed the raw fold change values to avoid long tails. The optimal scale for the auxiliary data is likely to depend on the relationship between the principal <italic toggle="yes">p</italic>-values and the auxiliary data, and is not something we have explored here, but as usual, data visualisation is likely to be helpful to confirm that the scale for the auxiliary data is sensible. By default, the Flexible cFDR software returns a plot of the fitted 2D KDE and the estimated density of the auxiliary data overlaid onto the real data values, enabling users to visually examine the fit of the KDE to their data. Investigating the KDE fitting procedure, including the suitability of the Gaussian kernel, is an interesting area for future research.</p>
    <p>Estimation of both FDR and local false discovery rates (often denoted “fdr”) [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>] require estimation of a ratio. In the case of FDR these are cumulative distribution functions (CDF), and in the case of the fdr these are probability density functions (PDF). The simple approach is to take a ratio of two separate estimates of the numerator and denominator. In the case of a 2d fdr proposed by Ploner et al. [<xref rid="pgen.1009853.ref034" ref-type="bibr">34</xref>], this approach was found to be numerically unstable, because the sparsity of the data across 2 dimensions means the uncertainty attached to the estimate of the denominator in particular may be large. Ploner et al. [<xref rid="pgen.1009853.ref034" ref-type="bibr">34</xref>] proposed a solution based on binomial regression, adapting the Poisson regression method used by Efron [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>] to estimate the denominator in the fdr ratio. Despite depending on a 2 dimensional density, we do not use a smoothing estimator for cFDR, yet it still performs well. This is because CDF estimates are typically more stable than PDF estimates at any given point (apart from towards the lower limits of the data), and is one of the attractive ideas for using cumulative rather than probability density functions.</p>
    <p>Our method has several limitations. Firstly, if applying Flexible cFDR iteratively then it is important that each iteration considers new information. That is, care must be taken to ensure that the auxiliary data to be leveraged iteratively is capturing distinct disease-relevant features to prevent multiple adjustment using the same auxiliary data. The definition of “distinct disease-relevant features” to leverage is at the user’s discretion and sparks an interesting philosophical discussion. For example, leveraging data iteratively from various genomic assays measuring the same genomic feature at different resolutions may be deemed invalid for some researchers but valid for others, since if the mark is repeatedly identified by different assays then it is more likely to be reliably present. Whilst we show that our method is robust to minor departures from <inline-formula id="pgen.1009853.e058"><alternatives><graphic xlink:href="pgen.1009853.e058.jpg" id="pgen.1009853.e058g" position="anchor"/><mml:math id="M58" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>⫫</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>l</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:msubsup><mml:mi>H</mml:mi><mml:mn>0</mml:mn><mml:mi>p</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>, this does not extend to strongly related <italic toggle="yes">q</italic>. We would argue that the conservative approach would be to average over correlated auxiliary data, to ensure that the <italic toggle="yes">q</italic> vectors are not strongly correlated.</p>
    <p>Secondly, Flexible cFDR requires that the auxiliary data to be leveraged is continuous. This means that the approach cannot currently be used to leverage functional genomic data that yields discrete or binary values, such as PHRED scores, whether SNPs are synonymous or non-synonymous or whether they reside in coding regions of the genome. A fruitful contribution to the field would be to extend the cFDR approach to support discrete or binary data, thus increasing applicability.</p>
    <p>Thirdly, the cFDR framework assumes a positive stochastically monotonic relationship between the test statistics and the auxiliary data: specifically, low <italic toggle="yes">p</italic>-values are enriched for low values in the auxiliary data. Our method automatically calculates the correlation between <italic toggle="yes">p</italic> and <italic toggle="yes">q</italic> and if this is negative then the auxiliary data is transformed to <italic toggle="yes">q</italic> ≔ −<italic toggle="yes">q</italic>. However, if the relationship is non-monotonic (for example low <italic toggle="yes">p</italic>-values are enriched for both very low and very high values in the auxiliary data) then the cFDR framework cannot simultaneously shrink <italic toggle="yes">v</italic>-values for these two extremes. This non-monotonic relationship is unlikely when leveraging single functional genomic marks, but may occur if, for example, multiple marks were decomposed via PCA. We therefore recommend that users use the <monospace>corr_plot</monospace> and <monospace>stratified_qqplot</monospace> functions in the <monospace>fcfdr</monospace> R package to visualise the relationship between the relationship between the two data types. Note that this restriction could be removed if we used density instead of distribution functions, and worked at the level of local false discovery rates [<xref rid="pgen.1009853.ref032" ref-type="bibr">32</xref>] as described earlier, but this would in turn reduce the robustness our method has to data sparsity in the (<italic toggle="yes">p</italic>, <italic toggle="yes">q</italic>) plane.</p>
    <p>Finally, in our asthma application we only leveraged data for a single histone modification across various cell types. Additional data measuring other histone modifications (e.g. repressive marks) could also be leveraged to further increase power.</p>
    <p>Overall, we anticipate that Flexible cFDR will be a valuable tool to leverage functional genomic data with GWAS test statistics to boost power for GWAS discovery.</p>
  </sec>
  <sec id="sec032" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pgen.1009853.s001" position="float" content-type="local-data">
      <label>S1 Fig</label>
      <caption>
        <title>Demonstration of the left-censoring procedure.</title>
        <p>Plots showing how many data points are in each grid space of the auxiliary data, <italic toggle="yes">q</italic>, over the support of the KDE for an example data set. (A) shows the full support of the KDE and (B) is zoomed in to the left tail. Black dashed line at <italic toggle="yes">y</italic> = 50 which is the default value of the <monospace>gridp</monospace> parameter in the <monospace>fcfdr::flexible_cfdr</monospace> function. Data points falling in grid spaces with fewer than 50 data points (those to the left of the blue dashed line) are left-censored, meaning that their value is replaced by the value of the left bound of the first grid space containing more than 50 data points. In practise, very few data points are left-censored.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s001.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s002" position="float" content-type="local-data">
      <label>S2 Fig</label>
      <caption>
        <title>Illustration of the spline correction procedure.</title>
        <p>A spline with 5 knots is fitted to <italic toggle="yes">log</italic><sub>10</sub>(<italic toggle="yes">v</italic>/<italic toggle="yes">p</italic>) against <italic toggle="yes">q</italic> using the <monospace>bigsplines</monospace> R package (<ext-link xlink:href="https://cran.r-project.org/web/packages/bigsplines/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/bigsplines/index.html</ext-link>) for an example data set. The distance between each data point and the fitted spline is calculated. If this distance is greater than the value of the <monospace>dist_thr</monospace> parameter in the <monospace>fcfdr::flexible_cfdr</monospace> function (default value is 0.5), then the data point is mapped back to the spline and the corresponding <italic toggle="yes">v</italic>-value is recalculated using the fitted spline. In this example, the red line shows the fitted spline and the grey triangular points are mapped back to the spline to generate new <italic toggle="yes">v</italic>-values.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s002.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s003" position="float" content-type="local-data">
      <label>S3 Fig</label>
      <caption>
        <title>Histograms of auxiliary data leveraged in simulation analysis.</title>
        <p>(A) Example data leveraged in simulation A (simulated from standard uniform distribution). (B) Example data leveraged in simulation B (simulated <italic toggle="yes">p</italic>-values for related traits). (C) Example data leveraged in simulations C, D and E (simulated from a mixture normal distribution).</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s003.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s004" position="float" content-type="local-data">
      <label>S4 Fig</label>
      <caption>
        <title>Choosing an FDR threshold corresponding to the genome-wide significance <italic toggle="yes">p</italic>-value threshold in the simulation analysis.</title>
        <p>Histogram of the maximum FDR-adjusted <italic toggle="yes">p</italic>-value (using BH method) amongst SNPs with <italic toggle="yes">p</italic> ≤ 5 × 10<sup>−8</sup> in the simulation analysis. Red dashed line at the selected FDR threshold of 5 × 10<sup>−6</sup>.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s004.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s005" position="float" content-type="local-data">
      <label>S5 Fig</label>
      <caption>
        <title>Histograms from GenoCanyon application.</title>
        <p>(A) Histogram of GenoCanyon scores for SNPs in the asthma GWAS data set. (B) Histogram of estimated pi0 values from BL.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s005.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s006" position="float" content-type="local-data">
      <label>S6 Fig</label>
      <caption>
        <title>Heatmap of the correlations between H3K27ac fold change values amongst asthma relevant cell types.</title>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s006.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s007" position="float" content-type="local-data">
      <label>S7 Fig</label>
      <caption>
        <title>Histograms of auxiliary data used in H3K27ac application.</title>
        <p>(A) q1 is the average of (log transformed) H3K27ac fold change values in lymphoid and CD56 cell types (B) q2 is the average of (log transformed) H3K27ac fold change values in lung tissue and CD14+ cells.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s007.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s008" position="float" content-type="local-data">
      <label>S8 Fig</label>
      <caption>
        <title>Simulation results assessing the sensitivity when increasing the <italic toggle="yes">r</italic><sup>2</sup> threshold used to call associated SNPs.</title>
        <p>Mean +/- standard error for the sensitivity of FDR values from empirical and Flexible cFDR when iterating over independent (A; “simulation A”) and dependent (B; “simulation B”) auxiliary data that is bounded by [0, 1]. Panels C and D show the results from Flexible cFDR when iterating over independent (C; “simulation C”) and dependent (D; “simulation D”) auxiliary data simulated from bimodal mixture normal distributions. BL refers to results when using Boca and Leek’s FDR regression to leverage the 5-dimensional covariate data. Iteration 0 corresponds to the original FDR values. Our sensitivity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≥ <italic toggle="yes">X</italic> with a causal variant (“truly associated”), that were detected with a FDR value less than 5 × 10<sup>−6</sup>, where results are faceted for <italic toggle="yes">X</italic> = 0.8, 0.9, 0.95. Results were averaged across 100 simulations.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s008.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s009" position="float" content-type="local-data">
      <label>S9 Fig</label>
      <caption>
        <title>Simulation results assessing the specificity when increasing the <italic toggle="yes">r</italic><sup>2</sup> threshold used to call not-associated SNPs.</title>
        <p>Mean +/- standard error for the specificity of FDR values from empirical and Flexible cFDR when iterating over independent (A; “simulation A”) and dependent (B; “simulation B”) auxiliary data that is bounded by [0, 1]. Panels C and D show the results from Flexible cFDR when iterating over independent (C; “simulation C”) and dependent (D; “simulation D”) auxiliary data simulated from bimodal mixture normal distributions. BL refers to results when using Boca and Leek’s FDR regression to leverage the 5-dimensional covariate data. Iteration 0 corresponds to the original FDR values. Our specificity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≤ <italic toggle="yes">X</italic> with all the causal variants (“truly not-associated”), that were not detected with a FDR value less than 5 × 10<sup>−6</sup>, where results are faceted for <italic toggle="yes">X</italic> = 0.01, 0.05. Results were averaged across 100 simulations.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s009.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s010" position="float" content-type="local-data">
      <label>S10 Fig</label>
      <caption>
        <title>Simulation results for using Flexible cFDR to iteratively leverage exactly the same auxiliary data.</title>
        <p>Mean +/- standard error for the sensitivity (A) specificity (B) and FDR (C) of FDR values from Flexible cFDR when iterating over the same dependent auxiliary data (“simulation E”). Iteration 0 corresponds to the original FDR values. Our sensitivity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≥ 0.8 with a causal variant (“truly associated”), that were detected with a FDR value less than 5 × 10<sup>−6</sup>. Our specificity proxy is calculated as the proportion of SNPs with <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”), that were not detected with a FDR value less than 5 × 10<sup>−6</sup>. Our FDR proxy is calculated as the proportion of SNPs that were detected with a FDR value less than 0.05, that had <italic toggle="yes">r</italic><sup>2</sup> ≤ 0.01 with all the causal variants (“truly not-associated”) (we raised <italic toggle="yes">α</italic> to 0.05 in order to assess FDR control within a manageable number of simulations). Results were averaged across 1000 simulations.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s010.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s011" position="float" content-type="local-data">
      <label>S11 Fig</label>
      <caption>
        <title>Stratified Q-Q plot of empirical -log<sub>10</sub> GWAS <italic toggle="yes">p</italic>-values for asthma against theoretical values stratified by GenoCanyon scores.</title>
        <p>The values that were used to threshold the GenoCanyon scores are the quantiles of the distribution (0.020 is the 0.25 quantile, 0.204 is the 0.5 quantile, 0.731 is the 0.75 quantile and 1 is the maximum value).</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s011.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s012" position="float" content-type="local-data">
      <label>S12 Fig</label>
      <caption>
        <title>Results when using Flexible cFDR to leverage GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
        <p>FDR values after using Flexible cFDR to leverage GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values against raw FDR values coloured by GenoCanyon score.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s012.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s013" position="float" content-type="local-data">
      <label>S13 Fig</label>
      <caption>
        <title>Results when using BL to leverage GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
        <p>Adjusted <italic toggle="yes">p</italic>-values from BL when leveraging GenoCanyon scores with asthma GWAS <italic toggle="yes">p</italic>-values against raw FDR values coloured by GenoCanyon score.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s013.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s014" position="float" content-type="local-data">
      <label>S14 Fig</label>
      <caption>
        <title>Heatmap of correlations between log-transformed asthma GWAS <italic toggle="yes">p</italic>-values and the summarised H3K27ac fold change values leveraged by Flexible cFDR.</title>
        <p>q1 is the average of (log transformed) H3K27ac fold change values in lymphoid and CD56 cell types. q2 is the average of (log transformed) H3K27ac fold change values in lung tissue and CD14+ cells.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s014.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s015" position="float" content-type="local-data">
      <label>S15 Fig</label>
      <caption>
        <title>Stratified Q-Q plot of empirical -log<sub>10</sub> GWAS <italic toggle="yes">p</italic>-values for asthma against theoretical values stratified by average H3K27ac fold change values in asthma relevant cell types.</title>
        <p>The values that were used to threshold <italic toggle="yes">q</italic> (average H3K27ac fold change values) are the quantiles of the distribution (0.174 is the 0.25 quantile, 0.271 is the 0.5 quantile, 0.419 is the 0.75 quantile and 4.583 is the maximum value).</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s015.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s016" position="float" content-type="local-data">
      <label>S16 Fig</label>
      <caption>
        <title>Effect sizes of significant SNPs.</title>
        <p>Absolute estimated effect sizes (|<italic toggle="yes">β</italic>|; log OR) +/ −1.96 × <italic toggle="yes">SE</italic> of SNPs significantly associated (<italic toggle="yes">FDR</italic> ≤ 0.000148249) with asthma in the original discovery GWAS data set (“iteration 0”) and those newly significant after iteration 1 and 2 of cFDR.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s016.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s017" position="float" content-type="local-data">
      <label>S17 Fig</label>
      <caption>
        <title>Switching the order of iteration.</title>
        <p>(-log<sub>10</sub>) <italic toggle="yes">v</italic>-values after 2 iterations of Flexible cFDR leveraging H3K27ac data when iterating over q2 and then q1 against (-log<sub>10</sub>) <italic toggle="yes">v</italic>-values when iterating over q1 then q2.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s017.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s018" position="float" content-type="local-data">
      <label>S18 Fig</label>
      <caption>
        <title>Manhattan plots for genomic region containing the <italic toggle="yes">STAT6</italic> gene.</title>
        <p>Manhattan plots of FDR values before (A) and after (B) applying Flexible cFDR for the region containing the <italic toggle="yes">STAT6</italic> gene (chr12:57489187–57525922). Black dashed line at FDR significant threshold. Red SNP is rs167769 (index SNP).</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s018.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s019" position="float" content-type="local-data">
      <label>S19 Fig</label>
      <caption>
        <title>Manhattan plots for region containing the index SNP rs12543811 that is no longer FDR significant after applying Flexible cFDR.</title>
        <p>Manhattan plots of FDR values before (A) and after (B) applying Flexible cFDR for the region (chr8:81100000–81500000) containing index SNP rs12543811 (chr6:81278885) that is no longer FDR significant when applying Flexible cFDR.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s019.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material id="pgen.1009853.s020" position="float" content-type="local-data">
      <label>S20 Fig</label>
      <caption>
        <title>Estimated pi0 values in BL when leveraging H3K27ac fold change values in relevant cell types with asthma GWAS <italic toggle="yes">p</italic>-values.</title>
        <p>(A) Average H3K27ac fold change values in asthma relevant cell types (<italic toggle="yes">q</italic>) against estimated probabilities that the null hypothesis is true (‘pi0’) (B) Histogram of pi0 values for all 1,968,651 SNPs.</p>
        <p>(TIF)</p>
      </caption>
      <media xlink:href="pgen.1009853.s020.tif">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pgen.1009853.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Sivakumaran</surname><given-names>S</given-names></name>, <name><surname>Agakov</surname><given-names>F</given-names></name>, <name><surname>Theodoratou</surname><given-names>E</given-names></name>, <name><surname>Prendergast</surname><given-names>JG</given-names></name>, <name><surname>Zgaga</surname><given-names>L</given-names></name>, <name><surname>Manolio</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Abundant Pleiotropy in Human Complex Diseases and Traits</article-title>. <source>American Journal of Human Genetics</source>. <year>2011</year>;<volume>89</volume>(<issue>5</issue>):<fpage>607</fpage>–<lpage>618</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.10.004</pub-id><?supplied-pmid 22077970?><pub-id pub-id-type="pmid">22077970</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Schork</surname><given-names>AJ</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Pham</surname><given-names>P</given-names></name>, <name><surname>Torkamani</surname><given-names>A</given-names></name>, <name><surname>Roddey</surname><given-names>JC</given-names></name>, <name><surname>Sullivan</surname><given-names>PF</given-names></name>, <etal>et al</etal>. <article-title>All SNPs Are Not Created Equal: Genome-Wide Association Studies Reveal a Consistent Pattern of Enrichment among Functionally Annotated SNPs</article-title>. <source>PLoS genetics</source>. <year>2013</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e1003449</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1003449</pub-id><?supplied-pmid 23637621?><pub-id pub-id-type="pmid">23637621</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Genovese</surname><given-names>CR</given-names></name>, <name><surname>Roeder</surname><given-names>K</given-names></name>, <name><surname>Wasserman</surname><given-names>L</given-names></name>. <article-title>False Discovery Control with P-Value Weighting</article-title>. <source>Biometrika</source>. <year>2006</year>;<volume>93</volume>(<issue>3</issue>):<fpage>509</fpage>–<lpage>524</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/biomet/93.3.509</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>L</given-names></name>, <name><surname>Craiu</surname><given-names>RV</given-names></name>, <name><surname>Paterson</surname><given-names>AD</given-names></name>, <name><surname>Bull</surname><given-names>SB</given-names></name>. <article-title>Stratified False Discovery Control for Large-Scale Hypothesis Testing with Application to Genome-Wide Association Studies</article-title>. <source>Genetic Epidemiology</source>. <year>2006</year>;<volume>30</volume>(<issue>6</issue>):<fpage>519</fpage>–<lpage>530</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/gepi.20164</pub-id><?supplied-pmid 16800000?><pub-id pub-id-type="pmid">16800000</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>JX</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>, <name><surname>Zhou</surname><given-names>HH</given-names></name>. <article-title>False Discovery Rate Control With Groups</article-title>. <source>Journal of the American Statistical Association</source>. <year>2010</year>;<volume>105</volume>(<issue>491</issue>):<fpage>1215</fpage>–<lpage>1227</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1198/jasa.2010.tm09329</pub-id><?supplied-pmid 21931466?><pub-id pub-id-type="pmid">21931466</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Ignatiadis</surname><given-names>N</given-names></name>, <name><surname>Klaus</surname><given-names>B</given-names></name>, <name><surname>Zaugg</surname><given-names>JB</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>. <article-title>Data-Driven Hypothesis Weighting Increases Detection Power in Genome-Scale Multiple Testing</article-title>. <source>Nature Methods</source>. <year>2016</year>;<volume>13</volume>(<issue>7</issue>):<fpage>577</fpage>–<lpage>580</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.3885</pub-id><?supplied-pmid 27240256?><pub-id pub-id-type="pmid">27240256</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Ferkingstad</surname><given-names>E</given-names></name>, <name><surname>Frigessi</surname><given-names>A</given-names></name>, <name><surname>Rue</surname><given-names>H</given-names></name>, <name><surname>Thorleifsson</surname><given-names>G</given-names></name>, <name><surname>Kong</surname><given-names>A</given-names></name>. <article-title>Unsupervised Empirical Bayesian Multiple Testing with External Covariates</article-title>. <source>The Annals of Applied Statistics</source>. <year>2008</year>;<volume>2</volume>(<issue>2</issue>):<fpage>714</fpage>–<lpage>735</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1214/08-AOAS158</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Basu</surname><given-names>P</given-names></name>, <name><surname>Cai</surname><given-names>TT</given-names></name>, <name><surname>Das</surname><given-names>K</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>. <article-title>Weighted False Discovery Rate Control in Large-Scale Multiple Testing</article-title>. <source>Journal of the American Statistical Association</source>. <year>2018</year>;<volume>113</volume>(<issue>523</issue>):<fpage>1172</fpage>–<lpage>1183</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/01621459.2017.1336443</pub-id><?supplied-pmid 31011234?><pub-id pub-id-type="pmid">31011234</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Bourgon</surname><given-names>R</given-names></name>, <name><surname>Gentleman</surname><given-names>R</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>. <article-title>Independent Filtering Increases Detection Power for High-Throughput Experiments</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2010</year>;<volume>107</volume>(<issue>21</issue>):<fpage>9546</fpage>–<lpage>9551</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.0914005107</pub-id><?supplied-pmid 20460310?><pub-id pub-id-type="pmid">20460310</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref010">
      <label>10</label>
      <mixed-citation publication-type="other">Lei L, Fithian W. AdaPT: An Interactive Procedure for Multiple Testing with Side Information. arXiv:160906035 [stat]. 2018.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref011">
      <label>11</label>
      <mixed-citation publication-type="other">Li A, Barber RF. Multiple Testing with the Structure Adaptive Benjamini-Hochberg Algorithm. arXiv:160607926 [stat]. 2017.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Roeder</surname><given-names>K</given-names></name>, <name><surname>Wasserman</surname><given-names>L</given-names></name>. <article-title>Genome-Wide Significance Levels and Weighted Hypothesis Testing</article-title>. <source>Statistical Science</source>. <year>2009</year>;<volume>24</volume>(<issue>4</issue>):<fpage>398</fpage>–<lpage>413</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1214/09-STS289</pub-id><?supplied-pmid 20711421?><pub-id pub-id-type="pmid">20711421</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>TT</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>. <article-title>Covariate-Assisted Ranking and Screening for Large-Scale Two-Sample Inference</article-title>. <source>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</source>. <year>2019</year>;<volume>81</volume>(<issue>2</issue>):<fpage>187</fpage>–<lpage>234</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/rssb.12304</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Yao</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>. <article-title>GenoWAP: GWAS Signal Prioritization through Integrated Analysis of Genomic Functional Annotation</article-title>. <source>Bioinformatics</source>. <year>2016</year>;<volume>32</volume>(<issue>4</issue>):<fpage>542</fpage>–<lpage>548</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btv610</pub-id><?supplied-pmid 26504140?><pub-id pub-id-type="pmid">26504140</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Kichaev</surname><given-names>G</given-names></name>, <name><surname>Bhatia</surname><given-names>G</given-names></name>, <name><surname>Loh</surname><given-names>PR</given-names></name>, <name><surname>Gazal</surname><given-names>S</given-names></name>, <name><surname>Burch</surname><given-names>K</given-names></name>, <name><surname>Freund</surname><given-names>MK</given-names></name>, <etal>et al</etal>. <article-title>Leveraging Polygenic Functional Enrichment to Improve GWAS Power</article-title>. <source>American Journal of Human Genetics</source>. <year>2019</year>;<volume>104</volume>(<issue>1</issue>):<fpage>65</fpage>–<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.11.008</pub-id><?supplied-pmid 30595370?><pub-id pub-id-type="pmid">30595370</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Pickrell</surname><given-names>JK</given-names></name>. <article-title>Joint Analysis of Functional Genomic Data and Genome-Wide Association Studies of 18 Human Traits</article-title>. <source>American Journal of Human Genetics</source>. <year>2014</year>;<volume>94</volume>(<issue>4</issue>):<fpage>559</fpage>–<lpage>573</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.004</pub-id><?supplied-pmid 24702953?><pub-id pub-id-type="pmid">24702953</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Hou</surname><given-names>L</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>. <article-title>A Review of Post-GWAS Prioritization Approaches</article-title>. <source>Frontiers in Genetics</source>. <year>2013</year>;<volume>4</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fgene.2013.00280</pub-id><?supplied-pmid 24367376?><pub-id pub-id-type="pmid">24367376</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Sveinbjornsson</surname><given-names>G</given-names></name>, <name><surname>Albrechtsen</surname><given-names>A</given-names></name>, <name><surname>Zink</surname><given-names>F</given-names></name>, <name><surname>Gudjonsson</surname><given-names>SA</given-names></name>, <name><surname>Oddson</surname><given-names>A</given-names></name>, <name><surname>Másson</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Weighting Sequence Variants Based on Their Annotation Increases Power of Whole-Genome Association Studies</article-title>. <source>Nature Genetics</source>. <year>2016</year>;<volume>48</volume>(<issue>3</issue>):<fpage>314</fpage>–<lpage>317</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3507</pub-id><?supplied-pmid 26854916?><pub-id pub-id-type="pmid">26854916</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Roeder</surname><given-names>K</given-names></name>, <name><surname>Devlin</surname><given-names>B</given-names></name>, <name><surname>Wasserman</surname><given-names>L</given-names></name>. <article-title>Improving Power in Genome-Wide Association Studies: Weights Tip the Scale</article-title>. <source>Genetic Epidemiology</source>. <year>2007</year>;<volume>31</volume>(<issue>7</issue>):<fpage>741</fpage>–<lpage>747</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/gepi.20237</pub-id><?supplied-pmid 17549760?><pub-id pub-id-type="pmid">17549760</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Eskin</surname><given-names>E</given-names></name>. <article-title>Increasing Power in Association Studies by Using Linkage Disequilibrium Structure and Molecular Function as Prior Information</article-title>. <source>Genome Research</source>. <year>2008</year>;<volume>18</volume>(<issue>4</issue>):<fpage>653</fpage>–<lpage>660</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.072785.107</pub-id><?supplied-pmid 18353808?><pub-id pub-id-type="pmid">18353808</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Darnell</surname><given-names>G</given-names></name>, <name><surname>Duong</surname><given-names>D</given-names></name>, <name><surname>Han</surname><given-names>B</given-names></name>, <name><surname>Eskin</surname><given-names>E</given-names></name>. <article-title>Incorporating Prior Information into Association Studies</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>(<issue>12</issue>):<fpage>i147</fpage>–<lpage>i153</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bts235</pub-id><?supplied-pmid 22689754?><pub-id pub-id-type="pmid">22689754</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Wen</surname><given-names>X</given-names></name>, <name><surname>Lee</surname><given-names>Y</given-names></name>, <name><surname>Luca</surname><given-names>F</given-names></name>, <name><surname>Pique-Regi</surname><given-names>R</given-names></name>. <article-title>Efficient Integrative Multi-SNP Association Analysis via Deterministic Approximation of Posteriors</article-title>. <source>American Journal of Human Genetics</source>. <year>2016</year>;<volume>98</volume>(<issue>6</issue>):<fpage>1114</fpage>–<lpage>1129</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.029</pub-id><?supplied-pmid 27236919?><pub-id pub-id-type="pmid">27236919</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Hochberg</surname><given-names>Y</given-names></name>. <article-title>Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing</article-title>. <source>Journal of the Royal Statistical Society Series B (Methodological)</source>. <year>1995</year>;<volume>57</volume>(<issue>1</issue>):<fpage>289</fpage>–<lpage>300</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Holm</surname><given-names>S</given-names></name>. <article-title>A Simple Sequentially Rejective Multiple Test Procedure</article-title>. <source>Scandinavian Journal of Statistics</source>. <year>1979</year>;<volume>6</volume>(<issue>2</issue>):<fpage>65</fpage>–<lpage>70</lpage>.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Krieger</surname><given-names>AM</given-names></name>, <name><surname>Yekutieli</surname><given-names>D</given-names></name>. <article-title>Adaptive Linear Step-up Procedures That Control the False Discovery Rate</article-title>. <source>Biometrika</source>. <year>2006</year>;<volume>93</volume>(<issue>3</issue>):<fpage>491</fpage>–<lpage>507</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/biomet/93.3.491</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Finucane</surname><given-names>HK</given-names></name>, <name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name>, <name><surname>Gusev</surname><given-names>A</given-names></name>, <name><surname>Trynka</surname><given-names>G</given-names></name>, <name><surname>Reshef</surname><given-names>Y</given-names></name>, <name><surname>Loh</surname><given-names>PR</given-names></name>, <etal>et al</etal>. <article-title>Partitioning Heritability by Functional Annotation Using Genome-Wide Association Summary Statistics</article-title>. <source>Nature Genetics</source>. <year>2015</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1228</fpage>–<lpage>1235</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3404</pub-id><?supplied-pmid 26414678?><pub-id pub-id-type="pmid">26414678</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Gazal</surname><given-names>S</given-names></name>, <name><surname>Finucane</surname><given-names>HK</given-names></name>, <name><surname>Furlotte</surname><given-names>NA</given-names></name>, <name><surname>Loh</surname><given-names>PR</given-names></name>, <name><surname>Palamara</surname><given-names>PF</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Linkage Disequilibrium–Dependent Architecture of Human Complex Traits Shows Action of Negative Selection</article-title>. <source>Nature Genetics</source>. <year>2017</year>;<volume>49</volume>(<issue>10</issue>):<fpage>1421</fpage>–<lpage>1427</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3954</pub-id><?supplied-pmid 28892061?><pub-id pub-id-type="pmid">28892061</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Storey</surname><given-names>JD</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>. <article-title>Statistical Significance for Genomewide Studies</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2003</year>;<volume>100</volume>(<issue>16</issue>):<fpage>9440</fpage>–<lpage>9445</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1530509100</pub-id><?supplied-pmid 12883005?><pub-id pub-id-type="pmid">12883005</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>J</given-names></name>, <name><surname>Cheng</surname><given-names>Y</given-names></name>, <name><surname>Cheung</surname><given-names>KH</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>. <article-title>A Statistical Framework to Predict Functional Non-Coding Regions in the Human Genome Through Integrated Analysis of Annotation Data</article-title>. <source>Scientific Reports</source>. <year>2015</year>;<volume>5</volume>(<issue>1</issue>):<fpage>10576</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/srep10576</pub-id><?supplied-pmid 26015273?><pub-id pub-id-type="pmid">26015273</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Storey</surname><given-names>JD</given-names></name>. <article-title>A Direct Approach to False Discovery Rates</article-title>. <source>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</source>. <year>2002</year>;<volume>64</volume>(<issue>3</issue>):<fpage>479</fpage>–<lpage>498</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/1467-9868.00346</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Boca</surname><given-names>SM</given-names></name>, <name><surname>Leek</surname><given-names>JT</given-names></name>. <article-title>A Direct Approach to Estimating False Discovery Rates Conditional on Covariates</article-title>. <source>PeerJ</source>. <year>2018</year>;<volume>6</volume>:<fpage>e6035</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7717/peerj.6035</pub-id><?supplied-pmid 30581661?><pub-id pub-id-type="pmid">30581661</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Efron</surname><given-names>B</given-names></name>. <article-title>Large-Scale Simultaneous Hypothesis Testing</article-title>. <source>Journal of the American Statistical Association</source>. <year>2004</year>;<volume>99</volume>(<issue>465</issue>):<fpage>96</fpage>–<lpage>104</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1198/016214504000000089</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>TT</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>. <article-title>Simultaneous Testing of Grouped Hypotheses: Finding Needles in Multiple Haystacks</article-title>. <source>Journal of the American Statistical Association</source>. <year>2009</year>;<volume>104</volume>(<issue>488</issue>):<fpage>1467</fpage>–<lpage>1481</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1198/jasa.2009.tm08415</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Ploner</surname><given-names>A</given-names></name>, <name><surname>Calza</surname><given-names>S</given-names></name>, <name><surname>Gusnanto</surname><given-names>A</given-names></name>, <name><surname>Pawitan</surname><given-names>Y</given-names></name>. <article-title>Multidimensional Local False Discovery Rate for Microarray Studies</article-title>. <source>Bioinformatics (Oxford, England)</source>. <year>2006</year>;<volume>22</volume>(<issue>5</issue>):<fpage>556</fpage>–<lpage>565</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btk013</pub-id><?supplied-pmid 16368770?><pub-id pub-id-type="pmid">16368770</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Barber</surname><given-names>RF</given-names></name>, <name><surname>Candès</surname><given-names>EJ</given-names></name>. <article-title>Controlling the False Discovery Rate via Knockoffs</article-title>. <source>Annals of Statistics</source>. <year>2015</year>;<volume>43</volume>(<issue>5</issue>):<fpage>2055</fpage>–<lpage>2085</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1214/15-AOS1337</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref036">
      <label>36</label>
      <mixed-citation publication-type="other">Lei L, Fithian W. Power of Ordered Hypothesis Testing. arXiv:160601969 [stat]. 2016.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Yurko</surname><given-names>R</given-names></name>, <name><surname>G’Sell</surname><given-names>M</given-names></name>, <name><surname>Roeder</surname><given-names>K</given-names></name>, <name><surname>Devlin</surname><given-names>B</given-names></name>. <article-title>A Selective Inference Approach for False Discovery Rate Control Using Multiomics Covariates Yields Insights into Disease Risk</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2020</year>;<volume>117</volume>(<issue>26</issue>):<fpage>15028</fpage>–<lpage>15035</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1918862117</pub-id><?supplied-pmid 32522875?><pub-id pub-id-type="pmid">32522875</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref038">
      <label>38</label>
      <mixed-citation publication-type="other">Ignatiadis N, Huber W. Covariate Powered Cross-Weighted Multiple Testing. arXiv:170105179 [stat]. 2020.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Andreassen</surname><given-names>OA</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Schork</surname><given-names>AJ</given-names></name>, <name><surname>Ripke</surname><given-names>S</given-names></name>, <name><surname>Mattingsdal</surname><given-names>M</given-names></name>, <name><surname>Kelsoe</surname><given-names>JR</given-names></name>, <etal>et al</etal>. <article-title>Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate</article-title>. <source>PLOS Genetics</source>. <year>2013</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e1003455</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1003455</pub-id><?supplied-pmid 23637625?><pub-id pub-id-type="pmid">23637625</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Andreassen</surname><given-names>OA</given-names></name>, <name><surname>McEvoy Linda</surname><given-names>K</given-names></name>, <name><surname>Thompson Wesley</surname><given-names>K</given-names></name>, <name><surname>Yunpeng</surname><given-names>Wang</given-names></name>, <name><surname>Sjur</surname><given-names>Reppe</given-names></name>, <name><surname>Schork Andrew</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Identifying Common Genetic Variants in Blood Pressure Due to Polygenic Pleiotropy With Associated Phenotypes</article-title>. <source>Hypertension</source>. <year>2014</year>;<volume>63</volume>(<issue>4</issue>):<fpage>819</fpage>–<lpage>826</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02077</pub-id><?supplied-pmid 24396023?><pub-id pub-id-type="pmid">24396023</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Andreassen</surname><given-names>OA</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Dale</surname><given-names>AM</given-names></name>. <article-title>Boosting the Power of Schizophrenia Genetics by Leveraging New Statistical Tools</article-title>. <source>Schizophrenia Bulletin</source>. <year>2014</year>;<volume>40</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/schbul/sbt168</pub-id><?supplied-pmid 24319118?><pub-id pub-id-type="pmid">24319118</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Andreassen</surname><given-names>OA</given-names></name>, <name><surname>Zuber</surname><given-names>V</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Schork</surname><given-names>AJ</given-names></name>, <name><surname>Bettella</surname><given-names>F</given-names></name>, <collab>the PRACTICAL Consortium</collab>, <etal>et al</etal>. <article-title>Shared Common Variants in Prostate Cancer and Blood Lipids</article-title>. <source>International Journal of Epidemiology</source>. <year>2014</year>;<volume>43</volume>(<issue>4</issue>):<fpage>1205</fpage>–<lpage>1214</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyu090</pub-id><?supplied-pmid 24786909?><pub-id pub-id-type="pmid">24786909</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Andreassen</surname><given-names>OA</given-names></name>, <name><surname>Harbo</surname><given-names>HF</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Schork</surname><given-names>AJ</given-names></name>, <name><surname>Mattingsdal</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Genetic Pleiotropy between Multiple Sclerosis and Schizophrenia but Not Bipolar Disorder: Differential Involvement of Immune-Related Gene Loci</article-title>. <source>Molecular Psychiatry</source>. <year>2015</year>;<volume>20</volume>(<issue>2</issue>):<fpage>207</fpage>–<lpage>214</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/mp.2013.195</pub-id><?supplied-pmid 24468824?><pub-id pub-id-type="pmid">24468824</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Liley</surname><given-names>J</given-names></name>, <name><surname>Wallace</surname><given-names>C</given-names></name>. <article-title>Accurate Error Control in High-Dimensional Association Testing Using Conditional False Discovery Rates</article-title>. <source>Biometrical Journal</source>. <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/bimj.201900254</pub-id><?supplied-pmid 33682201?><pub-id pub-id-type="pmid">33682201</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Maurano</surname><given-names>MT</given-names></name>, <name><surname>Humbert</surname><given-names>R</given-names></name>, <name><surname>Rynes</surname><given-names>E</given-names></name>, <name><surname>Thurman</surname><given-names>RE</given-names></name>, <name><surname>Haugen</surname><given-names>E</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Systematic Localization of Common Disease-Associated Variation in Regulatory DNA</article-title>. <source>Science</source>. <year>2012</year>;<volume>337</volume>(<issue>6099</issue>):<fpage>1190</fpage>–<lpage>1195</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1222794</pub-id><?supplied-pmid 22955828?><pub-id pub-id-type="pmid">22955828</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Cano-Gamez</surname><given-names>E</given-names></name>, <name><surname>Trynka</surname><given-names>G</given-names></name>. <article-title>From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases</article-title>. <source>Frontiers in Genetics</source>. <year>2020</year>;<volume>11</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fgene.2020.00424</pub-id><?supplied-pmid 32477401?><pub-id pub-id-type="pmid">32477401</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Demenais</surname><given-names>F</given-names></name>, <name><surname>Margaritte-Jeannin</surname><given-names>P</given-names></name>, <name><surname>Barnes</surname><given-names>KC</given-names></name>, <name><surname>Cookson</surname><given-names>WOC</given-names></name>, <name><surname>Altmüller</surname><given-names>J</given-names></name>, <name><surname>Ang</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Multiancestry Association Study Identifies New Asthma Risk Loci That Colocalize with Immune-Cell Enhancer Marks</article-title>. <source>Nature Genetics</source>. <year>2018</year>;<volume>50</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-017-0014-7</pub-id><?supplied-pmid 29273806?><pub-id pub-id-type="pmid">29273806</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Korthauer</surname><given-names>K</given-names></name>, <name><surname>Kimes</surname><given-names>PK</given-names></name>, <name><surname>Duvallet</surname><given-names>C</given-names></name>, <name><surname>Reyes</surname><given-names>A</given-names></name>, <name><surname>Subramanian</surname><given-names>A</given-names></name>, <name><surname>Teng</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A Practical Guide to Methods Controlling False Discoveries in Computational Biology</article-title>. <source>Genome Biology</source>. <year>2019</year>;<volume>20</volume>(<issue>1</issue>):<fpage>118</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13059-019-1716-1</pub-id><?supplied-pmid 31164141?><pub-id pub-id-type="pmid">31164141</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Sudlow</surname><given-names>C</given-names></name>, <name><surname>Gallacher</surname><given-names>J</given-names></name>, <name><surname>Allen</surname><given-names>N</given-names></name>, <name><surname>Beral</surname><given-names>V</given-names></name>, <name><surname>Burton</surname><given-names>P</given-names></name>, <name><surname>Danesh</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age</article-title>. <source>PLoS Medicine</source>. <year>2015</year>;<volume>12</volume>(<issue>3</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><?supplied-pmid 25826379?><pub-id pub-id-type="pmid">25826379</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Efron</surname><given-names>B</given-names></name>. <article-title>Size, Power and False Discovery Rates</article-title>. <source>Annals of Statistics</source>. <year>2007</year>;<volume>35</volume>(<issue>4</issue>):<fpage>1351</fpage>–<lpage>1377</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1214/009053606000001460</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref051">
      <label>51</label>
      <mixed-citation publication-type="other">Wen X. A Unified View of False Discovery Rate Control: Reconciliation of Bayesian and Frequentist Approaches. arXiv:180305284 [stat]. 2018.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Liley</surname><given-names>J</given-names></name>, <name><surname>Wallace</surname><given-names>C</given-names></name>. <article-title>A Pleiotropy-Informed Bayesian False Discovery Rate Adapted to a Shared Control Design Finds New Disease Associations From GWAS Summary Statistics</article-title>. <source>PLOS Genetics</source>. <year>2015</year>;<volume>11</volume>(<issue>2</issue>):<fpage>e1004926</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1004926</pub-id><?supplied-pmid 25658688?><pub-id pub-id-type="pmid">25658688</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref053">
      <label>53</label>
      <mixed-citation publication-type="book"><name><surname>Silverman</surname><given-names>B</given-names></name>. <source>Density Estimation for Statistics and Data Analysis</source>. <publisher-name>Chapman &amp; Hall</publisher-name>; <year>1986</year>.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref054">
      <label>54</label>
      <mixed-citation publication-type="book"><name><surname>Venables</surname><given-names>WN</given-names></name>, <name><surname>Ripley</surname><given-names>BD</given-names></name>. <part-title>Modern Applied Statistics with S</part-title>. <edition designator="4">4th ed</edition>. <source>Statistics and Computing</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>; <year>2002</year>.</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Speed</surname><given-names>D</given-names></name>, <name><surname>Holmes</surname><given-names>J</given-names></name>, <name><surname>Balding</surname><given-names>DJ</given-names></name>. <article-title>Evaluating and Improving Heritability Models Using Summary Statistics</article-title>. <source>Nature Genetics</source>. <year>2020</year>;<volume>52</volume>(<issue>4</issue>):<fpage>458</fpage>–<lpage>462</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-020-0600-y</pub-id><?supplied-pmid 32203469?><pub-id pub-id-type="pmid">32203469</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>CC</given-names></name>, <name><surname>Chow</surname><given-names>CC</given-names></name>, <name><surname>Tellier</surname><given-names>LC</given-names></name>, <name><surname>Vattikuti</surname><given-names>S</given-names></name>, <name><surname>Purcell</surname><given-names>SM</given-names></name>, <name><surname>Lee</surname><given-names>JJ</given-names></name>. <article-title>Second-Generation PLINK: Rising to the Challenge of Larger and Richer Datasets</article-title>. <source>GigaScience</source>. <year>2015</year>;<volume>4</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id><?supplied-pmid 25722852?><pub-id pub-id-type="pmid">25722852</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><collab>The UK10K Consortium</collab>. <article-title>The UK10K Project Identifies Rare Variants in Health and Disease</article-title>. <source>Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7571</issue>):<fpage>82</fpage>–<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature14962</pub-id><pub-id pub-id-type="pmid">26367797</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref058">
      <label>58</label>
      <mixed-citation publication-type="journal"><name><surname>Berisa</surname><given-names>T</given-names></name>, <name><surname>Pickrell</surname><given-names>JK</given-names></name>. <article-title>Approximately Independent Linkage Disequilibrium Blocks in Human Populations</article-title>. <source>Bioinformatics</source>. <year>2016</year>;<volume>32</volume>(<issue>2</issue>):<fpage>283</fpage>–<lpage>285</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btv546</pub-id><?supplied-pmid 26395773?><pub-id pub-id-type="pmid">26395773</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Wellcome Trust Case Control</surname><given-names>Consortium</given-names></name>. <article-title>Genome-Wide Association Study of 14,000 Cases of Seven Common Diseases and 3,000 Shared Controls</article-title>. <source>Nature</source>. <year>2007</year>;<volume>447</volume>(<issue>7145</issue>):<fpage>661</fpage>–<lpage>678</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature05911</pub-id><pub-id pub-id-type="pmid">17554300</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Fortune</surname><given-names>MD</given-names></name>, <name><surname>Wallace</surname><given-names>C</given-names></name>. <article-title>simGWAS: A Fast Method for Simulation of Large Scale Case–Control GWAS Summary Statistics</article-title>. <source>Bioinformatics</source>. <year>2019</year>;<volume>35</volume>(<issue>11</issue>):<fpage>1901</fpage>–<lpage>1906</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/bty898</pub-id><?supplied-pmid 30371734?><pub-id pub-id-type="pmid">30371734</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref061">
      <label>61</label>
      <mixed-citation publication-type="journal"><name><surname>Speed</surname><given-names>D</given-names></name>, <name><surname>Cai</surname><given-names>N</given-names></name>, <name><surname>Johnson</surname><given-names>MR</given-names></name>, <name><surname>Nejentsev</surname><given-names>S</given-names></name>, <name><surname>Balding</surname><given-names>DJ</given-names></name>. <article-title>Re-Evaluation of SNP Heritability in Complex Human Traits</article-title>. <source>Nature genetics</source>. <year>2017</year>;<volume>49</volume>(<issue>7</issue>):<fpage>986</fpage>–<lpage>992</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.3865</pub-id><?supplied-pmid 28530675?><pub-id pub-id-type="pmid">28530675</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref062">
      <label>62</label>
      <mixed-citation publication-type="journal"><name><surname>Buniello</surname><given-names>A</given-names></name>, <name><surname>MacArthur</surname><given-names>JAL</given-names></name>, <name><surname>Cerezo</surname><given-names>M</given-names></name>, <name><surname>Harris</surname><given-names>LW</given-names></name>, <name><surname>Hayhurst</surname><given-names>J</given-names></name>, <name><surname>Malangone</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>The NHGRI-EBI GWAS Catalog of Published Genome-Wide Association Studies, Targeted Arrays and Summary Statistics</article-title>. <source>Nucleic Acids Research</source>. <year>2019</year>;<volume>47</volume>(<issue>D1</issue>):<fpage>D1005</fpage>–<lpage>D1012</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id><?supplied-pmid 30445434?><pub-id pub-id-type="pmid">30445434</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref063">
      <label>63</label>
      <mixed-citation publication-type="journal"><name><surname>Kuhn</surname><given-names>RM</given-names></name>, <name><surname>Haussler</surname><given-names>D</given-names></name>, <name><surname>Kent</surname><given-names>WJ</given-names></name>. <article-title>The UCSC Genome Browser and Associated Tools</article-title>. <source>Briefings in Bioinformatics</source>. <year>2013</year>;<volume>14</volume>(<issue>2</issue>):<fpage>144</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bib/bbs038</pub-id><?supplied-pmid 22908213?><pub-id pub-id-type="pmid">22908213</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref064">
      <label>64</label>
      <mixed-citation publication-type="journal"><collab>The 1000 Genomes Project Consortium</collab>. <article-title>A Global Reference for Human Genetic Variation</article-title>. <source>Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7571</issue>):<fpage>68</fpage>–<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Boyle</surname><given-names>AP</given-names></name>, <name><surname>Hong</surname><given-names>EL</given-names></name>, <name><surname>Hariharan</surname><given-names>M</given-names></name>, <name><surname>Cheng</surname><given-names>Y</given-names></name>, <name><surname>Schaub</surname><given-names>MA</given-names></name>, <name><surname>Kasowski</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Annotation of Functional Variation in Personal Genomes Using RegulomeDB</article-title>. <source>Genome Research</source>. <year>2012</year>;<volume>22</volume>(<issue>9</issue>):<fpage>1790</fpage>–<lpage>1797</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.137323.112</pub-id><?supplied-pmid 22955989?><pub-id pub-id-type="pmid">22955989</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Khurana</surname><given-names>E</given-names></name>, <name><surname>Fu</surname><given-names>Y</given-names></name>, <name><surname>Colonna</surname><given-names>V</given-names></name>, <name><surname>Mu</surname><given-names>XJ</given-names></name>, <name><surname>Kang</surname><given-names>HM</given-names></name>, <name><surname>Lappalainen</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics</article-title>. <source>Science</source>. <year>2013</year>;<volume>342</volume> (<issue>6154</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1235587</pub-id>
<?supplied-pmid 24092746?><pub-id pub-id-type="pmid">24092746</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Ritchie</surname><given-names>GRS</given-names></name>, <name><surname>Dunham</surname><given-names>I</given-names></name>, <name><surname>Zeggini</surname><given-names>E</given-names></name>, <name><surname>Flicek</surname><given-names>P</given-names></name>. <article-title>Functional Annotation of Noncoding Sequence Variants</article-title>. <source>Nature Methods</source>. <year>2014</year>;<volume>11</volume>(<issue>3</issue>):<fpage>294</fpage>–<lpage>296</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth.2832</pub-id><?supplied-pmid 24487584?><pub-id pub-id-type="pmid">24487584</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>, <name><surname>Witten</surname><given-names>DM</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>O’Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>. <article-title>A General Framework for Estimating the Relative Pathogenicity of Human Genetic Variants</article-title>. <source>Nature Genetics</source>. <year>2014</year>;<volume>46</volume>(<issue>3</issue>):<fpage>310</fpage>–<lpage>315</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.2892</pub-id><?supplied-pmid 24487276?><pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Creyghton</surname><given-names>MP</given-names></name>, <name><surname>Cheng</surname><given-names>AW</given-names></name>, <name><surname>Welstead</surname><given-names>GG</given-names></name>, <name><surname>Kooistra</surname><given-names>T</given-names></name>, <name><surname>Carey</surname><given-names>BW</given-names></name>, <name><surname>Steine</surname><given-names>EJ</given-names></name>, <etal>et al</etal>. <article-title>Histone H3K27ac Separates Active from Poised Enhancers and Predicts Developmental State</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2010</year>;<volume>107</volume>(<issue>50</issue>):<fpage>21931</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1016071107</pub-id><?supplied-pmid 21106759?><pub-id pub-id-type="pmid">21106759</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Corradin</surname><given-names>O</given-names></name>, <name><surname>Scacheri</surname><given-names>PC</given-names></name>. <article-title>Enhancer Variants: Evaluating Functions in Common Disease</article-title>. <source>Genome Medicine</source>. <year>2014</year>;<volume>6</volume>(<issue>10</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13073-014-0085-3</pub-id><?supplied-pmid 25473424?><pub-id pub-id-type="pmid">25473424</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Bernstein</surname><given-names>BE</given-names></name>, <name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name>, <name><surname>Costello</surname><given-names>JF</given-names></name>, <name><surname>Ren</surname><given-names>B</given-names></name>, <name><surname>Milosavljevic</surname><given-names>A</given-names></name>, <name><surname>Meissner</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The NIH Roadmap Epigenomics Mapping Consortium</article-title>. <source>Nature biotechnology</source>. <year>2010</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1045</fpage>–<lpage>1048</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nbt1010-1045</pub-id><?supplied-pmid 20944595?><pub-id pub-id-type="pmid">20944595</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Quinlan</surname><given-names>AR</given-names></name>, <name><surname>Hall</surname><given-names>IM</given-names></name>. <article-title>BEDTools: A Flexible Suite of Utilities for Comparing Genomic Features</article-title>. <source>Bioinformatics</source>. <year>2010</year>;<volume>26</volume>(<issue>6</issue>):<fpage>841</fpage>–<lpage>842</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><?supplied-pmid 20110278?><pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref073">
      <label>73</label>
      <mixed-citation publication-type="other">Leek JT, Jager L, Boca SM, Konopka T. Swfdr: Science-Wise False Discovery Rate and Proportion of True Null Hypotheses Estimation; 2021. Bioconductor version: Release (3.12).</mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref074">
      <label>74</label>
      <mixed-citation publication-type="journal"><name><surname>Villar</surname><given-names>D</given-names></name>, <name><surname>Berthelot</surname><given-names>C</given-names></name>, <name><surname>Aldridge</surname><given-names>S</given-names></name>, <name><surname>Rayner</surname><given-names>TF</given-names></name>, <name><surname>Lukk</surname><given-names>M</given-names></name>, <name><surname>Pignatelli</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Enhancer Evolution across 20 Mammalian Species</article-title>. <source>Cell</source>. <year>2015</year>;<volume>160</volume>(<issue>3</issue>):<fpage>554</fpage>–<lpage>566</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2015.01.006</pub-id><?supplied-pmid 25635462?><pub-id pub-id-type="pmid">25635462</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref075">
      <label>75</label>
      <mixed-citation publication-type="journal"><name><surname>Marnetto</surname><given-names>D</given-names></name>, <name><surname>Mantica</surname><given-names>F</given-names></name>, <name><surname>Molineris</surname><given-names>I</given-names></name>, <name><surname>Grassi</surname><given-names>E</given-names></name>, <name><surname>Pesando</surname><given-names>I</given-names></name>, <name><surname>Provero</surname><given-names>P</given-names></name>. <article-title>Evolutionary Rewiring of Human Regulatory Networks by Waves of Genome Expansion</article-title>. <source>The American Journal of Human Genetics</source>. <year>2018</year>;<volume>102</volume>(<issue>2</issue>):<fpage>207</fpage>–<lpage>218</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.12.014</pub-id><?supplied-pmid 29357977?><pub-id pub-id-type="pmid">29357977</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref076">
      <label>76</label>
      <mixed-citation publication-type="journal"><name><surname>Hujoel</surname><given-names>MLA</given-names></name>, <name><surname>Gazal</surname><given-names>S</given-names></name>, <name><surname>Hormozdiari</surname><given-names>F</given-names></name>, <name><surname>van de Geijn</surname><given-names>B</given-names></name>, <name><surname>Price</surname><given-names>AL</given-names></name>. <article-title>Disease Heritability Enrichment of Regulatory Elements Is Concentrated in Elements with Ancient Sequence Age and Conserved Function across Species</article-title>. <source>The American Journal of Human Genetics</source>. <year>2019</year>;<volume>104</volume>(<issue>4</issue>):<fpage>611</fpage>–<lpage>624</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajhg.2019.02.008</pub-id><?supplied-pmid 30905396?><pub-id pub-id-type="pmid">30905396</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref077">
      <label>77</label>
      <mixed-citation publication-type="journal"><name><surname>Soskic</surname><given-names>B</given-names></name>, <name><surname>Cano-Gamez</surname><given-names>E</given-names></name>, <name><surname>Smyth</surname><given-names>DJ</given-names></name>, <name><surname>Rowan</surname><given-names>WC</given-names></name>, <name><surname>Nakic</surname><given-names>N</given-names></name>, <name><surname>Esparza-Gordillo</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Chromatin Activity at GWAS Loci Identifies T Cell States Driving Complex Immune Diseases</article-title>. <source>Nature Genetics</source>. <year>2019</year>;<volume>51</volume>(<issue>10</issue>):<fpage>1486</fpage>–<lpage>1493</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-019-0493-9</pub-id><?supplied-pmid 31548716?><pub-id pub-id-type="pmid">31548716</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref078">
      <label>78</label>
      <mixed-citation publication-type="journal"><name><surname>Villarreal-Martínez</surname><given-names>A</given-names></name>, <name><surname>Gallardo-Blanco</surname><given-names>H</given-names></name>, <name><surname>Cerda-Flores</surname><given-names>R</given-names></name>, <name><surname>Torres-Muñoz</surname><given-names>I</given-names></name>, <name><surname>Gómez-Flores</surname><given-names>M</given-names></name>, <name><surname>Salas-Alanís</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Candidate Gene Polymorphisms and Risk of Psoriasis: A Pilot Study</article-title>. <source>Experimental and Therapeutic Medicine</source>. <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>1217</fpage>–<lpage>1222</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3892/etm.2016.3066</pub-id><?supplied-pmid 27073425?><pub-id pub-id-type="pmid">27073425</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref079">
      <label>79</label>
      <mixed-citation publication-type="journal"><name><surname>Hewitt</surname><given-names>EW</given-names></name>. <article-title>The MHC Class I Antigen Presentation Pathway: Strategies for Viral Immune Evasion</article-title>. <source>Immunology</source>. <year>2003</year>;<volume>110</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>169</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2567.2003.01738.x</pub-id><?supplied-pmid 14511229?><pub-id pub-id-type="pmid">14511229</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref080">
      <label>80</label>
      <mixed-citation publication-type="journal"><name><surname>Tomer</surname><given-names>Y</given-names></name>, <name><surname>Dolan</surname><given-names>LM</given-names></name>, <name><surname>Kahaly</surname><given-names>G</given-names></name>, <name><surname>Divers</surname><given-names>J</given-names></name>, <name><surname>D’Agostino</surname><given-names>RB</given-names></name>, <name><surname>Imperatore</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Genome Wide Identification of New Genes and Pathways in Patients with Both Autoimmune Thyroiditis and Type 1 Diabetes</article-title>. <source>Journal of Autoimmunity</source>. <year>2015</year>;<volume>60</volume>:<fpage>32</fpage>–<lpage>39</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaut.2015.03.006</pub-id><?supplied-pmid 25936594?><pub-id pub-id-type="pmid">25936594</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref081">
      <label>81</label>
      <mixed-citation publication-type="journal"><name><surname>Carvalho-Silva</surname><given-names>D</given-names></name>, <name><surname>Pierleoni</surname><given-names>A</given-names></name>, <name><surname>Pignatelli</surname><given-names>M</given-names></name>, <name><surname>Ong</surname><given-names>C</given-names></name>, <name><surname>Fumis</surname><given-names>L</given-names></name>, <name><surname>Karamanis</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Open Targets Platform: New Developments and Updates Two Years On</article-title>. <source>Nucleic Acids Research</source>. <year>2019</year>;<volume>47</volume>(<issue>D1</issue>):<fpage>D1056</fpage>–<lpage>D1065</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gky1133</pub-id><?supplied-pmid 30462303?><pub-id pub-id-type="pmid">30462303</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref082">
      <label>82</label>
      <mixed-citation publication-type="journal"><name><surname>Naderi</surname><given-names>M</given-names></name>, <name><surname>Hashemi</surname><given-names>M</given-names></name>, <name><surname>Amininia</surname><given-names>S</given-names></name>. <article-title>Association of TAP1 and TAP2 Gene Polymorphisms with Susceptibility to Pulmonary Tuberculosis</article-title>. <source>Iranian Journal of Allergy, Asthma and Immunology</source>. <year>2016</year>; p. <fpage>62</fpage>–<lpage>68</lpage>. <?supplied-pmid 26996113?><pub-id pub-id-type="pmid">26996113</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref083">
      <label>83</label>
      <mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>P</given-names></name>, <name><surname>Xu</surname><given-names>G</given-names></name>, <name><surname>Yu</surname><given-names>F</given-names></name>, <name><surname>Ma</surname><given-names>Y</given-names></name>. <article-title>Integrative Genomics Analysis of Various Omics Data and Networks Identify Risk Genes and Variants Vulnerable to Childhood-Onset Asthma</article-title>. <source>BMC Medical Genomics</source>. <year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>123</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12920-020-00768-z</pub-id><?supplied-pmid 32867763?><pub-id pub-id-type="pmid">32867763</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref084">
      <label>84</label>
      <mixed-citation publication-type="journal"><name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Kamanaka</surname><given-names>M</given-names></name>, <name><surname>Tanaka</surname><given-names>T</given-names></name>, <name><surname>Kishimoto</surname><given-names>T</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name>. <article-title>Impaired IL-13-Mediated Functions of Macrophages in STAT6-Deficient Mice</article-title>. <source>The Journal of Immunology</source>. <year>1996</year>;<volume>157</volume>(<issue>8</issue>):<fpage>3220</fpage>–<lpage>3222</lpage>. <?supplied-pmid 8871614?><pub-id pub-id-type="pmid">8871614</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref085">
      <label>85</label>
      <mixed-citation publication-type="journal"><name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Tanaka</surname><given-names>T</given-names></name>, <name><surname>Shi</surname><given-names>W</given-names></name>, <name><surname>Matsumoto</surname><given-names>M</given-names></name>, <name><surname>Minami</surname><given-names>M</given-names></name>, <name><surname>Kashiwamura</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Essential Role of Stat6 in IL-4 Signalling</article-title>. <source>Nature</source>. <year>1996</year>;<volume>380</volume>(<issue>6575</issue>):<fpage>627</fpage>–<lpage>630</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/380627a0</pub-id><?supplied-pmid 8602263?><pub-id pub-id-type="pmid">8602263</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref086">
      <label>86</label>
      <mixed-citation publication-type="journal"><name><surname>Ohmori</surname><given-names>Y</given-names></name>, <name><surname>Hamilton</surname><given-names>TA</given-names></name>. <article-title>Interleukin-4/STAT6 Represses STAT1 and NF-Kappa B-Dependent Transcription through Distinct Mechanisms</article-title>. <source>The Journal of Biological Chemistry</source>. <year>2000</year>;<volume>275</volume>(<issue>48</issue>):<fpage>38095</fpage>–<lpage>38103</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1074/jbc.M006227200</pub-id><?supplied-pmid 10982806?><pub-id pub-id-type="pmid">10982806</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref087">
      <label>87</label>
      <mixed-citation publication-type="journal"><name><surname>Albanesi</surname><given-names>C</given-names></name>, <name><surname>Fairchild</surname><given-names>HR</given-names></name>, <name><surname>Madonna</surname><given-names>S</given-names></name>, <name><surname>Scarponi</surname><given-names>C</given-names></name>, <name><surname>Pità</surname><given-names>OD</given-names></name>, <name><surname>Leung</surname><given-names>DYM</given-names></name>, <etal>et al</etal>. <article-title>IL-4 and IL-13 Negatively Regulate TNF-<italic toggle="yes">α</italic>- and IFN-<italic toggle="yes">γ</italic>-Induced <italic toggle="yes">β</italic>-Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-3</article-title>. <source>The Journal of Immunology</source>. <year>2007</year>;<volume>179</volume>(<issue>2</issue>):<fpage>984</fpage>–<lpage>992</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.179.2.984</pub-id><?supplied-pmid 17617590?><pub-id pub-id-type="pmid">17617590</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref088">
      <label>88</label>
      <mixed-citation publication-type="journal"><name><surname>Bruns</surname><given-names>HA</given-names></name>, <name><surname>Schindler</surname><given-names>U</given-names></name>, <name><surname>Kaplan</surname><given-names>MH</given-names></name>. <article-title>Expression of a Constitutively Active Stat6 in Vivo Alters Lymphocyte Homeostasis with Distinct Effects in T and B Cells</article-title>. <source>Journal of Immunology</source>. <year>2003</year>;<volume>170</volume>(<issue>7</issue>):<fpage>3478</fpage>–<lpage>3487</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.170.7.3478</pub-id><?supplied-pmid 12646608?><pub-id pub-id-type="pmid">12646608</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref089">
      <label>89</label>
      <mixed-citation publication-type="journal"><name><surname>Kaplan</surname><given-names>MH</given-names></name>, <name><surname>Sehra</surname><given-names>S</given-names></name>, <name><surname>Chang</surname><given-names>HC</given-names></name>, <name><surname>O’Malley</surname><given-names>JT</given-names></name>, <name><surname>Mathur</surname><given-names>AN</given-names></name>, <name><surname>Bruns</surname><given-names>HA</given-names></name>. <article-title>Constitutively Active STAT6 Predisposes toward a Lymphoproliferative Disorder</article-title>. <source>Blood</source>. <year>2007</year>;<volume>110</volume>(<issue>13</issue>):<fpage>4367</fpage>–<lpage>4369</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1182/blood-2007-06-098244</pub-id><?supplied-pmid 17878403?><pub-id pub-id-type="pmid">17878403</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref090">
      <label>90</label>
      <mixed-citation publication-type="journal"><name><surname>Kuperman</surname><given-names>DA</given-names></name>, <name><surname>Huang</surname><given-names>X</given-names></name>, <name><surname>Koth</surname><given-names>LL</given-names></name>, <name><surname>Chang</surname><given-names>GH</given-names></name>, <name><surname>Dolganov</surname><given-names>GM</given-names></name>, <name><surname>Zhu</surname><given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Direct Effects of Interleukin-13 on Epithelial Cells Cause Airway Hyperreactivity and Mucus Overproduction in Asthma</article-title>. <source>Nature Medicine</source>. <year>2002</year>;<volume>8</volume>(<issue>8</issue>):<fpage>885</fpage>–<lpage>889</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nm734</pub-id><?supplied-pmid 12091879?><pub-id pub-id-type="pmid">12091879</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref091">
      <label>91</label>
      <mixed-citation publication-type="journal"><name><surname>Grundberg</surname><given-names>E</given-names></name>, <name><surname>Small</surname><given-names>KS</given-names></name>, <name><surname>Hedman</surname><given-names>ÅK</given-names></name>, <name><surname>Nica</surname><given-names>AC</given-names></name>, <name><surname>Buil</surname><given-names>A</given-names></name>, <name><surname>Keildson</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Mapping Cis- and Trans-Regulatory Effects across Multiple Tissues in Twins</article-title>. <source>Nature Genetics</source>. <year>2012</year>;<volume>44</volume>(<issue>10</issue>):<fpage>1084</fpage>–<lpage>1089</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.2394</pub-id><?supplied-pmid 22941192?><pub-id pub-id-type="pmid">22941192</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref092">
      <label>92</label>
      <mixed-citation publication-type="journal"><name><surname>Westra</surname><given-names>HJ</given-names></name>, <name><surname>Peters</surname><given-names>MJ</given-names></name>, <name><surname>Esko</surname><given-names>T</given-names></name>, <name><surname>Yaghootkar</surname><given-names>H</given-names></name>, <name><surname>Schurmann</surname><given-names>C</given-names></name>, <name><surname>Kettunen</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Systematic Identification of Trans eQTLs as Putative Drivers of Known Disease Associations</article-title>. <source>Nature Genetics</source>. <year>2013</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1238</fpage>–<lpage>1243</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.2756</pub-id><pub-id pub-id-type="pmid">24013639</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref093">
      <label>93</label>
      <mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Morar</surname><given-names>N</given-names></name>, <name><surname>Dixon</surname><given-names>AL</given-names></name>, <name><surname>Lathrop</surname><given-names>GM</given-names></name>, <name><surname>Abecasis</surname><given-names>GR</given-names></name>, <name><surname>Moffatt</surname><given-names>MF</given-names></name>, <etal>et al</etal>. <article-title>A Cross-Platform Analysis of 14,177 Expression Quantitative Trait Loci Derived from Lymphoblastoid Cell Lines</article-title>. <source>Genome Research</source>. <year>2013</year>;<volume>23</volume>(<issue>4</issue>):<fpage>716</fpage>–<lpage>726</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/gr.142521.112</pub-id><?supplied-pmid 23345460?><pub-id pub-id-type="pmid">23345460</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref094">
      <label>94</label>
      <mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>K</given-names></name>, <name><surname>Bossé</surname><given-names>Y</given-names></name>, <name><surname>Nickle</surname><given-names>DC</given-names></name>, <name><surname>Paré</surname><given-names>PD</given-names></name>, <name><surname>Postma</surname><given-names>DS</given-names></name>, <name><surname>Laviolette</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma</article-title>. <source>PLOS Genetics</source>. <year>2012</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e1003029</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1003029</pub-id><?supplied-pmid 23209423?><pub-id pub-id-type="pmid">23209423</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref095">
      <label>95</label>
      <mixed-citation publication-type="journal"><name><surname>Howell</surname><given-names>MD</given-names></name>, <name><surname>Gao</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>BE</given-names></name>, <name><surname>Lesley</surname><given-names>LJ</given-names></name>, <name><surname>Streib</surname><given-names>JE</given-names></name>, <name><surname>Taylor</surname><given-names>PA</given-names></name>, <etal>et al</etal>. <article-title>The Signal Transducer and Activator of Transcription 6 Gene (STAT6) Increases the Propensity of Patients with Atopic Dermatitis toward Disseminated Viral Skin Infections</article-title>. <source>The Journal of Allergy and Clinical Immunology</source>. <year>2011</year>;<volume>128</volume>(<issue>5</issue>):<fpage>1006</fpage>–<lpage>1014</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2011.06.003</pub-id><?supplied-pmid 21762972?><pub-id pub-id-type="pmid">21762972</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref096">
      <label>96</label>
      <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>YL</given-names></name>, <name><surname>Yen</surname><given-names>JJY</given-names></name>, <name><surname>Hsu</surname><given-names>LC</given-names></name>, <name><surname>Kuo</surname><given-names>NW</given-names></name>, <name><surname>Su</surname><given-names>MW</given-names></name>, <name><surname>Yang</surname><given-names>MF</given-names></name>, <etal>et al</etal>. <article-title>Association of STAT6 Genetic Variants with Childhood Atopic Dermatitis in Taiwanese Population</article-title>. <source>Journal of Dermatological Science</source>. <year>2015</year>;<volume>79</volume>(<issue>3</issue>):<fpage>222</fpage>–<lpage>228</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jdermsci.2015.05.006</pub-id><?supplied-pmid 26048407?><pub-id pub-id-type="pmid">26048407</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref097">
      <label>97</label>
      <mixed-citation publication-type="journal"><name><surname>Ferreira</surname><given-names>MAR</given-names></name>, <name><surname>Matheson</surname><given-names>MC</given-names></name>, <name><surname>Tang</surname><given-names>CS</given-names></name>, <name><surname>Granell</surname><given-names>R</given-names></name>, <name><surname>Ang</surname><given-names>W</given-names></name>, <name><surname>Hui</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Genome-Wide Association Analysis Identifies 11 Risk Variants Associated with the Asthma with Hay Fever Phenotype</article-title>. <source>The Journal of Allergy and Clinical Immunology</source>. <year>2014</year>;<volume>133</volume>(<issue>6</issue>):<fpage>1564</fpage>–<lpage>1571</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2013.10.030</pub-id><?supplied-pmid 24388013?><pub-id pub-id-type="pmid">24388013</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref098">
      <label>98</label>
      <mixed-citation publication-type="journal"><name><surname>Ferreira</surname><given-names>MAR</given-names></name>, <name><surname>Jansen</surname><given-names>R</given-names></name>, <name><surname>Willemsen</surname><given-names>G</given-names></name>, <name><surname>Penninx</surname><given-names>B</given-names></name>, <name><surname>Bain</surname><given-names>LM</given-names></name>, <name><surname>Vicente</surname><given-names>CT</given-names></name>, <etal>et al</etal>. <article-title>Gene-Based Analysis of Regulatory Variants Identifies Four Putative Novel Asthma Risk Genes Related to Nucleotide Synthesis and Signaling</article-title>. <source>The Journal of allergy and clinical immunology</source>. <year>2017</year>;<volume>139</volume>(<issue>4</issue>):<fpage>1148</fpage>–<lpage>1157</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2016.07.017</pub-id><?supplied-pmid 27554816?><pub-id pub-id-type="pmid">27554816</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref099">
      <label>99</label>
      <mixed-citation publication-type="journal"><name><surname>Hedl</surname><given-names>M</given-names></name>, <name><surname>Zheng</surname><given-names>S</given-names></name>, <name><surname>Abraham</surname><given-names>C</given-names></name>. <article-title>The IL18RAP Region Disease Polymorphism Decreases IL-18RAP/IL-18R1/IL-1R1 Expression and Signaling through Innate Receptor–Initiated Pathways</article-title>. <source>The Journal of Immunology</source>. <year>2014</year>;<volume>192</volume>(<issue>12</issue>):<fpage>5924</fpage>–<lpage>5932</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.1302727</pub-id><?supplied-pmid 24842757?><pub-id pub-id-type="pmid">24842757</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref100">
      <label>100</label>
      <mixed-citation publication-type="journal"><name><surname>Hirota</surname><given-names>T</given-names></name>, <name><surname>Takahashi</surname><given-names>A</given-names></name>, <name><surname>Kubo</surname><given-names>M</given-names></name>, <name><surname>Tsunoda</surname><given-names>T</given-names></name>, <name><surname>Tomita</surname><given-names>K</given-names></name>, <name><surname>Sakashita</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Genome-Wide Association Study Identifies Eight New Susceptibility Loci for Atopic Dermatitis in the Japanese Population</article-title>. <source>Nature genetics</source>. <year>2012</year>;<volume>44</volume>(<issue>11</issue>):<fpage>1222</fpage>–<lpage>1226</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ng.2438</pub-id><?supplied-pmid 23042114?><pub-id pub-id-type="pmid">23042114</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref101">
      <label>101</label>
      <mixed-citation publication-type="journal"><name><surname>Smyth</surname><given-names>DJ</given-names></name>, <name><surname>Plagnol</surname><given-names>V</given-names></name>, <name><surname>Walker</surname><given-names>NM</given-names></name>, <name><surname>Cooper</surname><given-names>JD</given-names></name>, <name><surname>Downes</surname><given-names>K</given-names></name>, <name><surname>Yang</surname><given-names>JHM</given-names></name>, <etal>et al</etal>. <article-title>Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease</article-title>. <source>The New England Journal of Medicine</source>. <year>2008</year>;<volume>359</volume>(<issue>26</issue>):<fpage>2767</fpage>–<lpage>2777</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa0807917</pub-id><?supplied-pmid 19073967?><pub-id pub-id-type="pmid">19073967</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref102">
      <label>102</label>
      <mixed-citation publication-type="journal"><name><surname>Shrine</surname><given-names>N</given-names></name>, <name><surname>Portelli</surname><given-names>MA</given-names></name>, <name><surname>John</surname><given-names>C</given-names></name>, <name><surname>Artigas</surname><given-names>MS</given-names></name>, <name><surname>Bennett</surname><given-names>N</given-names></name>, <name><surname>Hall</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Moderate-to-Severe Asthma in Individuals of European Ancestry: A Genome-Wide Association Study</article-title>. <source>The Lancet Respiratory Medicine</source>. <year>2019</year>;<volume>7</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2213-2600(18)30389-8</pub-id><?supplied-pmid 30552067?><pub-id pub-id-type="pmid">30552067</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref103">
      <label>103</label>
      <mixed-citation publication-type="journal"><name><surname>Javierre</surname><given-names>BM</given-names></name>, <name><surname>Burren</surname><given-names>OS</given-names></name>, <name><surname>Wilder</surname><given-names>SP</given-names></name>, <name><surname>Kreuzhuber</surname><given-names>R</given-names></name>, <name><surname>Hill</surname><given-names>SM</given-names></name>, <name><surname>Sewitz</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Lineage-Specific Genome Architecture Links Enhancers and Non-Coding Disease Variants to Target Gene Promoters</article-title>. <source>Cell</source>. <year>2016</year>;<volume>167</volume>(<issue>5</issue>):<fpage>1369</fpage>–<lpage>1384.e19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.037</pub-id><?supplied-pmid 27863249?><pub-id pub-id-type="pmid">27863249</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref104">
      <label>104</label>
      <mixed-citation publication-type="journal"><name><surname>Zeller</surname><given-names>T</given-names></name>, <name><surname>Wild</surname><given-names>P</given-names></name>, <name><surname>Szymczak</surname><given-names>S</given-names></name>, <name><surname>Rotival</surname><given-names>M</given-names></name>, <name><surname>Schillert</surname><given-names>A</given-names></name>, <name><surname>Castagne</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Genetics and Beyond—The Transcriptome of Human Monocytes and Disease Susceptibility</article-title>. <source>PLOS ONE</source>. <year>2010</year>;<volume>5</volume>(<issue>5</issue>):<fpage>e10693</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0010693</pub-id><?supplied-pmid 20502693?><pub-id pub-id-type="pmid">20502693</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref105">
      <label>105</label>
      <mixed-citation publication-type="journal"><name><surname>Vibhuti</surname><given-names>A</given-names></name>, <name><surname>Gupta</surname><given-names>K</given-names></name>, <name><surname>Subramanian</surname><given-names>H</given-names></name>, <name><surname>Guo</surname><given-names>Q</given-names></name>, <name><surname>Ali</surname><given-names>H</given-names></name>. <article-title>Distinct and Shared Roles of <italic toggle="yes">β</italic>-Arrestin-1 and <italic toggle="yes">β</italic>-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells</article-title>. <source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0019585</pub-id><?supplied-pmid 21589858?><pub-id pub-id-type="pmid">21589858</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref106">
      <label>106</label>
      <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>MJ</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Zou</surname><given-names>J</given-names></name>. <article-title>Fast and Covariate-Adaptive Method Amplifies Detection Power in Large-Scale Multiple Hypothesis Testing</article-title>. <source>Nature Communications</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3433</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-019-11247-0</pub-id><?supplied-pmid 31366926?><pub-id pub-id-type="pmid">31366926</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref107">
      <label>107</label>
      <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Powles</surname><given-names>RL</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>He</surname><given-names>BJ</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>. <article-title>Integrative Tissue-Specific Functional Annotations in the Human Genome Provide Novel Insights on Many Complex Traits and Improve Signal Prioritization in Genome Wide Association Studies</article-title>. <source>PLoS genetics</source>. <year>2016</year>;<volume>12</volume>(<issue>4</issue>):<fpage>e1005947</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1005947</pub-id><?supplied-pmid 27058395?><pub-id pub-id-type="pmid">27058395</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref108">
      <label>108</label>
      <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Powles</surname><given-names>RL</given-names></name>, <name><surname>Abdallah</surname><given-names>S</given-names></name>, <name><surname>Ou</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Systematic Tissue-Specific Functional Annotation of the Human Genome Highlights Immune-Related DNA Elements for Late-Onset Alzheimer’s Disease</article-title>. <source>PLOS Genetics</source>. <year>2017</year>;<volume>13</volume>(<issue>7</issue>):<fpage>e1006933</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1006933</pub-id><?supplied-pmid 28742084?><pub-id pub-id-type="pmid">28742084</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref109">
      <label>109</label>
      <mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Yekutieli</surname><given-names>D</given-names></name>. <article-title>The Control of the False Discovery Rate in Multiple Testing under Dependency</article-title>. <source>The Annals of Statistics</source>. <year>2001</year>;<volume>29</volume>(<issue>4</issue>):<fpage>1165</fpage>–<lpage>1188</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1214/aos/1013699998</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref110">
      <label>110</label>
      <mixed-citation publication-type="journal"><name><surname>Thaventhiran</surname><given-names>JED</given-names></name>, <name><surname>Lango Allen</surname><given-names>H</given-names></name>, <name><surname>Burren</surname><given-names>OS</given-names></name>, <name><surname>Rae</surname><given-names>W</given-names></name>, <name><surname>Greene</surname><given-names>D</given-names></name>, <name><surname>Staples</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Whole-Genome Sequencing of a Sporadic Primary Immunodeficiency Cohort</article-title>. <source>Nature</source>. <year>2020</year>;<volume>583</volume>(<issue>7814</issue>):<fpage>90</fpage>–<lpage>95</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41586-020-2265-1</pub-id><?supplied-pmid 32499645?><pub-id pub-id-type="pmid">32499645</pub-id></mixed-citation>
    </ref>
    <ref id="pgen.1009853.ref111">
      <label>111</label>
      <mixed-citation publication-type="journal"><name><surname>Iotchkova</surname><given-names>V</given-names></name>, <name><surname>Ritchie</surname><given-names>GRS</given-names></name>, <name><surname>Geihs</surname><given-names>M</given-names></name>, <name><surname>Morganella</surname><given-names>S</given-names></name>, <name><surname>Min</surname><given-names>JL</given-names></name>, <name><surname>Walter</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>GARFIELD Classifies Disease-Relevant Genomic Features through Integration of Functional Annotations with Association Signals</article-title>. <source>Nature genetics</source>. <year>2019</year>;<volume>51</volume>(<issue>2</issue>):<fpage>343</fpage>–<lpage>353</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41588-018-0322-6</pub-id><?supplied-pmid 30692680?><pub-id pub-id-type="pmid">30692680</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article article-type="author-comment" id="pgen.1009853.r001" specific-use="rebutted-decision-letter-unavailable">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r001</article-id>
    <title-group>
      <article-title>Author response to previous submission</article-title>
    </title-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">1 Jul 2021</named-content>
    </p>
    <supplementary-material id="pgen.1009853.s021" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">review-response.pdf</named-content></p>
      </caption>
      <media xlink:href="pgen.1009853.s021.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pgen.1009853.r002" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r002</article-id>
    <title-group>
      <article-title>Decision Letter 0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Balding</surname>
          <given-names>David</given-names>
        </name>
        <role>Section Editor: Methods</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Balding, Yang</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Balding, Yang</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj002" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">5 Sep 2021</named-content>
    </p>
    <p>Dear Dr Hutchinson,</p>
    <p>Thank you very much for submitting your Research Article entitled 'Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR' to PLOS Genetics.</p>
    <p>The manuscript was evaluated at the editorial level and by independent peer reviewers. Two reviewers have made comments and raised concerns and that we would like you to address in a revised version. Technically the issues raised are substantial enough that we have made a "major revision" decision, but we believe that you should be able to respond to them without great difficulty.</p>
    <p>Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.</p>
    <p>If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to <email>plosgenetics@plos.org</email>.</p>
    <p>If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist" ext-link-type="uri">Submission Checklist</ext-link>.</p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
    <p>Please be aware that our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link> requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.</p>
    <p>While revising your submission, please upload your figure files to the <ext-link xlink:href="http://pace.apexcovantage.com/" ext-link-type="uri">Preflight Analysis and Conversion Engine</ext-link> (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
    <p>PLOS has incorporated <ext-link xlink:href="http://www.crossref.org/crosscheck.html" ext-link-type="uri">Similarity Check</ext-link>, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.</p>
    <p>To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.</p>
    <p>[LINK]</p>
    <p>We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.</p>
    <p>Yours sincerely,</p>
    <p>Jingjing Yang, Ph.D.</p>
    <p>Guest Editor</p>
    <p>PLOS Genetics</p>
    <p>David Balding</p>
    <p>Section Editor: Methods</p>
    <p>PLOS Genetics</p>
    <p>Reviewer's Responses to Questions</p>
    <p>Reviewer #1: The authors have done a good job of addressing comments from the previous round of reviews.</p>
    <p>Reviewer #2: The manuscript, "Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR", describes an FDR approach for GWAS in the presence of secondary data-sets such as GWAS summary statistics of related traits or variant-level annotation scores. The methods is based on a widely accepted concept, the conditional false discovery rate (cFDR). It overcomes a major limition of previous work that the secondary data-set must follow a mixture Gaussian distribution, thus enabling the application of the proposed approach to integrating a variety of secondary data-sets for GWAS on a complex trait, in particular functional genomic features. The data application is thorough, with examples from large GWAS (UK Biobank) integrating predicted variant function scores (GenoCanyon) and epigenomic features (H3K27ac marks).</p>
    <p>Overall I find the manuscript well-written. The method, albeit a seemingly straightforward extension to a recent work by the same research group, is a timely and highly useful contribution to the current "multi-omics" study theme for many complex trait studies. It could be a good addition to the omics data integration toolbox. However, I think the manuscript can benefit a lot with improved Methods section, to emphasize the novelty and contrast more with the published empirical cFDR method. Specifically,</p>
    <p>1. In Introduction I suggest adding some narrative to motivate the method with biological applications. Current manuscript simply mentions in passing that the approach can integration functional genomic data. Even for GWAS data integration, would the new method help to integrate Bayes Factors without having to convert them to z-scores? A list of concrete example along with a few citations of existing approaches to integrate such data with GWAS will help the readers appreciate the contribution of the new method.</p>
    <p>2. In Methods, please explicitly summarize key differences between Flexible cFDR and empirical cFDR, and why this is relevant to the proposed application -- it helps to simply listing examples of functional annotation scores that are obviously not a mixture of Gaussian. Also please explain what it is meant by "sparse data" and how exactly it may impact the cFDR approach because I can think of versions of Gaussian mixture that handles sparse data; unless I'm wrong about what sparse data means in this context.</p>
    <p>3. One improvement is the use of a flexible threshold rather than a hard threshold of 1/2 when computing cFDR. I can think of a specific version of cFDR without using such a threshold as described in the manuscript, but still uses mixture Gaussian for the auxiliary data. Is that preferable for when the secondary data is also GWAS results, or the new flexible cFDR should replace the empirical cFDR approach for all applications?</p>
    <p>4. A concern on line 169 is that it uses a Gaussian kernel. While this is a common KDE choice, is it good enough for arbitrary distribution of secondary data (which can be a positive score, a probability, a binary variable or on phred scale)? Please justify.</p>
    <p>Also some additional high level comments:</p>
    <p>1. Alternative to cFDR, various multivariate analysis approaches (eg bi-variate GWAS) and data integration methods (eg fGWAS or those based on stratified LDSC) can perform data integration. These are completely different, but possibly more popular alternatives, to cFDR. Please discuss cFDR in the context of these methods.</p>
    <p>2. Related to comment above, one limitation of cFDR is that it seems to allow for one auxiliary data-set at a time. Please comment on applications where multiple functional annotations need to be integrated. The application of H3K27ac data integration seems to simply average over different tissues and cell types?</p>
    <p>Minor points on the methods:</p>
    <p>1. Please briefly recap the definition of boundary effect in KDE.</p>
    <p>2. Line 214 please refer to eqn. (9) to clarify how it works.</p>
    <p>Reviewer #3: The authors have proposed a new method, flexible cFDR, that generalizes the conditional FDR approach to incorporate auxiliary data information in GWAS of a trait. Usually the auxiliary data incorporated in existing method include p-values from a related trait. Here the authors have leveraged auxiliary data from arbitrary distributions such as functional genomic data. They have done extensive simulation analysis and benchmarking. They also performed two real data analyses with validation to illustrate properties of their approach against existing ones. In my opinion, the authors have done a good job of addressing previous reviewer comments. I have no additional comments; just the 3 very minor comments below.</p>
    <p>*Minor Comments*</p>
    <p>1. If possible, provide links from which GenoCanyon scores and ChIP-seq counts were downloaded.</p>
    <p>2. Suggest that scientific notation be used instead of E-notation for small numbers like p-values.</p>
    <p>3. Currently, the article is a tad lengthy. Perhaps the authors can move some details in the Methods and the Results sections to the supplementary.</p>
    <p>**********</p>
    <p>
      <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
    </p>
    <p>Large-scale datasets should be made available via a public repository as described in the <italic toggle="yes">PLOS Genetics</italic>
<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: Yes</p>
    <p>Reviewer #3: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: No</p>
    <p>Reviewer #3: No</p>
  </body>
</sub-article>
<sub-article article-type="author-comment" id="pgen.1009853.r003">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r003</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 0</article-title>
    </title-group>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj003" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">13 Sep 2021</named-content>
    </p>
    <supplementary-material id="pgen.1009853.s022" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">review-response.pdf</named-content></p>
      </caption>
      <media xlink:href="pgen.1009853.s022.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pgen.1009853.r004" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r004</article-id>
    <title-group>
      <article-title>Decision Letter 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Balding</surname>
          <given-names>David</given-names>
        </name>
        <role>Section Editor: Methods</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Balding, Yang</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Balding, Yang</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj004" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">24 Sep 2021</named-content>
    </p>
    <p>Dear Dr Hutchinson,</p>
    <p>Thank you very much for submitting your Research Article entitled 'Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR' to PLOS Genetics.</p>
    <p>Both reviewers are satisfied with your submitted revision, except for one minor comment from Reviewer 2. Please submit a revised version addressing the issue of any effect of the order of incorporating multiple auxiliary data. While we expect only a minor revision to the manuscript, we require some form of evidence of no effect or some measure of  size and implications of any effect.</p>
    <p>In addition we ask that you:</p>
    <p>1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.</p>
    <p>2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our <ext-link xlink:href="https://journals.plos.org/plosgenetics/volume" ext-link-type="uri">archive</ext-link>. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.</p>
    <p>We hope to receive your revised manuscript within the next 15 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to <email>plosgenetics@plos.org</email>.</p>
    <p>If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist" ext-link-type="uri">Submission Checklist</ext-link>.</p>
    <p>While revising your submission, please upload your figure files to the <ext-link xlink:href="http://pace.apexcovantage.com/" ext-link-type="uri">Preflight Analysis and Conversion Engine</ext-link> (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p>
    <p>Please be aware that our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link> requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.</p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
    <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
    <p>PLOS has incorporated <ext-link xlink:href="http://www.crossref.org/crosscheck.html" ext-link-type="uri">Similarity Check</ext-link>, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.</p>
    <p>To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.</p>
    <p>[LINK]</p>
    <p>Please let us know if you have any questions while making these revisions.</p>
    <p>Yours sincerely,</p>
    <p>Jingjing Yang, Ph.D.</p>
    <p>Guest Editor</p>
    <p>PLOS Genetics</p>
    <p>David Balding</p>
    <p>Section Editor: Methods</p>
    <p>PLOS Genetics</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>Reviewer #2: The authors have satisfactorily addressed and clarified my previous concerns. My only remaining question on the method relates to the iterative approach to incorporate multiple auxiliary data. Different from a formal multivariate analysis, the order of data-sets entering the iterative approach seem to matter. If that is the case, is the result sensitive to the order of input? I suggest the authors show with theoretical or empirical results that this is not a concern, or acknowledge it as a short-coming for multiple auxiliary data.</p>
    <p>Reviewer #3: I had only minor comments in the previous review, which the authors have addressed. I have no more comment to add.</p>
    <p>**********</p>
    <p>
      <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
    </p>
    <p>Large-scale datasets should be made available via a public repository as described in the <italic toggle="yes">PLOS Genetics</italic>
<ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
    <p>Reviewer #2: Yes</p>
    <p>Reviewer #3: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #2: No</p>
    <p>Reviewer #3: No</p>
  </body>
</sub-article>
<sub-article article-type="author-comment" id="pgen.1009853.r005">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r005</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 1</article-title>
    </title-group>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj005" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>2</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">29 Sep 2021</named-content>
    </p>
    <supplementary-material id="pgen.1009853.s023" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">Responses to comments.pdf</named-content></p>
      </caption>
      <media xlink:href="pgen.1009853.s023.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="pgen.1009853.r006" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r006</article-id>
    <title-group>
      <article-title>Decision Letter 2</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Balding</surname>
          <given-names>David</given-names>
        </name>
        <role>Section Editor: Methods</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Balding, Yang</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Balding, Yang</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj006" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>2</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">30 Sep 2021</named-content>
    </p>
    <p>Dear Dr Hutchinson,</p>
    <p>We are pleased to inform you that your manuscript entitled "Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR" has been editorially accepted for publication in PLOS Genetics. Congratulations!</p>
    <p>Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.</p>
    <p>Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <email>plosgenetics@plos.org</email>.</p>
    <p>In the meantime, please log into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pgenetics/" ext-link-type="uri">https://www.editorialmanager.com/pgenetics/</ext-link>, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.</p>
    <p>If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.</p>
    <p>Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!</p>
    <p>Yours sincerely,</p>
    <p>Jingjing Yang, Ph.D.</p>
    <p>Guest Editor</p>
    <p>PLOS Genetics</p>
    <p>David Balding</p>
    <p>Section Editor: Methods</p>
    <p>PLOS Genetics</p>
    <p>
      <ext-link xlink:href="http://www.plosgenetics.org" ext-link-type="uri">www.plosgenetics.org</ext-link>
    </p>
    <p>Twitter: @PLOSGenetics</p>
    <p>----------------------------------------------------</p>
    <p>
      <bold>Data Deposition</bold>
    </p>
    <p>If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the <ext-link xlink:href="http://www.datadryad.org/" ext-link-type="uri">Dryad Digital Repository</ext-link>. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability#loc-recommended-repositories" ext-link-type="uri">website</ext-link>.</p>
    <p>The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: </p>
    <p>
      <ext-link xlink:href="http://datadryad.org/submit?journalID=pgenetics&amp;manu=PGENETICS-D-21-00900R2" ext-link-type="uri">http://datadryad.org/submit?journalID=pgenetics&amp;manu=PGENETICS-D-21-00900R2</ext-link>
    </p>
    <p>More information about depositing data in Dryad is available at <ext-link xlink:href="http://www.datadryad.org/depositing" ext-link-type="uri">http://www.datadryad.org/depositing</ext-link>. If you experience any difficulties in submitting your data, please contact <email>help@datadryad.org</email> for support.</p>
    <p>Additionally, please be aware that our <ext-link xlink:href="http://journals.plos.org/plosgenetics/s/data-availability" ext-link-type="uri">data availability policy</ext-link> requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.</p>
    <p>----------------------------------------------------</p>
    <p>
      <bold>Press Queries</bold>
    </p>
    <p>If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via <email>plosgenetics@plos.org</email>.</p>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="pgen.1009853.r007" specific-use="acceptance-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pgen.1009853.r007</article-id>
    <title-group>
      <article-title>Acceptance letter</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Balding</surname>
          <given-names>David</given-names>
        </name>
        <role>Section Editor: Methods</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <role>Guest Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 Balding, Yang</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Balding, Yang</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pgen.1009853" id="rel-obj007" related-article-type="reviewed-article"/>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">15 Oct 2021</named-content>
    </p>
    <p>PGENETICS-D-21-00900R2 </p>
    <p>Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR </p>
    <p>Dear Dr Hutchinson, </p>
    <p>We are pleased to inform you that your manuscript entitled "Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
    <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
    <p>Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
    <p>Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! </p>
    <p>With kind regards,</p>
    <p>Anita Estes</p>
    <p>PLOS Genetics</p>
    <p>On behalf of:</p>
    <p>The PLOS Genetics Team</p>
    <p>Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom</p>
    <p><email>plosgenetics@plos.org</email> | +44 (0) 1223-442823</p>
    <p><ext-link xlink:href="http://plosgenetics.org" ext-link-type="uri">plosgenetics.org</ext-link> | Twitter: @PLOSGenetics</p>
  </body>
</sub-article>
